CLOSE ×

    Aging

    Jiang R, Gao J, Shen J, Zhu X, Wang H, Feng S, Huang C, Shen H, Liu H., Glycyrrhizic Acid Improves Cognitive Levels of Aging Mice by Regulating T/B Cell Proliferation, Front Aging Neurosci. 2020 Oct 7;12:570116. doi: 10.3389/fnagi.2020.570116. eCollection 2020.
    Thunhorst, R. L., Beltz, T., & Johnson, A. K. (2014)., Age-related declines in thirst and salt appetite responses in male fischer 344xBrown norway rats., Physiology & Behavior, 135, 180-188. doi:10.1016/j.physbeh.2014.06.010 [doi]
    Ding, Q., Ash, C., Mracek, T., Merry, B., & Bing, C. (2012)., Caloric restriction increases adiponectin expression by adipose tissue and prevents the inhibitory effect of insulin on circulating adiponectin in rats., The Journal of Nutritional Biochemistry, 23(8), 867-874. doi:10.1016/j.jnutbio.2011.04.011 [doi]
    Barsony, J., Manigrasso, M. B., Xu, Q., Tam, H., & Verbalis, J. G. (2013)., Chronic hyponatremia exacerbates multiple manifestations of senescence in male rats., Age (Dordrecht, Netherlands), 35(2), 271-288. doi:10.1007/s11357-011-9347-9 [doi]
    Wu, L. W., Wang, Y. L., Christensen, J. M., Khalifian, S., Schneeberger, S., Raimondi, G., . . . Brandacher, G. (2014)., Donor age negatively affects the immunoregulatory properties of both adipose and bone marrow derived mesenchymal stem cells., Transplant Immunology, 30(4), 122-127. doi:10.1016/j.trim.2014.03.001 [doi]
    LaCroix, A. S., Duenwald-Kuehl, S. E., Brickson, S., Akins, T. L., Diffee, G., Aiken, J., . . . Lakes, R. S. (2013)., Effect of age and exercise on the viscoelastic properties of rat tail tendon., Annals of Biomedical Engineering, 41(6), 1120-1128. doi:10.1007/s10439-013-0796-4 [doi]
    Zhang, C., & Gao, Y. (2014)., Effects of aging on the lateral transmission of force in rat skeletal muscle., Journal of Biomechanics, 47(5), 944-948. doi:10.1016/j.jbiomech.2014.01.026 [doi]
    Morgan, D., Mitzelfelt, J. D., Koerper, L. M., & Carter, C. S. (2012)., Effects of morphine on thermal sensitivity in adult and aged rats., The Journals of Gerontology.Series A, Biological Sciences and Medical Sciences, 67(7), 705-713. doi:10.1093/gerona/glr210 [doi]
    Sittig, L. J., Herzing, L. B., Xie, H., Batra, K. K., Shukla, P. K., & Redei, E. E. (2012)., Excess folate during adolescence suppresses thyroid function with permanent deficits in motivation and spatial memory., Genes, Brain, and Behavior, 11(2), 193-200. doi:10.1111/j.1601-183X.2011.00749.x [doi]
    Kang, C., Chung, E., Diffee, G., & Ji, L. L. (2013)., Exercise training attenuates aging-associated mitochondrial dysfunction in rat skeletal muscle: Role of PGC-1alpha., Experimental Gerontology, 48(11), 1343-1350. doi:10.1016/j.exger.2013.08.004 [doi]
    Wright, K. J., Thomas, M. M., Betik, A. C., Belke, D., & Hepple, R. T. (2014)., Exercise training initiated in late middle age attenuates cardiac fibrosis and advanced glycation end-product accumulation in senescent rats., Experimental Gerontology, 50, 9-18. doi:10.1016/j.exger.2013.11.006 [doi]
    VanGuilder Starkey, H. D., Bixler, G. V., Sonntag, W. E., & Freeman, W. M. (2013)., Expression of NgR1-antagonizing proteins decreases with aging and cognitive decline in rat hippocampus., Cellular and Molecular Neurobiology, 33(4), 483-488. doi:10.1007/s10571-013-9929-4 [doi]
    Mattson, D. L., Kunert, M. P., Kaldunski, M. L., Greene, A. S., Roman, R. J., Jacob, H. J., & Cowley, A. W.,Jr. (2004)., Influence of diet and genetics on hypertension and renal disease in dahl salt-sensitive rats., Physiological Genomics, 16(2), 194-203. doi:10.1152/physiolgenomics.00151.2003 [doi]
    Selvaratnam, J., Paul, C., & Robaire, B. (2015)., Male rat germ cells display age-dependent and cell-specific susceptibility in response to oxidative stress challenges., Biology of Reproduction, doi:biolreprod.115.131318 [pii]
    Nieves-Martinez, E., Haynes, K., Childers, S. R., Sonntag, W. E., & Nicolle, M. M. (2012)., Muscarinic receptor/G-protein coupling is reduced in the dorsomedial striatum of cognitively impaired aged rats., Behavioural Brain Research, 227(1), 258-264. doi:10.1016/j.bbr.2011.10.048 [doi]
    Durbin, S. M., Jackson, J. R., Ryan, M. J., Gigliotti, J. C., Alway, S. E., & Tou, J. C. (2014)., Resveratrol supplementation preserves long bone mass, microstructure, and strength in hindlimb-suspended old male rats., Journal of Bone and Mineral Metabolism, 32(1), 38-47. doi:10.1007/s00774-013-0469-2 [doi]
    McQuail, J. A., & Nicolle, M. M. (2015)., Spatial reference memory in normal aging fischer 344 x brown norway F1 hybrid rats., Neurobiology of Aging, 36(1), 323-333. doi:10.1016/j.neurobiolaging.2014.06.030 [doi]
    MacPhail, R. C., Farmer, J. D., & Jarema, K. A. (2012)., Toluene effects on the motor activity of adolescent, young-adult, middle-age and senescent male brown norway rats., Neurotoxicology, 33(1), 111-118. doi:10.1016/j.neuro.2011.12.006 [doi]
    Beccari, S., Valero, J., Maletic-Savatic, M., & Sierra, A. (2017)., A simulation model of neuroprogenitor proliferation dynamics predicts age-related loss of hippocampal neurogenesis but not astrogenesis., Scientific Reports, 7(1), 16528-017-16466-3. doi:10.1038/s41598-017-16466-3 [doi]
    Bauernfeind, F., Niepmann, S., Knolle, P. A., & Hornung, V. (2016)., Aging-associated TNF production primes inflammasome activation and NLRP3-related metabolic disturbances., Journal of Immunology (Baltimore, Md.: 1950), 197(7), 2900-2908. doi:10.4049/jimmunol.1501336 [doi]
    Panagiotou, M., Vyazovskiy, V. V., Meijer, J. H., & Deboer, T. (2017)., Differences in electroencephalographic non-rapid-eye movement sleep slow-wave characteristics between young and old mice, Scientific Reports, 7, 43656. doi:10.1038/srep43656 [doi]
    Wolf, G., Lotan, A., Lifschytz, T., Ben-Ari, H., Kreisel Merzel, T., Tatarskyy, P., . . . Lerer, B. (2017)., Differentially severe cognitive effects of compromised cerebral blood flow in aged mice: Association with myelin degradation and microglia activation., Frontiers in Aging Neuroscience, 9, 191. doi:10.3389/fnagi.2017.00191 [doi]
    Panagiotou, M., Papagiannopoulos, K., Rohling, J. H. T., Meijer, J. H., & Deboer, T. (2018)., How old is your brain? slow-wave activity in non-rapid-eye-movement sleep as a marker of brain rejuvenation after long-term exercise in mice., Frontiers in Aging Neuroscience, 10, 233. doi:10.3389/fnagi.2018.00233 [doi]
    Nitzan, Keren; Benhamron, Sandrine; Valitsky, Michael; Kesner, Eyal E; Lichtenstein, Michal; Ben-Zvi, Ayal; Ella, Ezra; Segalstein, Yehudit; Saada, Ann; Lorberboum-Galski, Haya; Rosenmann, Hanna;, Mitochondrial Transfer Ameliorates Cognitive Deficits, Neuronal Loss, and Gliosis in Alzheimers Disease Mice, Journal of Alzheimer's disease : JAD Vol.72, 2019
    Davis, H. M., Aref, M. W., Aguilar-Perez, A., Pacheco-Costa, R., Allen, K., Valdez, S., . . . Plotkin, L. I. (2018)., x43 overexpression in osteocytes prevents osteocyte apoptosis and preserves cortical bone quality in aging mice., JBMR Plus, 2(4), 206-216. doi:10.1002/jbm4.10035 [doi]
    Kubik, L. L., Landis, R. W., Remmer, H., Bergin, I. L., & Philbert, M. A. (2015)., 1,3-dinitrobenzene induces age- and region-specific oxidation to mitochondria-related proteins in brain., Toxicological Sciences : An Official Journal of the Society of Toxicology, 145(1), 48-58. doi:10.1093/toxsci/kfv015 [doi]
    Shahaduzzaman, M., Golden, J. E., Green, S., Gronda, A. E., Adrien, E., Ahmed, A., . . . Willing, A. E. (2013), A single administration of human umbilical cord blood T cells produces long-lasting effects in the aging hippocampus, Age (Dordrecht, Netherlands), 35(6), 2071-2087. doi:10.1007/s11357-012-9496-5 [doi]
    Pabon, M. M., Jernberg, J. N., Morganti, J., Contreras, J., Hudson, C. E., Klein, R. L., & Bickford, P. C. (2012), A spirulina-enhanced diet provides neuroprotection in an alpha-synuclein model of parkinson's disease., . PloS One, 7(9), e45256. doi:10.1371/journal.pone.0045256 [doi]
    Kerner, J., Yohannes, E., Lee, K., Virmani, A., Koverech, A., Cavazza, C., . . . Hoppel, C. (2015)., Acetyl-L-carnitine increases mitochondrial protein acetylation in the aged rat heart., Mechanisms of Ageing and Development, 145, 39-50. doi:10.1016/j.mad.2015.01.003 [doi]
    Sindler, A. L., Reyes, R., Chen, B., Ghosh, P., Gurovich, A. N., Kang, L. S., . . . Muller-Delp, J. M. (2013)., Age and exercise training alter signaling through reactive oxygen species in the endothelium of skeletal muscle arterioles, Journal of Applied Physiology (Bethesda, Md.: 1985), 114(5), 681-693. doi:10.1152/japplphysiol.00341.2012 [doi]
    Arimoto, J. M., Wong, A., Rozovsky, I., Lin, S. W., Morgan, T. E., & Finch, C. E. (2013)., Age increase of estrogen receptor-alpha (ERalpha) in cortical astrocytes impairs neurotrophic support in male and female rats, Endocrinology, 154(6), 2101-2113. doi:10.1210/en.2012-2046 [doi]
    Gu, X., Neric, N. J., Crabb, J. S., Crabb, J. W., Bhattacharya, S. K., Rayborn, M. E., . . . Bonilha, V. L. (2012)., Age-related changes in the retinal pigment epithelium (RPE)., PloS One, 7(6), e38673. doi:10.1371/journal.pone.0038673 [doi]
    Marrone, D. F., Satvat, E., & Patel, A. (2018)., Age-related deficits in recognition memory are protocol-dependent., Aging and Disease, 9(5), 798-807. doi:10.14336/AD.2017.1223 [doi]
    Bielefeld, E. C., Coling, D., Chen, G. D., Li, M., Tanaka, C., Hu, B. H., & Henderson, D. (2008)., Age-related hearing loss in the fischer 344/NHsd rat substrain., Hearing Research, 241(1-2), 26-33. doi:10.1016/j.heares.2008.04.006 [doi]
    Bielefeld, E. C. (2013)., Age-related hearing loss patterns in fischer 344/NHsd rats with cisplatin-induced hearing loss., Hearing Research, 306, 46-53. doi:10.1016/j.heares.2013.09.003 [doi]
    Galeffi, F., Shetty, P. K., Sadgrove, M. P., & Turner, D. A. (2015)., Age-related metabolic fatigue during low glucose conditions in rat hippocampus., Neurobiology of Aging, 36(2), 982-992. doi:10.1016/j.neurobiolaging.2014.09.016 [doi]
    Prisby, R. D., Dominguez, J. M.,2nd, Muller-Delp, J., Allen, M. R., & Delp, M. D. (2012), Aging and estrogen status: A possible endothelium-dependent vascular coupling mechanism in bone remodeling, PloS One, 7(11), e48564. doi:10.1371/journal.pone.0048564 [doi]
    Solinas, P., Fujioka, H., Radivoyevitch, T., Tandler, B., & Hoppel, C. L. (2014), Aging effects on oxidative phosphorylation in rat adrenocortical mitochondria, Mechanisms of Ageing and Development, 138, 10-14. doi:10.1016/j.mad.2014.01.009 [doi]
    Birder, Lori A; Wolf-Johnston, Amanda S; Jackson, Edwin K; Wein, Alan J; Dmochowski, Roger, Aging increases the expression of vasopressin receptors in both the kidney and urinary bladder., Neurourology and urodynamics Vol.38, 2019
    Jian, B., Yang, S., Chen, D., Zou, L., Chatham, J. C., Chaudry, I., & Raju, R. (2011)., Aging influences cardiac mitochondrial gene expression and cardiovascular function following hemorrhage injury, Molecular Medicine (Cambridge, Mass.), 17(5-6), 542-549. doi:10.2119/molmed.2010.00195 [doi]
    He, L., Yadgarov, A., Sharif, S., & McCluskey, L. P. (2012)., Aging profoundly delays functional recovery from gustatory nerve injury., Neuroscience, 209, 208-218. doi:10.1016/j.neuroscience.2012.02.012 [doi]
    Gao, X. H., Qanungo, S., Pai, H. V., Starke, D. W., Steller, K. M., Fujioka, H., . . . Mieyal, J. J. (2013)., Aging-dependent changes in rat heart mitochondrial glutaredoxins--implications for redox regulation., Redox Biology, 1, 586-598. doi:10.1016/j.redox.2013.10.010 [doi]
    Campbell, S. G., Haynes, P., Kelsey Snapp, W., Nava, K. E., & Campbell, K. S. (2013), Altered ventricular torsion and transmural patterns of myocyte relaxation precede heart failure in aging F344 rats., American Journal of Physiology.Heart and Circulatory Physiology, 305(5), H676-86. doi:10.1152/ajpheart.00797.2012 [doi]
    Tanaka, C., Bielefeld, E. C., Chen, G. D., Li, M., & Henderson, D. (2009)., Ameliorative effects of an augmented acoustic environment on age-related hearing loss in middle-aged fischer 344/NHsd rats, The Laryngoscope, 119(7), 1374-1379. doi:10.1002/lary.20244 [doi]
    Guidi, M., Kumar, A., Rani, A., & Foster, T. C. (2014), Assessing the emergence and reliability of cognitive decline over the life span in fisher 344 rats using the spatial water maze., Frontiers in Aging Neuroscience, 6, 2. doi:10.3389/fnagi.2014.00002 [doi]
    Akopian, G., Crawford, C., Petzinger, G., Jakowec, M. W., & Walsh, J. P. (2012), Brief mitochondrial inhibition causes lasting changes in motor behavior and corticostriatal synaptic physiology in the fischer 344 rat., . Neuroscience, 215, 149-159. doi:10.1016/j.neuroscience.2012.04.060 [doi]
    Sangaralingham, S. J., Wang, B. H., Huang, L., Kumfu, S., Ichiki, T., Krum, H., & Burnett, J. C.,Jr. (2016)., Cardiorenal fibrosis and dysfunction in aging: Imbalance in mediators and regulators of collagen., Peptides, 76, 108-114. doi:10.1016/j.peptides.2016.01.004 [doi]
    Das, A., Bortner, J. D.,Jr, Aliaga, C. A., Baker, A., Stanley, A., Stanley, B. A., . . . El-Bayoumy, K. (2013)., Changes in proteomic profiles in different prostate lobes of male rats throughout growth and development and aging stages of the life span., The Prostate, 73(4), 363-375. doi:10.1002/pros.22576 [doi]
    Perez, S. D., Kozic, B., Molinaro, C. A., Thyagarajan, S., Ghamsary, M., Lubahn, C. L., . . . Bellinger, D. L. (2012)., Chronically lowering sympathetic activity protects sympathetic nerves in spleens from aging F344 rats., Journal of Neuroimmunology, 247(1-2), 38-51. doi:10.1016/j.jneuroim.2012.03.022 [doi]
    Yimam, M., Burnett, B. P., Brownell, L., & Jia, Q. (2016)., Clinical and preclinical cognitive function improvement after oral treatment of a botanical composition composed of extracts from scutellaria baicalensis and acacia catechu, Behavioural Neurology, 2016, 7240802. doi:10.1155/2016/7240802 [doi]
    Hopp, S. C., Royer, S. E., D'Angelo, H. M., Kaercher, R. M., Fisher, D. A., & Wenk, G. L. (2015)., Differential neuroprotective and anti-inflammatory effects of L-type voltage dependent calcium channel and ryanodine receptor antagonists in the substantia nigra and locus coeruleus, Journal of Neuroimmune Pharmacology : The Official Journal of the Society on NeuroImmune Pharmacology, 10(1), 35-44. doi:10.1007/s11481-014-9568-7 [doi]
    Fuqua, J. L., Littrell, O. M., Lundblad, M., Turchan-Cholewo, J., Abdelmoti, L. G., Galperin, E., . . . Gerhardt, G. A. (2014), Dynamic changes in dopamine neuron function after DNSP-11 treatment: Effects in vivo and increased ERK 1/2 phosphorylation in vitro, Peptides, 54, 1-8. doi:10.1016/j.peptides.2013.12.007 [doi]
    Pancani, T., Anderson, K. L., Brewer, L. D., Kadish, I., DeMoll, C., Landfield, P. W., . . . Thibault, O. (2013)., Effect of high-fat diet on metabolic indices, cognition, and neuronal physiology in aging F344 rats., Neurobiology of Aging, 34(8), 1977-1987. doi:10.1016/j.neurobiolaging.2013.02.019 [doi]
    Tobey, Hope; Lucas, Tyler; Bledsoe, Douglas; Mykins, Michael; Campbell, Caroline; Berr, Stuart S; Sasser, Todd; Helm, Richard; Brolinson, Per Gunnar; Klein, Bradley G; Costa, Blaise M;, Effect of Osteopathic Cranial Manipulative Medicine on an Aged Rat Model of Alzheimer Disease., The Journal of the American Osteopathic Association Vol.13, 2019
    Thunhorst, R. L., Beltz, T. G., & Johnson, A. K. (2013)., Effects of aging on mineralocorticoid-induced salt appetite in rats., American Journal of Physiology.Regulatory, Integrative and Comparative Physiology, 305(12), R1498-505. doi:10.1152/ajpregu.00349.2013 [doi]
    Ma, D., Shuler, J. M., Raider, K. D., Rogers, R. S., Wheatley, J. L., Geiger, P. C., & Stanford, J. A. (2015), Effects of discontinuing a high-fat diet on mitochondrial proteins and 6-hydroxydopamine-induced dopamine depletion in rats., Brain Research, 1613, 49-58. doi:10.1016/j.brainres.2015.03.053 [doi]
    Moningka, N. C., Cunningham, M. W.,Jr, Sterling, M., West, C. A., Verlander, J. W., Croker, B. P., . . . Baylis, C. (2013)., Effects of voluntary wheel running on the kidney at baseline and after ischaemia-reperfusion-induced acute kidney injury: A strain difference comparison., null
    Speisman, R. B., Kumar, A., Rani, A., Pastoriza, J. M., Severance, J. E., Foster, T. C., & Ormerod, B. K. (2013)., Environmental enrichment restores neurogenesis and rapid acquisition in aged rats., Neurobiology of Aging, 34(1), 263-274. doi:10.1016/j.neurobiolaging.2012.05.023 [doi]
    Adzovic, L., Lynn, A. E., D'Angelo, H. M., Crockett, A. M., Kaercher, R. M., Royer, S. E., . . . Wenk, G. L. (2015)., Erratum to: Insulin improves memory and reduces chronic neuroinflammation in the hippocampus of young but not aged brains., Journal of Neuroinflammation, 12, 142-015-0321-9. doi:10.1186/s12974-015-0321-9 [doi]
    Tomicek, N. J., Miller-Lee, J. L., Hunter, J. C., & Korzick, D. H. (2013)., Estrogen receptor beta does not influence ischemic tolerance in the aged female rat heart, Cardiovascular Therapeutics, 31(1), 32-37. doi:10.1111/j.1755-5922.2011.00288.x [doi]
    Tanaka, C., Coling, D. E., Manohar, S., Chen, G. D., Hu, B. H., Salvi, R., & Henderson, D. (2012)., Expression pattern of oxidative stress and antioxidant defense-related genes in the aging fischer 344/NHsd rat cochlea., Neurobiology of Aging, 33(8), 1842.e1-1842.14. doi:10.1016/j.neurobiolaging.2011.12.027 [doi]
    Frutos, M. G., Pistell, P. J., Ingram, D. K., & Berthoud, H. R. (2012)., Feed efficiency, food choice, and food reward behaviors in young and old fischer rats., Neurobiology of Aging, 33(1), 206.e41-206.e53. doi:10.1016/j.neurobiolaging.2010.09.006 [doi]
    Nash, K. R., Moran, P., Finneran, D. J., Hudson, C., Robinson, J., Morgan, D., & Bickford, P. C. (2015)., Fractalkine over expression suppresses alpha-synuclein-mediated neurodegeneration. Molecular Therapy, The Journal of the American Society of Gene Therapy, 23(1), 17-23. doi:10.1038/mt.2014.175 [doi]
    McQuail, J. A., Banuelos, C., LaSarge, C. L., Nicolle, M. M., & Bizon, J. L. (2012), GABA(B) receptor GTP-binding is decreased in the prefrontal cortex but not the hippocampus of aged rats., Neurobiology of Aging, 33(6), 1124.e1-1124.12. doi:10.1016/j.neurobiolaging.2011.11.011 [doi]
    Gerstein, H., Lindstrom, M. J., & Burger, C. (2013)., Gene delivery of Homer1c rescues spatial learning in a rodent model of cognitive aging., Neurobiology of Aging, 34(8), 1963-1970. doi:10.1016/j.neurobiolaging.2013.02.006 [doi]
    Chaloner, A., & Greenwood-Van Meerveld, B. (2013)., Genetic diversity contributes to abnormalities in pain behaviors between young and old rats., Age (Dordrecht, Netherlands), 35(1), 1-10. doi:10.1007/s11357-011-9323-4 [doi]
    Chen, K. C., Blalock, E. M., Curran-Rauhut, M. A., Kadish, I., Blalock, S. J., Brewer, L., . . . Landfield, P. W. (2013), Glucocorticoid-dependent hippocampal transcriptome in male rats: Pathway-specific alterations with aging., Endocrinology, 154(8), 2807-2820. doi:10.1210/en.2013-1139 [doi]
    Porter, N. M., Bohannon, J. H., Curran-Rauhut, M., Buechel, H. M., Dowling, A. L., Brewer, L. D., . . . Blalock, E. M. (2012)., Hippocampal CA1 transcriptional profile of sleep deprivation: Relation to aging and stress., PloS One, 7(7), e40128. doi:10.1371/journal.pone.0040128 [doi]
    Abbondanzo, S. J., & Chang, S. L. (2014), HIV-1 transgenic rats display alterations in immunophenotype and cellular responses associated with aging., PloS One, 9(8), e105256. doi:10.1371/journal.pone.0105256 [doi]
    Kumar, A., Rani, A., Tchigranova, O., Lee, W. H., & Foster, T. C. (2012)., Influence of late-life exposure to environmental enrichment or exercise on hippocampal function and CA1 senescent physiology., Neurobiology of Aging, 33(4), 828.e1-828.17. doi:10.1016/j.neurobiolaging.2011.06.023 [doi]
    Adzovic, L., Lynn, A. E., D'Angelo, H. M., Crockett, A. M., Kaercher, R. M., Royer, S. E., . . . Wenk, G. L. (2015), Insulin improves memory and reduces chronic neuroinflammation in the hippocampus of young but not aged brains., Journal of Neuroinflammation, 12, 63-015-0282-z. doi:10.1186/s12974-015-0282-z [doi]
    Collier, T. J., O'Malley, J., Rademacher, D. J., Stancati, J. A., Sisson, K. A., Sortwell, C. E., . . . Steece-Collier, K. (2015), Interrogating the aged striatum: Robust survival of grafted dopamine neurons in aging rats produces inferior behavioral recovery and evidence of impaired integration., Neurobiology of Disease, 77, 191-203. doi:10.1016/j.nbd.2015.03.005 [doi]
    Jeong, J. J., Woo, J. Y., Kim, K. A., Han, M. J., & Kim, D. H. (2015), Lactobacillus pentosus var. plantarum C29 ameliorates age-dependent memory impairment in fischer 344 rats., Letters in Applied Microbiology, 60(4), 307-314. doi:10.1111/lam.12393 [doi]
    Kim, J. H., Lee, Y., Kwak, H. B., & Lawler, J. M. (2015)., Lifelong wheel running exercise and mild caloric restriction attenuate nuclear EndoG in the aging plantaris muscle., Experimental Gerontology, 69, 122-128. doi:10.1016/j.exger.2015.06.007 [doi]
    Kumar, A., & Foster, T. C. (2013)., Linking redox regulation of NMDAR synaptic function to cognitive decline during aging., The Journal of Neuroscience : The Official Journal of the Society for Neuroscience, 33(40), 15710-15715. doi:10.1523/JNEUROSCI.2176-13.2013 [doi]
    Phillips, R. J., & Powley, T. L. (2012)., Macrophages associated with the intrinsic and extrinsic autonomic innervation of the rat gastrointestinal tract., Autonomic Neuroscience : Basic & Clinical, 169(1), 12-27. doi:10.1016/j.autneu.2012.02.004 [doi]
    Kim, J. H., Torgerud, W. S., Mosser, K. H., Hirai, H., Watanabe, S., Asakura, A., & Thompson, L. V. (2012)., Myosin light chain 3f attenuates age-induced decline in contractile velocity in MHC type II single muscle fibers., Aging Cell, 11(2), 203-212. doi:10.1111/j.1474-9726.2011.00774.x [doi]
    Biane, J., Conner, J. M., & Tuszynski, M. H. (2014)., Nerve growth factor is primarily produced by GABAergic neurons of the adult rat cortex., Frontiers in Cellular Neuroscience, 8, 220. doi:10.3389/fncel.2014.00220 [doi]
    Shetty, G. A., Hattiangady, B., & Shetty, A. K. (2013), Neural stem cell- and neurogenesis-related gene expression profiles in the young and aged dentate gyrus, Age (Dordrecht, Netherlands), 35(6), 2165-2176. doi:10.1007/s11357-012-9507-6 [doi]
    Hattiangady, B., & Shetty, A. K. (2012)., Neural stem cell grafting counteracts hippocampal injury-mediated impairments in mood, memory, and neurogenesis., Stem Cells Translational Medicine, 1(9), 696-708. doi:10.5966/sctm.2012-0050 [doi]

    Oncology

    McCoy A, Besch-Williford CL, Franklin CL, Weinstein EJ, Cui X., Creation and preliminary characterization of a Tp53 knockout rat., Dis Model Mech. 2013 Jan;6(1):269-78.
    Zungu-Edmondson M, Shults NV, Wong CM, Suzuki YJ., Modulators of right ventricular apoptosis and contractility in a rat model of pulmonary hypertension., Cardiovasc Res. 2016 May 1;110(1):30-9.
    Dai MS, Hall SJ, Vantangoli Policelli MM, Boekelheide K, Spade DJ., Spontaneous testicular atrophy occurs despite normal spermatogonial proliferation in a Tp53 knockout rat., Andrology. 2017 Nov;5(6):1141-1152.
    Tsuchida, T; Zheng, Y-W; Zhang, R-R; Takebe, T; Ueno, Y; Sekine, K; Taniguchi, H;, The development of humanized liver with Rag1 knockout rats., Transplantation proceedings Vol.46, 2014
    Siddique AB, Kilgore PCSR, Tajmim A, Singh SS, Meyer SA, Jois SD, Cvek U, Trutschl M, Sayed KAE., (-)-Oleocanthal as a Dual c-MET-COX2 Inhibitor for the Control of Lung Cancer, Nutrients. 2020 Jun 11;12(6):1749. doi: 10.3390/nu12061749.
    Masoodi, K. Z., Ramos Garcia, R., Pascal, L. E., Wang, Y., Ma, H. M., O'Malley, K., . . . Wang, Z. (2013)., 5alpha-reductase inhibition suppresses testosterone-induced initial regrowth of regressed xenograft prostate tumors in animal models., Endocrinology, 154(7), 2296-2307. doi:10.1210/en.2012-2077 [doi]
    Yang, Hailing; Shu, Zhang; Jiang, Yongying; Mao, Weiqun; Pang, Lan; Redwood, Abena; Jeter-Jones, Sabrina L; Jennings, Nicholas B; Ornelas, Argentina; Zhou, Jinhua; Rodriguez-Aguayo, Cristian; Bartholomeusz, Geoffrey; Iles, LaKesla R; Zacharias, Niki M; Millward, Steven W; Lopez-Berestein, Gabriel; Le, Xiao-Feng; Ahmed, Ahmed A; Piwnica-Worms, Helen; Sood, Anil K; Bast, Robert C; Lu, Zhen, 6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase-2 Regulates TP53-Dependent Paclitaxel Sensitivity in Ovarian and Breast Cancers, Clinical cancer research : an official journal of the American Association for Cancer Research Vol.25, 2019
    Marayati R, Bownes LV, Stafman LL, Williams AP, Quinn CH, Atigadda V, Aye JM, Stewart JE, Yoon KJ, Beierle EA., 9-cis-UAB30, a novel rexinoid agonist, decreases tumorigenicity and cancer cell stemness of human neuroblastoma patient-derived xenografts, Transl Oncol. 2021 Jan;14(1):100893. doi: 10.1016/j.tranon.2020.100893. Epub 2020 Sep 30.
    Deng, Y., Wang, Z., Zhang, F., Qiao, M., Yan, Z., Wei, Q., . . . Zhang, J. (2016), A blockade of IGF signaling sensitizes human ovarian cancer cells to the anthelmintic niclosamide-induced anti-proliferative and anticancer activities, Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology, 39(3), 871-888. doi:10.1159/000447797 [doi]
    Luderer, M. J., Muz, B., de la Puente, P., Chavalmane, S., Kapoor, V., Marcelo, R., . . . Azab, A. K. (2016), A hypoxia-targeted boron neutron capture therapy agent for the treatment of glioma., Pharmaceutical Research, 33(10), 2530-2539. doi:10.1007/s11095-016-1977-2 [doi]
    Hight, M. R., Cheung, Y. Y., Nickels, M. L., Dawson, E. S., Zhao, P., Saleh, S., . . . Manning, H. C. (2014)., A peptide-based positron emission tomography probe for in vivo detection of caspase activity in apoptotic cells., Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 20(8), 2126-2135. doi:10.1158/1078-0432.CCR-13-2444 [doi]
    Dey, J., Kerwin, W. S., Grenley, M. O., Casalini, J. R., Tretyak, I., Ditzler, S. H., . . . Klinghoffer, R. A. (2016), A platform for rapid, quantitative assessment of multiple drug combinations simultaneously in solid tumors in vivo., PloS One, 11(6), e0158617. doi:10.1371/journal.pone.0158617 [doi]
    Green, D. J., Orgun, N. N., Jones, J. C., Hylarides, M. D., Pagel, J. M., Hamlin, D. K., . . . Press, O. W. (2014), A preclinical model of CD38-pretargeted radioimmunotherapy for plasma cell malignancies., Cancer Research, 74(4), 1179-1189. doi:10.1158/0008-5472.CAN-13-1589 [doi]
    Yang, Lu; Li, Yun; Bhattacharya, Arup; Zhang, Yuesheng;, A recombinant human protein targeting HER2 overcomes drug resistance in HER2-positive breast cancer., Science translational medicine Vol.11, 2019
    Neiveyans, Madeline; Melhem, Rana; Arnoult, Christophe; Bourquard, Thomas; Jarlier, Marta; Busson, Muriel; Laroche, Adrien; Cerutti, Martine; Pugnière, Martine; Ternant, David; Gaborit, Nadège; Chardès, Thierry; Poupon, Anne; Gouilleux-Gruart, Valérie; Pèlegrin, Andre; Poul, Marie-Alix;, A recycling anti-transferrin receptor-1 monoclonal antibody as an efficient therapy for erythroleukemia through target up-regulation and antibody-dependent cytotoxic effector functions, mAbs Vol.11, 2019
    Santich BH, Cheal SM, Ahmed M, McDevitt MR, Ouerfelli O, Yang G, Veach DR, Fung EK, Patel M, Burnes Vargas D, Malik AA, Guo HF, Zanzonico PB, Monette S, Michel AO, Rudin CM, Larson SM, Cheung NK., A Self-Assembling and Disassembling (SADA) Bispecific Antibody (BsAb) Platform for Curative Two-step Pretargeted Radioimmunotherapy, Clin Cancer Res. 2020 Sep 21. doi: 10.1158/1078-0432.CCR-20-2150. Online ahead of print.
    Roy, L. D., Dillon, L. M., Zhou, R., Moore, L. J., Livasy, C., El-Khoury, J. M., . . . Mukherjee, P. (2017)., A tumor specific antibody to aid breast cancer screening in women with dense breast tissue., Genes & Cancer, 8(3-4), 536-549. doi:10.18632/genesandcancer.134 [doi]
    Kim, S. S., Rait, A., Kim, E., Pirollo, K. F., & Chang, E. H. (2015)., A tumor-targeting p53 nanodelivery system limits chemoresistance to temozolomide prolonging survival in a mouse model of glioblastoma multiforme., Nanomedicine : Nanotechnology, Biology, and Medicine, 11(2), 301-311. doi:10.1016/j.nano.2014.09.005 [doi]
    Formisano, Luigi; Lu, Yao; Servetto, Alberto; Hanker, Ariella B; Jansen, Valerie M; Bauer, Joshua A; Sudhan, Dhivya R; Guerrero-Zotano, Angel L; Croessmann, Sarah; Guo, Yan; Ericsson, Paula Gonzalez; Lee, Kyung-Min; Nixon, Mellissa J; Schwarz, Luis J; Sanders, Melinda E; Dugger, Teresa C; Cruz, Marcelo Rocha; Behdad, Amir; Cristofanilli, Massimo; Bardia, Aditya; OShaughnessy, Joyce; Nagy, Rebecca J; Lanman, Richard B; Solovieff, Nadia; He, Wei; Miller, Michelle; Su, Fei; Shyr, Yu; Mayer, Ingrid A; Balko, Justin M; Arteaga, Carlos L;, Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer., Nature communications Vol.10, 2019
    Li M, Li J, Guo X, Pan H, Zhou Q., Absence of HTATIP2 Expression in A549 Lung Adenocarcinoma Cells Promotes Tumor Plasticity in Response to Hypoxic Stress, Cancers (Basel). 2020 Jun 11;12(6):1538. doi: 10.3390/cancers12061538.
    Tansi, F. L., Ruger, R., Bohm, C., Steiniger, F., Kontermann, R. E., Teichgraeber, U. K., . . . Hilger, I. (2017)., Activatable bispecific liposomes bearing fibroblast activation protein directed single chain fragment/Trastuzumab deliver encapsulated cargo into the nuclei of tumor cells and the tumor microenvironment simultaneously., Acta Biomaterialia, 54, 281-293. doi:S1742-7061(17)30203-9 [pii]
    Young, N. R., Soneru, C., Liu, J., Grushko, T. A., Hardeman, A., Olopade, O. I., . . . Cohen, E. E. (2015)., Afatinib efficacy against squamous cell carcinoma of the head and neck cell lines in vitro and in vivo., Targeted Oncology, 10(4), 501-508. doi:10.1007/s11523-014-0353-6 [doi]
    Ziegler, J., Bastian, A., Lerner, M., Bailey-Downs, L., Saunders, D., Smith, N., . . . Towner, R. A. (2017)., AG488 as a therapy against gliomas., Oncotarget, 8(42), 71833-71844. doi:10.18632/oncotarget.18284 [doi]
    Gomes AP, Ilter D, Low V, Endress JE, Fernández-García J, Rosenzweig A, Schild T, Broekaert D, Ahmed A, Planque M, Elia I, Han J, Kinzig C, Mullarky E, Mutvei AP, Asara J, de Cabo R, Cantley LC, Dephoure N, Fendt SM, Blenis J., Age-induced accumulation of methylmalonic acid promotes tumour progression, Nature. 2020 Sep;585(7824):283-287. doi: 10.1038/s41586-020-2630-0. Epub 2020 Aug 19.
    Sun Y, Meyers BA, Czako B, Leonard P, Mseeh F, Harris AL, Wu Q, Johnson S, Parker CA, Cross JB, Di Francesco ME, Bivona BJ, Bristow CA, Burke JP, Carrillo CC, Carroll CL, Chang Q, Feng N, Gao G, Gera S, Giuliani V, Huang JK, Jiang Y, Kang Z, Kovacs JJ, Liu CY, Lopez AM, Ma X, Mandal PK, McAfoos T, Miller MA, Mullinax RA, Peoples M, Ramamoorthy V, Seth S, Spencer ND, Suzuki E, Williams CC, Yu SS, Zuniga AM, Draetta GF, Marszalek JR, Heffernan TP, Kohl NE, Jones P., Allosteric SHP2 Inhibitor, IACS-13909, Overcomes EGFR-Dependent and EGFR-Independent Resistance Mechanisms toward Osimertinib, Cancer Res. 2020 Nov 1;80(21):4840-4853. doi: 10.1158/0008-5472.CAN-20-1634. Epub 2020 Sep 14.
    Zhang, R., Pan, D., Cai, X., Yang, X., Senpan, A., Allen, J. S., . . . Wang, L. V. (2015), alphaVbeta3-targeted copper nanoparticles incorporating an sn 2 lipase-labile fumagillin prodrug for photoacoustic neovascular imaging and treatment., Theranostics, 5(2), 124-133. doi:10.7150/thno.10014 [doi]
    Bush, T. L., Payton, M., Heller, S., Chung, G., Hanestad, K., Rottman, J. B., . . . Radinsky, R. (2013), AMG 900, a small-molecule inhibitor of aurora kinases, potentiates the activity of microtubule-targeting agents in human metastatic breast cancer models, Molecular Cancer Therapeutics, 12(11), 2356-2366. doi:10.1158/1535-7163.MCT-12-1178 [doi]
    Asundi, J., Crocker, L., Tremayne, J., Chang, P., Sakanaka, C., Tanguay, J., . . . Firestein, R. (2015), An antibody-drug conjugate directed against lymphocyte antigen 6 complex, locus E (LY6E) provides robust tumor killing in a wide range of solid tumor malignancies., Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 21(14), 3252-3262. doi:10.1158/1078-0432.CCR-15-0156 [doi]
    Citron, F., Armenia, J., Franchin, G., Polesel, J., Talamini, R., D'Andrea, S., . . . Baldassarre, G. (2017), An integrated approach identifies mediators of local recurrence in head and neck squamous carcinoma, Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 23(14), 3769-3780. doi:10.1158/1078-0432.CCR-16-2814 [doi]
    Zhang, F., Li, Y., Zhang, H., Huang, E., Gao, L., Luo, W., . . . Ji, P. (2017)., Anthelmintic mebendazole enhances cisplatin's effect on suppressing cell proliferation and promotes differentiation of head and neck squamous cell carcinoma (HNSCC)., Oncotarget, 8(8), 12968-12982. doi:10.18632/oncotarget.14673 [doi]
    Miles, L. A., Burga, L. N., Gardner, E. E., Bostina, M., Poirier, J. T., & Rudin, C. M. (2017)., Anthrax toxin receptor 1 is the cellular receptor for seneca valley virus., The Journal of Clinical Investigation, 127(8), 2957-2967. doi:10.1172/JCI93472 [doi]
    Moody, G., Belmontes, B., Masterman, S., Wang, W., King, C., Murawsky, C., . . . Beltran, P. J. (2016)., Antibody-mediated neutralization of autocrine Gas6 inhibits the growth of pancreatic ductal adenocarcinoma tumors in vivo, International Journal of Cancer, 139(6), 1340-1349. doi:10.1002/ijc.30180 [doi]
    Tabernero, J., Chawla, S. P., Kindler, H., Reckamp, K., Chiorean, E. G., Azad, N. S., . . . Baselga, J. (2015)., Anticancer activity of the type I insulin-like growth factor receptor antagonist, ganitumab, in combination with the death receptor 5 agonist, conatumumab., argeted Oncology, 10(1), 65-76. doi:10.1007/s11523-014-0315-z [doi]
    Li, X., Wu, J. B., Chung, L. W., & Huang, W. C. (2015)., Anti-cancer efficacy of SREBP inhibitor, alone or in combination with docetaxel, in prostate cancer harboring p53 mutations., Oncotarget, 6(38), 41018-41032. doi:10.18632/oncotarget.5879 [doi]
    Yan, H., Kapoor, V., Nguyen, K., Akers, W. J., Li, H., Scott, J., . . . Hallahan, D. (2016)., Anti-tax interacting protein-1 (TIP-1) monoclonal antibody targets human cancers., Oncotarget, 7(28), 43352-43362. doi:10.18632/oncotarget.9713 [doi]
    Juzeniene, A., Bernoulli, J., Suominen, M., Halleen, J., & Larsen, R. H. (2018)., Antitumor activity of novel bone-seeking, alpha-emitting (224)ra-solution in a breast cancer skeletal metastases model, Anticancer Research, 38(4), 1947-1955. doi:38/4/1947 [pii]
    Zumwalt, T. J., Wodarz, D., Komarova, N. L., Toden, S., Turner, J., Cardenas, J., . . . Goel, A. (2017)., Aspirin-induced chemoprevention and response kinetics are enhanced by PIK3CA mutations in colorectal cancer cells., Cancer Prevention Research (Philadelphia, Pa.), 10(3), 208-218. doi:10.1158/1940-6207.CAPR-16-0175 [doi]
    Green, D. J., Shadman, M., Jones, J. C., Frayo, S. L., Kenoyer, A. L., Hylarides, M. D., . . . Press, O. W. (2015)., Astatine-211 conjugated to an anti-CD20 monoclonal antibody eradicates disseminated B-cell lymphoma in a mouse model, Blood, 125(13), 2111-2119. doi:10.1182/blood-2014-11-612770 [doi]
    Yeo, S. K., Wen, J., Chen, S., & Guan, J. L. (2016)., Autophagy differentially regulates distinct breast cancer stem-like cells in murine models via EGFR/Stat3 and Tgfbeta/Smad signaling, Cancer Research, 76(11), 3397-3410. doi:10.1158/0008-5472.CAN-15-2946 [doi]
    Wang Y, Xie W, Humeau J, Chen G, Liu P, Pol J, Zhang Z, Kepp O, Kroemer G., Autophagy induction by thiostrepton improves the efficacy of immunogenic chemotherapy, J Immunother Cancer. 2020 Mar;8(1):e000462. doi: 10.1136/jitc-2019-000462.
    Loddick, S. A., Ross, S. J., Thomason, A. G., Robinson, D. M., Walker, G. E., Dunkley, T. P., . . . Brooks, A. N. (2013)., AZD3514: A small molecule that modulates androgen receptor signaling and function in vitro and in vivo., Molecular Cancer Therapeutics, 12(9), 1715-1727. doi:10.1158/1535-7163.MCT-12-1174 [doi]
    Fok, Jacqueline H L; Ramos-Montoya, Antonio; Vazquez-Chantada, Mercedes; Wijnhoven, Paul W G; Follia, Valeria; James, Neil; Farrington, Paul M; Karmokar, Ankur; Willis, Sophie E; Cairns, Jonathan; Nikkilä, Jenni; Beattie, David; Lamont, Gillian M; Finlay, M Raymond V; Wilson, Joanne; Smith, Aaron; OConnor, Lenka Oplustil; Ling, Stephanie; Fawell, Stephen E; OConnor, Mark J; Hollingsworth, Simon J; Dean, Emma; Goldberg, Frederick W; Davies, Barry R; Cadogan, Elaine B;, AZD7648 is a potent and selective DNA-PK inhibitor that enhances radiation, chemotherapy and olaparib activity., Nature communications Vol.10, 2019
    Rello-Varona, Santi; Fuentes-Guirado, Miriam; López-Alemany, Roser; Contreras-Pérez, Aida; Mulet-Margalef, Núria; García-Monclús, Silvia; Tirado, Oscar M; García Del Muro, Xavier, Bcl-xL inhibition enhances Dinaciclib-induced cell death in soft-tissue sarcomas, Scientific reports Vol.9, 2019
    San Millan, C., Soldevilla, B., Martin, P., Gil-Calderon, B., Compte, M., Perez-Sacristan, B., . . . Dominguez, G. (2015), Beta-cryptoxanthin synergistically enhances the antitumoral activity of oxaliplatin through DeltaNP73 negative regulation in colon cancer, Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 21(19), 4398-4409. doi:10.1158/1078-0432.CCR-14-2027 [doi]
    Jansen, M. H., Lagerweij, T., Sewing, A. C., Vugts, D. J., van Vuurden, D. G., Molthoff, C. F., . . . Hulleman, E. (2016)., Bevacizumab targeting diffuse intrinsic pontine glioma: Results of 89Zr-bevacizumab PET imaging in brain tumor models., Molecular Cancer Therapeutics, 15(9), 2166-2174. doi:10.1158/1535-7163.MCT-15-0558 [doi]
    Zhang, Y., Chen, X., Qiao, M., Zhang, B. Q., Wang, N., Zhang, Z., . . . Zhang, H. (2014)., Bone morphogenetic protein 2 inhibits the proliferation and growth of human colorectal cancer cells., Oncology Reports, 32(3), 1013-1020. doi:10.3892/or.2014.3308 [doi]
    Bort, A., Spinola, E., Rodriguez-Henche, N., & Diaz-Laviada, I. (2017)., Capsaicin exerts synergistic antitumor effect with sorafenib in hepatocellular carcinoma cells through AMPK activation, Oncotarget, 8(50), 87684-87698. doi:10.18632/oncotarget.21196 [doi]
    Kim, H. S., Masko, E. M., Poulton, S. L., Kennedy, K. M., Pizzo, S. V., Dewhirst, M. W., & Freedland, S. J. (2012)., Carbohydrate restriction and lactate transporter inhibition in a mouse xenograft model of human prostate cancer., BJU International, 110(7), 1062-1069. doi:10.1111/j.1464-410X.2012.10971.x [doi]
    Moon, Henry H; Clines, Katrina L; Cooks, Mark A; Cialek, Charlotte A; Esvelt, Marian A; Clines, Gregory A;, Castration Determines the Efficacy of ETAR Blockade in a Mouse Model of Prostate Cancer Bone, Endocrinology Vol.160, 2019
    Li, H., Xie, N., Gleave, M. E., & Dong, X. (2015, Catalytic inhibitors of DNA topoisomerase II suppress the androgen receptor signaling and prostate cancer progression., Oncotarget, 6(24), 20474-20484. doi:4105 [pii]
    Assimon, Victoria A; Tang, Yangzhong; Vargas, Jesse D; Lee, Grace J; Wu, Zhi Yong; Lou, Kenny; Yao, Bing; Menon, Mary-Kamala; Pios, Ariel; Perez, Kristy C; Madriaga, Antonett; Buchowiecki, Peter K; Rolfe, Mark; Shawver, Laura; Jiao, Xianyun; Le Moigne, Ronan; Zhou, Han-Jie; Anderson, Daniel J;, CB-6644 Is a Selective Inhibitor of the RUVBL1/2 Complex with Anticancer Activity. ACS chemical biology, ACS chemical biology Vol.14, 2019
    Casagrande, Naike; Borghese, Cinzia; Visser, Lydia; Mongiat, Maurizio; Colombatti, Alfonso; Aldinucci, Donatella, CCR5 antagonism by maraviroc inhibits Hodgkin lymphoma microenvironment interactions and xenograft growth., Haematologica Vol.104, 2019
    Domínguez JM, Pérez-Chacón G, Guillén MJ, Muñoz-Alonso MJ, Somovilla-Crespo B, Cibrián D, Acosta-Iborra B, Adrados M, Muñoz-Calleja C, Cuevas C, Sánchez-Madrid F, Avilés P, Zapata JM., CD13 as a new tumor target for antibody-drug conjugates: validation with the conjugate MI130110, J Hematol Oncol. 2020 Apr 7;13(1):32. doi: 10.1186/s13045-020-00865-7.
    Hernandez, R., Sun, H., England, C. G., Valdovinos, H. F., Ehlerding, E. B., Barnhart, T. E., . . . Cai, W. (2016), CD146-targeted immunoPET and NIRF imaging of hepatocellular carcinoma with a dual-labeled monoclonal antibody., Theranostics, 6(11), 1918-1933. doi:10.7150/thno.15568 [doi]
    McKnight BN, Kim S, Boerner JL, Viola NT., Cetuximab PET delineated changes in cellular distribution of EGFR upon dasatinib treatment in triple negative breast cancer, Breast Cancer Res. 2020 Apr 15;22(1):37. doi: 10.1186/s13058-020-01270-1.
    Smith, M. C., Mader, M. M., Cook, J. A., Iversen, P., Ajamie, R., Perkins, E., . . . Wacheck, V. (2016)., Characterization of LY3023414, a novel PI3K/mTOR dual inhibitor eliciting transient target modulation to impede tumor growth., Molecular Cancer Therapeutics, 15(10), 2344-2356. doi:1535-7163.MCT-15-0996 [pii]
    Weitzenfeld, P., Kossover, O., Korner, C., Meshel, T., Wiemann, S., Seliktar, D., . . . Ben-Baruch, A. (2016)., Chemokine axes in breast cancer: Factors of the tumor microenvironment reshape the CCR7-driven metastatic spread of luminal-A breast tumors., Journal of Leukocyte Biology, 99(6), 1009-1025. doi:10.1189/jlb.3MA0815-373R [doi]
    Hain, Brian A; Xu, Haifang; Wilcox, Jenna R; Mutua, Daniel; Waning, David L;, Chemotherapy-induced loss of bone and muscle mass in a mouse model of breast cancer bone metastases and cachexia., JCSM rapid communications Vol.2,
    Sen, T., Tong, P., Stewart, C. A., Cristea, S., Valliani, A., Shames, D. S., . . . Byers, L. A. (2017)., CHK1 inhibition in small-cell lung cancer produces single-agent activity in biomarker-defined disease subsets and combination activity with cisplatin or olaparib., Cancer Research, 77(14), 3870-3884. doi:10.1158/0008-5472.CAN-16-3409 [doi]
    Li, J., Qu, X., Tian, J., Zhang, J. T., & Cheng, J. X. (2018)., Cholesterol esterification inhibition and gemcitabine synergistically suppress pancreatic ductal adenocarcinoma proliferation., PloS One, 13(2), e0193318. doi:10.1371/journal.pone.0193318 [doi]
    Sobot, D., Mura, S., Rouquette, M., Vukosavljevic, B., Cayre, F., Buchy, E., . . . Couvreur, P. (2017)., Circulating lipoproteins: A trojan horse guiding squalenoylated drugs to LDL-accumulating cancer cells., Molecular Therapy : The Journal of the American Society of Gene Therapy, 25(7), 1596-1605. doi:S1525-0016(17)30234-4 [pii]
    Yu, W., Chen, Y., Dubrulle, J., Stossi, F., Putluri, V., Sreekumar, A., . . . Sandulache, V. C. (2018)., Cisplatin generates oxidative stress which is accompanied by rapid shifts in central carbon metabolism, Scientific Reports, 8(1), 4306-018-22640-y. doi:10.1038/s41598-018-22640-y [doi]
    Parsels LA, Engelke CG, Parsels J, Flanagan SA, Zhang Q, Tanska D, Wahl DR, Canman CE, Lawrence TS, Morgan MA., Combinatorial efficacy of olaparib with radiation and ATR inhibitor requires PARP1 protein in homologous recombination proficient pancreatic cancer, Mol Cancer Ther. 2020 Dec 2:molcanther.0365.2020. doi: 10.1158/1535-7163.MCT-20-0365. Online ahead of print.
    Belli, Valentina; Matrone, Nunzia; Napolitano, Stefania; Migliardi, Giorgia; Cottino, Francesca; Bertotti, Andrea; Trusolino, Livio; Martinelli, Erika; Morgillo, Floriana; Ciardiello, Davide; De Falco, Vincenzo; Giunta, Emilio Francesco; Bracale, Umberto; Ciardiello, Fortunato; Troiani, Teresa;, Combined blockade of MEK and PI3KCA as an effective antitumor strategy in HER2 gene amplified human colorectal cancer models., Journal of experimental & clinical cancer research : CR Vol.38, 2019
    Frost, S. H., Frayo, S. L., Miller, B. W., Orozco, J. J., Booth, G. C., Hylarides, M. D., . . . Press, O. W. (2015), Comparative efficacy of 177Lu and 90Y for anti-CD20 pretargeted radioimmunotherapy in murine lymphoma xenograft models., PloS One, 10(3), e0120561. doi:10.1371/journal.pone.0120561 [doi]
    Vugts, D. J., Klaver, C., Sewing, C., Poot, A. J., Adamzek, K., Huegli, S., . . . van Dongen, G. A. (2017)., Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for (89)zr-immuno-PET., European Journal of Nuclear Medicine and Molecular Imaging, 44(2), 286-295. doi:10.1007/s00259-016-3499-x [doi]
    Pattarawat P, Hong T, Wallace S, Hu Y, Donnell R, Wang TH, Tsai CL, Wang J, Wang HR., Compensatory combination of romidepsin with gemcitabine and cisplatin to effectively and safely control urothelial carcinoma, Br J Cancer. 2020 Jul;123(2):226-239. doi: 10.1038/s41416-020-0877-8. Epub 2020 May 11.
    Kennedy AL, Rai R, Isingizwe ZR, Zhao YD, Lightfoot SA, Benbrook DM., Complementary Targeting of Rb Phosphorylation and Growth in Cervical Cancer Cell Cultures and a Xenograft Mouse Model by SHetA2 and Palbociclib, Cancers (Basel). 2020 May 17;12(5):1269. doi: 10.3390/cancers12051269.
    Shibata M, Ooki A, Inokawa Y, Sadhukhan P, Ugurlu MT, Izumchenko E, Munari E, Bogina G, Rudin CM, Gabrielson E, Singh A, Hoque MO., Concurrent Targeting of Potential Cancer Stem Cells Regulating Pathways Sensitizes Lung Adenocarcinoma to Standard Chemotherapy, Mol Cancer Ther. 2020 Oct;19(10):2175-2185. doi: 10.1158/1535-7163.MCT-20-0024. Epub 2020 Aug 26.
    Liu, Peng; Zhao, Liwei; Pol, Jonathan; Levesque, Sarah; Petrazzuolo, Adriana; Pfirschke, Christina; Engblom, Camilla; Rickelt, Steffen; Yamazaki, Takahiro; Iribarren, Kristina; Senovilla, Laura; Bezu, Lucillia; Vacchelli, Erika; Sica, Valentina; Melis, Andréa; Martin, Tiffany; Xia, Lin; Yang, Heng; Li, Qingqing; Chen, Jinfeng; Durand, Sylvère; Aprahamian, Fanny; Lefevre, Deborah; Broutin, Sophie; Paci, Angelo; Bongers, Amaury; Minard-Colin, Veronique; Tartour, Eric; Zitvogel, Laurence; Apetoh, Lionel; Ma, Yuting; Pittet, Mikael J; Kepp, Oliver; Kroemer, Guido;, Crizotinib-induced immunogenic cell death in non-small cell lung cancer, Nature communications Vol.10, 2019
    Yamaguchi, M., Zhu, S., Zhang, S., Wu, D., Moore, T. M., Snyder, J. P., & Shoji, M. (2014)., Curcumin analogue UBS109 prevents bone loss in breast cancer bone metastasis mouse model: Involvement in osteoblastogenesis and osteoclastogenesis, Cell and Tissue Research, 357(1), 245-252. doi:10.1007/s00441-014-1846-4 [doi]
    Domanska, U. M., Boer, J. C., Timmer-Bosscha, H., van Vugt, M. A., Hoving, H. D., Kliphuis, N. M., . . . Walenkamp, A. M. (2014)., CXCR4 inhibition enhances radiosensitivity, while inducing cancer cell mobilization in a prostate cancer mouse model, Clinical & Experimental Metastasis, 31(7), 829-839. doi:10.1007/s10585-014-9673-2 [doi]
    Garcia, M., Velez, R., Romagosa, C., Majem, B., Pedrola, N., Olivan, M., . . . Doll, A. (2014)., Cyclooxygenase-2 inhibitor suppresses tumour progression of prostate cancer bone metastases in nude mice, BJU International, 113(5b), E164-77. doi:10.1111/bju.12503 [doi]
    Perez, O. D., Logg, C. R., Hiraoka, K., Diago, O., Burnett, R., Inagaki, A., . . . Jolly, D. J. (2012)., Design and selection of toca 511 for clinical use: Modified retroviral replicating vector with improved stability and gene expression, Molecular Therapy : The Journal of the American Society of Gene Therapy, 20(9), 1689-1698. doi:10.1038/mt.2012.83 [doi]
    D'Hollander, A., Mathieu, E., Jans, H., Vande Velde, G., Stakenborg, T., Van Dorpe, P., . . . Lagae, L. (2016), Development of nanostars as a biocompatible tumor contrast agent: Toward in vivo SERS imaging., International Journal of Nanomedicine, 11, 3703-3714. doi:10.2147/IJN.S91340 [doi]
    Navarro-Villaran, E., Tinoco, J., Jimenez, G., Pereira, S., Wang, J., Aliseda, S., . . . Muntane, J. (2016)., Differential antitumoral properties and renal-associated tissue damage induced by tacrolimus and mammalian target of rapamycin inhibitors in hepatocarcinoma: In vitro and in vivo studies, PloS One, 11(8), e0160979. doi:10.1371/journal.pone.0160979 [doi]
    Oksala, R., Moilanen, A., Riikonen, R., Rummakko, P., Karjalainen, A., Passiniemi, M., . . . Mustonen, M. V. (2018), Discovery and development of ODM-204: A novel nonsteroidal compound for the treatment of castration-resistant prostate cancer by blocking the androgen receptor and inhibiting CYP17A1, The Journal of Steroid Biochemistry and Molecular Biology, doi:S0960-0760(18)30078-5 [pii]
    Hiriyan, J., Shivarudraiah, P., Gavara, G., Annamalai, P., Natesan, S., Sambasivam, G., & Sukumaran, S. K. (2015)., Discovery of PAT-1102, a novel, potent and orally active histone deacetylase inhibitor with antitumor activity in cancer mouse models. Anticancer, Anticancer Research, 35(1), 229-237. doi:35/1/229 [pii]
    Donabedian, P. L., Kossatz, S., Engelbach, J. A., Jannetti, S. A., Carney, B., Young, R. J., . . . Reiner, T. (2018)., Discriminating radiation injury from recurrent tumor with [(18)F]PARPi and amino acid PET in mouse models., EJNMMI Research, 8(1), 59-018-0399-z. doi:10.1186/s13550-018-0399-z [doi]
    Ridwan SM, El-Tayyeb F, Hainfeld JF, Smilowitz HM., Distributions of intravenous injected iodine nanoparticles in orthotopic u87 human glioma xenografts over time and tumor therapy, Nanomedicine (Lond). 2020 Oct;15(24):2369-2383. doi: 10.2217/nnm-2020-0178. Epub 2020 Sep 25.
    Tuomela, J., Sandholm, J., Kaakinen, M., Patel, A., Kauppila, J. H., Ilvesaro, J., . . . Selander, K. S. (2013)., DNA from dead cancer cells induces TLR9-mediated invasion and inflammation in living cancer cells., Breast Cancer Research and Treatment, 142(3), 477-487. doi:10.1007/s10549-013-2762-0 [doi]
    Sciegienka, S. J., Solst, S. R., Falls, K. C., Schoenfeld, J. D., Klinger, A. R., Ross, N. L., . . . Fath, M. A. (2017)., D-penicillamine combined with inhibitors of hydroperoxide metabolism enhances lung and breast cancer cell responses to radiation and carboplatin via H2O2-mediated oxidative stress., Free Radical Biology & Medicine, 108, 354-361. doi:S0891-5849(17)30192-2 [pii]
    Tsoneva, D., Stritzker, J., Bedenk, K., Zhang, Q., Frentzen, A., Cappello, J., . . . Szalay, A. A. (2015)., Drug-encoded biomarkers for monitoring biological therapies, PloS One, 10(9), e0137573. doi:10.1371/journal.pone.0137573 [doi]
    Ohana, J., Sandler, U., Kass, G., Stemmer, S. M., & Devary, Y. (2017)., dTCApFs, a derivative of a novel human hormone peptide, induces apoptosis in cancer cells through a mechanism involving loss of golgi function., Molecular and Clinical Oncology, 7(6), 991-999. doi:10.3892/mco.2017.1453 [doi]
    Luo, H., England, C. G., Shi, S., Graves, S. A., Hernandez, R., Liu, B., . . . Cai, W. (2016)., Dual targeting of tissue factor and CD105 for preclinical PET imaging of pancreatic cancer., Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 22(15), 3821-3830. doi:10.1158/1078-0432.CCR-15-2054 [doi]
    Tan, Q., Joshua, A. M., Saggar, J. K., Yu, M., Wang, M., Kanga, N., . . . Tannock, I. F. (2015), Effect of pantoprazole to enhance activity of docetaxel against human tumour xenografts by inhibiting autophagy., British Journal of Cancer, 112(5), 832-840. doi:10.1038/bjc.2015.17 [doi]
    Ionkina, A. A., Tentler, J. J., Kim, J., Capasso, A., Pitts, T. M., Ryall, K. A., . . . Diamond, J. R. (2017)., Efficacy and molecular mechanisms of differentiated response to the aurora and angiogenic kinase inhibitor ENMD-2076 in preclinical models of p53-mutated triple-negative breast cancer., Frontiers in Oncology, 7, 94. doi:10.3389/fonc.2017.00094 [doi]
    Kong, Y., Barisone, G. A., Sidhu, R. S., O'Donnell, R. T., & Tuscano, J. M. (2015)., Efficacy of combined histone deacetylase and checkpoint kinase inhibition in a preclinical model of human burkitt lymphoma., Molecular Medicine (Cambridge, Mass.), 21(1), 824-832. doi:10.2119/molmed.2015.00032 [doi]
    Akla, Barbara; Broussas, Matthieu; Loukili, Noureddine; Robert, Alain; Beau-Larvor, Charlotte; Malissard, Martine; Boute, Nicolas; Champion, Thierry; Haeuw, Jean-Francois; Beck, Alain; Perez, Michel; Dreyfus, Cyrille; Pavlyuk, Mariya; Chetaille, Eric; Corvaia, Nathalie;, Efficacy of the Antibody-Drug Conjugate W0101 in Preclinical Models of IGF-1 Receptor Overexpressing Solid Tumors., Molecular cancer therapeutics Vol.19, 2020
    Choi, A. H., O'Leary, M. P., Lu, J., Kim, S. I., Fong, Y., & Chen, N. G. (2018), Endogenous akt activity promotes virus entry and predicts efficacy of novel chimeric orthopoxvirus in triple-negative breast cancer., Molecular Therapy Oncolytics, 9, 22-29. doi:10.1016/j.omto.2018.04.001 [doi]
    Nwagwu CD, Defensor E, Jiang MY, Rolle-McFarland DA, Carbonell AE, Carbonell WS., Endpoint in ovarian cancer xenograft model predicted by nighttime motion metrics, Lab Anim (NY). 2020 Aug;49(8):227-232. doi: 10.1038/s41684-020-0594-1. Epub 2020 Jul 20.
    Toden, S., Tran, H. M., Tovar-Camargo, O. A., Okugawa, Y., & Goel, A. (2016), Epigallocatechin-3-gallate targets cancer stem-like cells and enhances 5-fluorouracil chemosensitivity in colorectal cancer., Oncotarget, 7(13), 16158-16171. doi:10.18632/oncotarget.7567 [doi]
    Wang, X., Tan, Y., Cao, X., Kim, J. A., Chen, T., Hu, Y., . . . Wang, X. (2018)., Epigenetic activation of HORMAD1 in basal-like breast cancer: Role in rucaparib sensitivity., Oncotarget, 9(53), 30115-30127. doi:10.18632/oncotarget.25728 [doi]
    Li, D., & Marchenko, N. D. (2017), ErbB2 inhibition by lapatinib promotes degradation of mutant p53 protein in cancer cells, Oncotarget, 8(4), 5823-5833. doi:10.18632/oncotarget.12878 [doi]
    Schmitt, D. C., Madeira da Silva, L., Zhang, W., Liu, Z., Arora, R., Lim, S., . . . Tan, M. (2015)., ErbB2-intronic microRNA-4728: A novel tumor suppressor and antagonist of oncogenic MAPK signaling., Cell Death & Disease, 6, e1742. doi:10.1038/cddis.2015.116 [doi]
    Bhagwat SV, McMillen WT, Cai S, Zhao B, Whitesell M, Shen W, Kindler L, Flack RS, Wu W, Anderson B, Zhai Y, Yuan XJ, Pogue M, Van Horn RD, Rao X, McCann D, Dropsey AJ, Manro J, Walgren J, Yuen E, Rodriguez MJ, Plowman GD, Tiu RV, Joseph S, Peng SB., ERK Inhibitor LY3214996 Targets ERK Pathway-Driven Cancers: A Therapeutic Approach Toward Precision Medicine, Mol Cancer Ther. 2020 Feb;19(2):325-336. doi: 10.1158/1535-7163.MCT-19-0183. Epub 2019 Nov 19.
    Maaland, Astri Fjelde; Heyerdahl, Helen; OShea, Adam; Eiriksdottir, Bergthora; Pascal, Véronique; Andersen, Jan Terje; Kolstad, Arne; Dahle, Jostein;, European journal of nuclear medicine and molecular imaging Vol.46, 2019, European journal of nuclear medicine and molecular imaging Vol.46, 2019
    Tuominen S, Keller T, Petruk N, López-Picón F, Eichin D, Löyttyniemi E, Verhassel A, Rajander J, Sandholm J, Tuomela J, Grönroos TJ., Evaluation of [(18)F]F-DPA as a target for TSPO in head and neck cancer under normal conditions and after radiotherapy, Eur J Nucl Med Mol Imaging. 2020 Dec 19. doi: 10.1007/s00259-020-05115-z. Online ahead of print.
    Rossi SM, Ryan BK, Kelly HM., Evaluation of the activity of a chemo-ablative, thermoresponsive hydrogel in a murine xenograft model of lung cancer, Br J Cancer. 2020 Aug;123(3):369-377. doi: 10.1038/s41416-020-0904-9. Epub 2020 May 27.
    Scott, A. J., Song, E. K., Bagby, S., Purkey, A., McCarter, M., Gajdos, C., . . . Messersmith, W. A. (2017)., Evaluation of the efficacy of dasatinib, a Src/Abl inhibitor, in colorectal cancer cell lines and explant mouse model., PloS One, 12(11), e0187173. doi:10.1371/journal.pone.0187173 [doi]
    Siddiqui, I. A., Bharali, D. J., Nihal, M., Adhami, V. M., Khan, N., Chamcheu, J. C., . . . Mukhtar, H. (2014)., Excellent anti-proliferative and pro-apoptotic effects of (-)-epigallocatechin-3-gallate encapsulated in chitosan nanoparticles on human melanoma cell growth both in vitro and in vivo., Nanomedicine : Nanotechnology, Biology, and Medicine, 10(8), 1619-1626. doi:10.1016/j.nano.2014.05.007 [doi]
    Gonzalez-Sanchez L, Cobos-Fernandez MA, Lopez-Nieva P, Villa-Morales M, Stamatakis K, Cuezva JM, Marin-Rubio JL, Vazquez-Dominguez I, Gonzalez-Vasconcellos I, Salido E, Llamas P, Lopez-Lorenzo JL, Santos J, Fernandez-Piqueras J., Exploiting the passenger ACO1-deficiency arising from 9p21 deletions to kill T-cell lymphoblastic neoplasia cells, Carcinogenesis. 2020 Aug 12;41(8):1113-1122. doi: 10.1093/carcin/bgz185.
    Capasso, Anna; Bagby, Stacey M; Dailey, Kyrie L; Currimjee, Naomi; Yacob, Betelehem W; Ionkina, Anastasia; Frank, Julie G; Kim, Deog Joong; George, Christina; Lee, Young B; Benaim, Ely; Gittleman, Brian; Hartman, Sarah J; Tan, Aik Choon; Kim, Jihye; Pitts, Todd M; Eckhardt, S Gail; Tentler, John J; Diamond, Jennifer R;, First-in-Class Phosphorylated-p68 Inhibitor RX-5902 Inhibits ??-Catenin Signaling and Demonstrates Antitumor Activity in Triple-Negative Breast Cancer, Molecular cancer therapeutics Vol.18, 2019
    Xu, L., Yeudall, W. A., & Yang, H. (2017)., Folic acid-decorated polyamidoamine dendrimer exhibits high tumor uptake and sustained highly localized retention in solid tumors: Its utility for local siRNA delivery., Acta Biomaterialia, 57, 251-261. doi:S1742-7061(17)30262-3 [pii]
    Faugeroux V, Pailler E, Oulhen M, Deas O, Brulle-Soumare L, Hervieu C, Marty V, Alexandrova K, Andree KC, Stoecklein NH, Tramalloni D, Cairo S, NgoCamus M, Nicotra C, Terstappen LWMM, Manaresi N, Lapierre V, Fizazi K, Scoazec JY, Loriot Y, Judde JG, Farace F., Genetic characterization of a unique neuroendocrine transdifferentiation prostate circulating tumor cell-derived eXplant model, Nat Commun. 2020 Apr 20;11(1):1884. doi: 10.1038/s41467-020-15426-2.
    Sasaki, K., Kurahara, H., Young, E. D., Natsugoe, S., Ijichi, A., Iwakuma, T., & Welch, D. R. (2017)., Genome-wide in vivo RNAi screen identifies ITIH5 as a metastasis suppressor in pancreatic cancer., Clinical & Experimental Metastasis, 34(3-4), 229-239. doi:10.1007/s10585-017-9840-3 [doi]
    Lampa, M., Arlt, H., He, T., Ospina, B., Reeves, J., Zhang, B., . . . Srinivasan, L. (2017)., Glutaminase is essential for the growth of triple-negative breast cancer cells with a deregulated glutamine metabolism pathway and its suppression synergizes with mTOR inhibition, PloS One, 12(9), e0185092. doi:10.1371/journal.pone.0185092 [doi]
    Sorin, V., Ohana, P., Gallula, J., Birman, T., Matouk, I., Hubert, A., . . . Czerniak, A. (2012)., H19-promoter-targeted therapy combined with gemcitabine in the treatment of pancreatic cancer, ISRN Oncology, 2012, 351750. doi:10.5402/2012/351750 [doi]
    Zhou, Y., Li, G., Zhu, L., Li, C., Cornelius, L. A., & Wang, L. V. (2015)., Handheld photoacoustic probe to detect both melanoma depth and volume at high speed in vivo., Journal of Biophotonics, 8(11-12), 961-967. doi:10.1002/jbio.201400143 [doi]
    Arzumanyan, A., Sambandam, V., Clayton, M. M., Choi, S. S., Xie, G., Diehl, A. M., . . . Feitelson, M. A. (2012)., Hedgehog signaling blockade delays hepatocarcinogenesis induced by hepatitis B virus X protein., Cancer Research, 72(22), 5912-5920. doi:10.1158/0008-5472.CAN-12-2329 [doi]
    Elwaie TA, Abbas SE, Aly EI, George RF, Ali H, Kraiouchkine N, Abdelwahed KS, Fandy TE, El Sayed KA, Abd Elmageed ZY, Ali HI., HER2 Kinase-Targeted Breast Cancer Therapy: Design, Synthesis, and In Vitro and In Vivo Evaluation of Novel Lapatinib Congeners as Selective and Potent HER2 Inhibitors with Favorable Metabolic Stability, J Med Chem. 2020 Dec 24;63(24):15906-15945. doi: 10.1021/acs.jmedchem.0c01647. Epub 2020 Dec 14.
    Efimova, E. V., Ricco, N., Labay, E., Mauceri, H. J., Flor, A. C., Ramamurthy, A., . . . Kron, S. J. (2018)., HMG-CoA reductase inhibition delays DNA repair and promotes senescence after tumor irradiation., Molecular Cancer Therapeutics, 17(2), 407-418. doi:10.1158/1535-7163.MCT-17-0288 [doi]
    Lelj-Garolla, B., Kumano, M., Beraldi, E., Nappi, L., Rocchi, P., Ionescu, D. N., . . . Gleave, M. E. (2015)., Hsp27 inhibition with OGX-427 sensitizes non-small cell lung cancer cells to erlotinib and chemotherapy., Molecular Cancer Therapeutics, 14(5), 1107-1116. doi:10.1158/1535-7163.MCT-14-0866 [doi]
    Lu, Y., Liu, Y., Oeck, S., & Glazer, P. M. (2018)., Hypoxia promotes resistance to EGFR inhibition in NSCLC cells via the histone demethylases, LSD1 and PLU-1., Molecular Cancer Research : MCR, 16(10), 1458-1469. doi:10.1158/1541-7786.MCR-17-0637 [doi]
    Lu, Y., Liu, Y., Oeck, S., & Glazer, P. M. (2018)., Hypoxia promotes resistance to EGFR inhibition in NSCLC cells via the histone demethylases, LSD1 and PLU-1., Molecular Cancer Research : MCR, 16(10), 1458-1469. doi:10.1158/1541-7786.MCR-17-0637 [doi]
    Fell JB, Fischer JP, Baer BR, Blake JF, Bouhana K, Briere DM, Brown KD, Burgess LE, Burns AC, Burkard MR, Chiang H, Chicarelli MJ, Cook AW, Gaudino JJ, Hallin J, Hanson L, Hartley DP, Hicken EJ, Hingorani GP, Hinklin RJ, Mejia MJ, Olson P, Otten JN, Rhodes SP, Rodriguez ME, Savechenkov P, Smith DJ, Sudhakar N, Sullivan FX, Tang TP, Vigers GP, Wollenberg L, Christensen JG, Marx MA., Identification of the Clinical Development Candidate MRTX849, a Covalent KRAS(G12C) Inhibitor for the Treatment of Cancer, J Med Chem. 2020 Jul 9;63(13):6679-6693. doi: 10.1021/acs.jmedchem.9b02052. Epub 2020 Apr 6.
    Abourbeh, G., Itamar, B., Salnikov, O., Beltsov, S., & Mishani, E. (2015)., Identifying erlotinib-sensitive non-small cell lung carcinoma tumors in mice using [(11)C]erlotinib PET., EJNMMI Research, 5, 4-014-0080-0. eCollection 2015. doi:10.1186/s13550-014-0080-0 [doi]
    Attaluri, A., Seshadri, M., Mirpour, S., Wabler, M., Marinho, T., Furqan, M., . . . Liapi, E. (2016), Image-guided thermal therapy with a dual-contrast magnetic nanoparticle formulation: A feasibility study. International Journal of Hyperthermia, The Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 32(5), 543-557. doi:10.3109/02656736.2016.1159737 [doi]
    Brignole, C., Pastorino, F., Marimpietri, D., Pagnan, G., Pistorio, A., Allen, T. M., . . . Ponzoni, M. (2004)., Immune cell-mediated antitumor activities of GD2-targeted liposomal c-myb antisense oligonucleotides containing CpG motifs., Journal of the National Cancer Institute, 96(15), 1171-1180. doi:10.1093/jnci/djh221 [doi]
    Sun, H., England, C. G., Hernandez, R., Graves, S. A., Majewski, R. L., Kamkaew, A., . . . Cai, W. (2016)., ImmunoPET for assessing the differential uptake of a CD146-specific monoclonal antibody in lung cancer, European Journal of Nuclear Medicine and Molecular Imaging, 43(12), 2169-2179. doi:10.1007/s00259-016-3442-1 [doi]
    Hernandez, R., England, C. G., Yang, Y., Valdovinos, H. F., Liu, B., Wong, H. C., . . . Cai, W. (2017)., ImmunoPET imaging of tissue factor expression in pancreatic cancer with (89)zr-df-ALT-836, Journal of Controlled Release : Official Journal of the Controlled Release Society, 264, 160-168. doi:S0168-3659(17)30796-4 [pii]
    Guffanti F, Alvisi MF, Caiola E, Ricci F, De Maglie M, Soldati S, Ganzinelli M, Decio A, Giavazzi R, Rulli E, Damia G., Impact of ERCC1, XPF and DNA Polymerase ? Expression on Platinum Response in Patient-Derived Ovarian Cancer Xenografts, Cancers (Basel). 2020 Aug 24;12(9):2398. doi: 10.3390/cancers12092398.
    Heinrich, A. K., Lucas, H., Schindler, L., Chytil, P., Etrych, T., Mader, K., & Mueller, T. (2016), Improved tumor-specific drug accumulation by polymer therapeutics with pH-sensitive drug release overcomes chemotherapy resistance, Molecular Cancer Therapeutics, 15(5), 998-1007. doi:10.1158/1535-7163.MCT-15-0824 [doi]
    Hughes, P. E., Rex, K., Caenepeel, S., Yang, Y., Zhang, Y., Broome, M. A., . . . Coxon, A. (2016)., In vitro and in vivo activity of AMG 337, a potent and selective MET kinase inhibitor, in MET-dependent cancer models., Molecular Cancer Therapeutics, 15(7), 1568-1579. doi:10.1158/1535-7163.MCT-15-0871 [doi]
    Xia, C. F., Chen, G., Gangadharmath, U., Gomez, L. F., Liang, Q., Mu, F., . . . Kolb, H. C. (2013), In vitro and in vivo evaluation of the caspase-3 substrate-based radiotracer [(18)F]-CP18 for PET imaging of apoptosis in tumors., Molecular Imaging and Biology : MIB : The Official Publication of the Academy of Molecular Imaging, 15(6), 748-757. doi:10.1007/s11307-013-0646-7 [doi]
    He, Y., Wang, L., Shi, J., Yao, J., Li, L., Zhang, R., . . . Wang, L. V. (2016), In vivo label-free photoacoustic flow cytography and on-the-spot laser killing of single circulating melanoma cells, Scientific Reports, 6, 39616. doi:10.1038/srep39616 [doi]
    Rybczynska, A. A., de Bruyn, M., Ramakrishnan, N. K., de Jong, J. R., Elsinga, P. H., Helfrich, W., . . . van Waarde, A. (2013)., In vivo responses of human A375M melanoma to a sigma ligand: 18F-FDG PET imaging., Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, 54(9), 1613-1620. doi:10.2967/jnumed.113.122655 [doi]
    Colmegna, B., Uboldi, S., Frapolli, R., Licandro, S. A., Panini, N., Galmarini, C. M., . . . D'Incalci, M. (2015), Increased sensitivity to platinum drugs of cancer cells with acquired resistance to trabectedin., British Journal of Cancer, 113(12), 1687-1693. doi:10.1038/bjc.2015.407 [doi]
    Gunsalus, K. T., Wagoner, M. P., Meyer, K., Potter, W. B., Schoenike, B., Kim, S., . . . Roopra, A. (2012)., Induction of the RNA regulator LIN28A is required for the growth and pathogenesis of RESTless breast tumors, Cancer Research, 72(13), 3207-3216. doi:10.1158/0008-5472.CAN-11-1639 [doi]
    Wang, X., Solban, N., Khanna, P., Callea, M., Song, J., Alsop, D. C., . . . Bhatt, R. S. (2016)., Inhibition of ALK1 signaling with dalantercept combined with VEGFR TKI leads to tumor stasis in renal cell carcinoma., Oncotarget, 7(27), 41857-41869. doi:10.18632/oncotarget.9621 [doi]
    Cook Sangar, M. L., Genovesi, L. A., Nakamoto, M. W., Davis, M. J., Knobluagh, S. E., Ji, P., . . . Olson, J. M. (2017)., Inhibition of CDK4/6 by palbociclib significantly extends survival in medulloblastoma patient-derived xenograft mouse models., Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 23(19), 5802-5813. doi:10.1158/1078-0432.CCR-16-2943 [doi]
    Zhang, Y., Wang, Q., Chen, L., & Yang, H. S. (2015), Inhibition of p70S6K1 activation by Pdcd4 overcomes the resistance to an IGF-1R/IR inhibitor in colon carcinoma cells., Molecular Cancer Therapeutics, 14(3), 799-809. doi:10.1158/1535-7163.MCT-14-0648 [doi]
    Shao, C., Ahmad, N., Hodges, K., Kuang, S., Ratliff, T., & Liu, X. (2015)., Inhibition of polo-like kinase 1 (Plk1) enhances the antineoplastic activity of metformin in prostate cancer., The Journal of Biological Chemistry, 290(4), 2024-2033. doi:10.1074/jbc.M114.596817 [doi]
    Gómez-Aleza C, Nguyen B, Yoldi G, Ciscar M, Barranco A, Hernández-Jiménez E, Maetens M, Salgado R, Zafeiroglou M, Pellegrini P, Venet D, Garaud S, Trinidad EM, Benítez S, Vuylsteke P, Polastro L, Wildiers H, Simon P, Lindeman G, Larsimont D, Van den Eynden G, Velghe C, Rothé F, Willard-Gallo K, Michiels S, Muñoz P, Walzer T, Planelles L, Penninger J, Azim HA Jr, Loi S, Piccart M, Sotiriou C, González-Suárez E., Inhibition of RANK signaling in breast cancer induces an anti-tumor immune response orchestrated by CD8+ T cells, Nat Commun. 2020 Dec 10;11(1):6335. doi: 10.1038/s41467-020-20138-8.
    Humeau J, Sauvat A, Cerrato G, Xie W, Loos F, Iannantuoni F, Bezu L, Lévesque S, Paillet J, Pol J, Leduc M, Zitvogel L, de Thé H, Kepp O, Kroemer G., Inhibition of transcription by dactinomycin reveals a new characteristic of immunogenic cell stress, EMBO Mol Med. 2020 May 8;12(5):e11622. doi: 10.15252/emmm.201911622. Epub 2020 Apr 23.
    Puente, P., Fettig, N., Luderer, M. J., Jin, A., Shah, S., Muz, B., . . . Azab, A. K. (2018)., Injectable hydrogels for localized chemotherapy and radiotherapy in brain tumors., Journal of Pharmaceutical Sciences, 107(3), 922-933. doi:S0022-3549(17)30829-8 [pii]
    Wu, Jiao; Minikes, Alexander M; Gao, Minghui; Bian, Huijie; Li, Yong; Stockwell, Brent R; Chen, Zhi-Nan; Jiang, Xuejun;, Intercellular interaction dictates cancer cell ferroptosis via NF2-YAP signalling, Nature Vol.572, 2019
    Wang, W., Cho, H. Y., Rosenstein-Sisson, R., Marin Ramos, N. I., Price, R., Hurth, K., . . . Chen, T. C. (2018), Intratumoral delivery of bortezomib: Impact on survival in an intracranial glioma tumor model, Journal of Neurosurgery, 128(3), 695-700. doi:10.3171/2016.11.JNS161212 [doi]
    Relation, T., Yi, T., Guess, A. J., La Perle, K., Otsuru, S., Hasgur, S., . . . Horwitz, E. M. (2018)., Intratumoral delivery of interferongamma-secreting mesenchymal stromal cells repolarizes tumor-associated macrophages and suppresses neuroblastoma proliferation in vivo., Stem Cells (Dayton, Ohio), 36(6), 915-924. doi:10.1002/stem.2801 [doi]
    Turchan, W. T., Shapiro, R. H., Sevigny, G. V., Chin-Sinex, H., Pruden, B., & Mendonca, M. S. (2016)., Irradiated human endothelial progenitor cells induce bystander killing in human non-small cell lung and pancreatic cancer cells, International Journal of Radiation Biology, 92(8), 427-433. doi:10.1080/09553002.2016.1186299 [doi]
    Wu Q, Tian AL, Durand S, Aprahamian F, Nirmalathasan N, Xie W, Liu P, Zhao L, Zhang S, Pan H, Carmona-Gutierrez D, Madeo F, Tu Y, Kepp O, Kroemer G., Isobacachalcone induces autophagy and improves the outcome of immunogenic chemotherapy, Cell Death Dis. 2020 Nov 26;11(11):1015. doi: 10.1038/s41419-020-03226-x.
    Gelsomino L, Naimo GD, Malivindi R, Augimeri G, Panza S, Giordano C, Barone I, Bonofiglio D, Mauro L, Catalano S, Andò S., Knockdown of Leptin Receptor Affects Macrophage Phenotype in the Tumor Microenvironment Inhibiting Breast Cancer Growth and Progression, Cancers (Basel). 2020 Jul 27;12(8):2078. doi: 10.3390/cancers12082078.
    Dwivedi SKD, Shameer K, Dey A, Mustafi SB, Xiong X, Bhattacharya U, Neizer-Ashun F, Rao G, Wang Y, Ivan C, Yang D, Dudley JT, Xu C, Wren JD, Mukherjee P, Bhattacharya R., KRCC1: A potential therapeutic target in ovarian cancer, FASEB J. 2020 Feb;34(2):2287-2300. doi: 10.1096/fj.201902259R. Epub 2019 Dec 23.
    Eskra, Jillian N; Schlicht, Michael J; Bosland, Maarten C;, Lack of combination effects of soy isoflavones and taxane chemotherapy of castration-resistant prostate cancer., The Prostate Vol.79, 2019
    Haedicke, K., Graefe, S., Teichgraeber, U., & Hilger, I. (2016)., Lowering photosensitizer doses and increasing fluences induce apoptosis in tumor bearing mice, Biomedical Optics Express, 7(7), 2641-2649. doi:10.1364/BOE.7.002641 [doi]
    Santamaria Nunez, G., Robles, C. M., Giraudon, C., Martinez-Leal, J. F., Compe, E., Coin, F., . . . Egly, J. M. (2016)., Lurbinectedin specifically triggers the degradation of phosphorylated RNA polymerase II and the formation of DNA breaks in cancer cells., Molecular Cancer Therapeutics, 15(10), 2399-2412. doi:1535-7163.MCT-16-0172 [pii]
    Johnson, J. L., Dia, V. P., Wallig, M., & Gonzalez de Mejia, E. (2015), Luteolin and gemcitabine protect against pancreatic cancer in an orthotopic mouse model., Pancreas, 44(1), 144-151. doi:10.1097/MPA.0000000000000215 [doi]
    Schregel K, Nowicki MO, Palotai M, Nazari N, Zane R, Sinkus R, Lawler SE, Patz S., Magnetic Resonance Elastography reveals effects of anti-angiogenic glioblastoma treatment on tumor stiffness and captures progression in an orthotopic mouse model, Cancer Imaging. 2020 May 12;20(1):35. doi: 10.1186/s40644-020-00314-1.
    Roger E, Gout J, Arnold F, Beutel AK, Müller M, Abaei A, Barth TFE, Rasche V, Seufferlein T, Perkhofer L, Kleger A., Maintenance Therapy for ATM-Deficient Pancreatic Cancer by Multiple DNA Damage Response Interferences after Platinum-Based Chemotherapy, Cells. 2020 Sep 16;9(9):2110. doi: 10.3390/cells9092110.
    Bernardo, M. M., Kaplun, A., Dzinic, S. H., Li, X., Irish, J., Mujagic, A., . . . Sheng, S. (2015), Maspin expression in prostate tumor cells averts stemness and stratifies drug sensitivity, Cancer Research, 75(18), 3970-3979. doi:10.1158/0008-5472.CAN-15-0234 [doi]
    Franklin DA, Sharick JT, Ericsson-Gonzalez PI, Sanchez V, Dean PT, Opalenik SR, Cairo S, Judde JG, Lewis MT, Chang JC, Sanders ME, Cook RS, Skala MC, Bordeaux J, Orozco Bender J, Vaupel C, Geiss G, Hinerfeld D, Balko JM., MEK activation modulates glycolysis and supports suppressive myeloid cells in TNBC, JCI Insight. 2020 Aug 6;5(15):e134290. doi: 10.1172/jci.insight.134290.
    García-García, Celina; Rivas, Martín A; Ibrahim, Yasir H; Calvo, María Teresa; Gris-Oliver, Albert; Rodríguez, Olga; Grueso, Judit; Antón, Pilar; Guzmán, Marta; Aura, Claudia; Nuciforo, Paolo; Jessen, Katti; Argilés, Guillem; Dienstmann, Rodrigo; Bertotti, Andrea; Trusolino, Livio; Matito, Judit; Vivancos, Ana; Chicote, Irene; Palmer, Héctor G; Tabernero, Josep; Scaltriti, Maurizio; Baselga, José; Serra, Violeta, MEK plus PI3K/mTORC1/2 Therapeutic Efficacy Is Impacted by TP53 Mutation in Preclinical Models of Colorectal Cancer., Clinical cancer research : an official journal of the American Association for Cancer Research Vol.21, 2015
    Sharick JT, Walsh CM, Sprackling CM, Pasch CA, Pham DL, Esbona K, Choudhary A, Garcia-Valera R, Burkard ME, McGregor SM, Matkowskyj KA, Parikh AA, Meszoely IM, Kelley MC, Tsai S, Deming DA, Skala MC., Metabolic Heterogeneity in Patient Tumor-Derived Organoids by Primary Site and Drug Treatment, Front Oncol. 2020 May 15;10:553. doi: 10.3389/fonc.2020.00553. eCollection 2020.
    Yan, S. B., Um, S. L., Peek, V. L., Stephens, J. R., Zeng, W., Konicek, B. W., . . . Walgren, R. A. (2018)., MET-targeting antibody (emibetuzumab) and kinase inhibitor (merestinib) as single agent or in combination in a cancer model bearing MET exon 14 skipping., Investigational New Drugs, 36(4), 536-544. doi:10.1007/s10637-017-0545-x [doi]
    Yan P, Patel HJ, Sharma S, Corben A, Wang T, Panchal P, Yang C, Sun W, Araujo TL, Rodina A, Joshi S, Robzyk K, Gandu S, White JR, de Stanchina E, Modi S, Janjigian YY, Hill EG, Liu B, Erdjument-Bromage H, Neubert TA, Que NLS, Li Z, Gewirth DT, Taldone T, Chiosis G., Molecular Stressors Engender Protein Connectivity Dysfunction through Aberrant N-Glycosylation of a Chaperone, Cell Rep. 2020 Jun 30;31(13):107840. doi: 10.1016/j.celrep.2020.107840.
    Yan P, Patel HJ, Sharma S, Corben A, Wang T, Panchal P, Yang C, Sun W, Araujo TL, Rodina A, Joshi S, Robzyk K, Gandu S, White JR, de Stanchina E, Modi S, Janjigian YY, Hill EG, Liu B, Erdjument-Bromage H, Neubert TA, Que NLS, Li Z, Gewirth DT, Taldone T, Chiosis G., Molecular Stressors Engender Protein Connectivity Dysfunction through Aberrant N-Glycosylation of a Chaperone, Cell Rep. 2020 Jun 30;31(13):107840. doi: 10.1016/j.celrep.2020.107840.
    Morcillo, M. A., Garcia de Lucas, A., Oteo, M., Romero, E., Magro, N., Ibanez, M., . . . Martinez-Torrecuadrada, J. (2018)., MT1-MMP as a PET imaging biomarker for pancreas cancer management., Contrast Media & Molecular Imaging, 2018, 8382148. doi:10.1155/2018/8382148 [doi]
    Kumar, A., Dhar, S., Campanelli, G., Butt, N. A., Schallheim, J. M., Gomez, C. R., & Levenson, A. S. (2018), MTA1 drives malignant progression and bone metastasis in prostate cancer., Molecular Oncology, 12(9), 1596-1607. doi:10.1002/1878-0261.12360 [doi]
    Haedicke, K., Kozlova, D., Grafe, S., Teichgraber, U., Epple, M., & Hilger, I. (2015)., Multifunctional calcium phosphate nanoparticles for combining near-infrared fluorescence imaging and photodynamic therapy, Acta Biomaterialia, 14, 197-207. doi:10.1016/j.actbio.2014.12.009 [doi]
    Peddi S, Roberts SK, MacKay JA., Nanotoxicology of an Elastin-like Polypeptide Rapamycin Formulation for Breast Cancer, Biomacromolecules. 2020 Mar 9;21(3):1091-1102. doi: 10.1021/acs.biomac.9b01431. Epub 2020 Feb 6.
    Wang, P. Y., Swain, H. M., Kunkler, A. L., Chen, C. Y., Hutzen, B. J., Arnold, M. A., . . . Cripe, T. P. (2016)., Neuroblastomas vary widely in their sensitivities to herpes simplex virotherapy unrelated to virus receptors and susceptibility., Gene Therapy, 23(2), 135-143. doi:10.1038/gt.2015.105 [doi]
    Zheng ZY, Anurag M, Lei JT, Cao J, Singh P, Peng J, Kennedy H, Nguyen NC, Chen Y, Lavere P, Li J, Du XH, Cakar B, Song W, Kim BJ, Shi J, Seker S, Chan DW, Zhao GQ, Chen X, Banks KC, Lanman RB, Shafaee MN, Zhang XH, Vasaikar S, Zhang B, Hilsenbeck SG, Li W, Foulds CE, Ellis MJ, Chang EC., Neurofibromin Is an Estrogen Receptor-α Transcriptional Co-repressor in Breast Cancer, Cancer Cell. 2020 Mar 16;37(3):387-402.e7. doi: 10.1016/j.ccell.2020.02.003. Epub 2020 Mar 5.
    Yu, X., Liu, F., Zeng, L., He, F., Zhang, R., Yan, S., . . . Chen, L. (2018)., Niclosamide exhibits potent anticancer activity and synergizes with sorafenib in human renal cell cancer cells., Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology, 47(3), 957-971. doi:10.1159/000490140 [doi]
    Bousquet Mur E, Bernardo S, Papon L, Mancini M, Fabbrizio E, Goussard M, Ferrer I, Giry A, Quantin X, Pujol JL, Calvayrac O, Moll HP, Glasson Y, Pirot N, Turtoi A, Cañamero M, Wong KK, Yarden Y, Casanova E, Soria JC, Colinge J, Siebel CW, Mazieres J, Favre G, Paz-Ares L, Maraver A., Notch inhibition overcomes resistance to tyrosine kinase inhibitors in EGFR-driven lung adenocarcinoma, J Clin Invest. 2020 Feb 3;130(2):612-624. doi: 10.1172/JCI126896.
    Chen, H., Jacobson, O., Niu, G., Weiss, I. D., Kiesewetter, D. O., Liu, Y., . . . Chen, X. (2017)., Novel "add-on" molecule based on evans blue confers superior pharmacokinetics and transforms drugs to theranostic agents. Journal of Nuclear Medicin, Official Publication, Society of Nuclear Medicine, 58(4), 590-597. doi:10.2967/jnumed.116.182097 [doi]
    Choi, A. H., O'Leary, M. P., Chaurasiya, S., Lu, J., Kim, S. I., Fong, Y., & Chen, N. G. (2018)., Novel chimeric parapoxvirus CF189 as an oncolytic immunotherapy in triple-negative breast cancer, Surgery, 163(2), 336-342. doi:S0039-6060(17)30670-0 [pii]
    Kanthala, S., Banappagari, S., Gokhale, A., Liu, Y. Y., Xin, G., Zhao, Y., & Jois, S. (2015)., Novel peptidomimetics for inhibition of HER2:HER3 heterodimerization in HER2-positive breast cancer., Chemical Biology & Drug Design, 85(6), 702-714. doi:10.1111/cbdd.12453 [doi]
    Marayati R, Williams AP, Bownes LV, Quinn CH, Stewart JE, Mroczek-Musulman E, Atigadda VR, Beierle EA., Novel retinoic acid derivative induces differentiation and growth arrest in neuroblastoma, J Pediatr Surg. 2020 Jun;55(6):1072-1080. doi: 10.1016/j.jpedsurg.2020.02.027. Epub 2020 Feb 28.
    Chen Y, Li X, Mamouni K, Yang Y, Danaher A, White J, Liu H, Kucuk O, Gera L, Wu D., Novel small-molecule LG1836 inhibits the in vivo growth of castration-resistant prostate cancer, Prostate. 2020 Sep;80(12):993-1005. doi: 10.1002/pros.24032. Epub 2020 Jun 19.
    Hegde, Ganapati V; de la Cruz, Cecile; Giltnane, Jennifer M; Crocker, Lisa; Venkatanarayan, Avinashnarayan; Schaefer, Gabriele; Dunlap, Debra; Hoeck, Joerg D; Piskol, Robert; Gnad, Florian; Modrusan, Zora; de Sauvage, Frederic J; Siebel, Christian W; Jackson, Erica L;, NRG1 is a critical regulator of differentiation in TP63-driven squamous cell carcinoma, eLife Vol.8, 2019
    Somwar R, Hofmann NE, Smith B, Odintsov I, Vojnic M, Linkov I, Tam A, Khodos I, Mattar MS, de Stanchina E, Flynn D, Ladanyi M, Drilon A, Shinde U, Davare MA., NTRK kinase domain mutations in cancer variably impact sensitivity to type I and type II inhibitors, Commun Biol. 2020 Dec 16;3(1):776. doi: 10.1038/s42003-020-01508-w.
    Yi J, Zhu J, Wu J, Thompson CB, Jiang X., Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis, Proc Natl Acad Sci U S A. 2020 Dec 8;117(49):31189-31197. doi: 10.1073/pnas.2017152117. Epub 2020 Nov 23.
    Lagerweij, T., Dusoswa, S. A., Negrean, A., Hendrikx, E. M. L., de Vries, H. E., Kole, J., . . . Wurdinger, T. (2017)., Optical clearing and fluorescence deep-tissue imaging for 3D quantitative analysis of the brain tumor microenvironment., Angiogenesis, 20(4), 533-546. doi:10.1007/s10456-017-9565-6 [doi]
    Walsh, Alex J; Castellanos, Jason A; Nagathihalli, Nagaraj S; Merchant, Nipun B; Skala, Melissa C;, Optical Imaging of Drug-Induced Metabolism Changes in Murine and Human Pancreatic Cancer Organoids Reveals Heterogeneous Drug Response., Pancreas Vol.45, 2016
    Pearson, H. E., Iida, M., Orbuch, R. A., McDaniel, N. K., Nickel, K. P., Kimple, R. J., . . . Wheeler, D. L. (2018)., Overcoming resistance to cetuximab with honokiol, A small-molecule polyphenol., Molecular Cancer Therapeutics, 17(1), 204-214. doi:10.1158/1535-7163.MCT-17-0384 [doi]
    Al-Azayzih, A., Gao, F., & Somanath, P. R. (2015)., P21 activated kinase-1 mediates transforming growth factor beta1-induced prostate cancer cell epithelial to mesenchymal transition., Biochimica Et Biophysica Acta, 1853(5), 1229-1239. doi:10.1016/j.bbamcr.2015.02.023 [doi]
    Lubik, A. A., Nouri, M., Truong, S., Ghaffari, M., Adomat, H. H., Corey, E., . . . Buttyan, R. (2017), Paracrine sonic hedgehog signaling contributes significantly to acquired steroidogenesis in the prostate tumor microenvironment., International Journal of Cancer, 140(2), 358-369. doi:10.1002/ijc.30450 [doi]
    Kamiyama, H., Rauenzahn, S., Shim, J. S., Karikari, C. A., Feldmann, G., Hua, L., . . . Eshleman, J. R. (2013)., Personalized chemotherapy profiling using cancer cell lines from selectable mice., Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 19(5), 1139-1146. doi:10.1158/1078-0432.CCR-12-2127 [doi]
    Alexander, M. S., Wilkes, J. G., Schroeder, S. R., Buettner, G. R., Wagner, B. A., Du, J., . . . Cullen, J. J. (2018)., Pharmacological ascorbate reduces radiation-induced normal tissue toxicity and enhances tumor radiosensitization in pancreatic cancer., Cancer Research, doi:canres.1680.2018 [pii]
    Zhang, Y. J., Zhan, X., Wang, L., Ho, R. J., & Sasaki, T. (2015), pH-responsive artemisinin dimer in lipid nanoparticles are effective against human breast cancer in a xenograft model., Journal of Pharmaceutical Sciences, 104(5), 1815-1824. doi:10.1002/jps.24407 [doi]
    Pandya, K., Wyatt, D., Gallagher, B., Shah, D., Baker, A., Bloodworth, J., . . . Osipo, C. (2016)., PKCalpha attenuates jagged-1-mediated notch signaling in ErbB-2-positive breast cancer to reverse trastuzumab resistance., Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 22(1), 175-186. doi:10.1158/1078-0432.CCR-15-0179 [doi]
    Galmarini, C. M., Martin, M., Bouchet, B. P., Guillen-Navarro, M. J., Martinez-Diez, M., Martinez-Leal, J. F., . . . Aviles, P. (2018)., Plocabulin, a novel tubulin-binding agent, inhibits angiogenesis by modulation of microtubule dynamics in endothelial cells., BMC Cancer, 18(1), 164-018-4086-2. doi:10.1186/s12885-018-4086-2 [doi]
    Carlier, C., Strese, S., Viktorsson, K., Velander, E., Nygren, P., Uustalu, M., . . . Gullbo, J. (2016)., Preclinical activity of melflufen (J1) in ovarian cancer., Oncotarget, 7(37), 59322-59335. doi:10.18632/oncotarget.11163 [doi]
    Scribner JA, Brown JG, Son T, Chiechi M, Li P, Sharma S, Li H, De Costa A, Li Y, Chen Y, Easton A, Yee-Toy NC, Chen FZ, Gorlatov S, Barat B, Huang L, Wolff CR, Hooley J, Hotaling TE, Gaynutdinov T, Ciccarone V, Tamura J, Koenig S, Moore PA, Bonvini E, Loo D., Preclinical Development of MGC018, a Duocarmycin-based Antibody-drug Conjugate Targeting B7-H3 for Solid Cancer, Mol Cancer Ther. 2020 Sep 23:molcanther.0116.2020. doi: 10.1158/1535-7163.MCT-20-0116. Online ahead of print.
    Hammer S, Hagemann UB, Zitzmann-Kolbe S, Larsen A, Ellingsen C, Geraudie S, Grant D, Indrevoll B, Smeets R, von Ahsen O, Kristian A, Lejeune P, Hennekes H, Karlsson J, Bjerke RM, Ryan OB, Cuthbertson AS, Mumberg D., Preclinical Efficacy of a PSMA-Targeted Thorium-227 Conjugate (PSMA-TTC), a Targeted Alpha Therapy for Prostate Cancer, Clin Cancer Res. 2020 Apr 15;26(8):1985-1996. doi: 10.1158/1078-0432.CCR-19-2268. Epub 2019 Dec 12.
    Verreault, M., Schmitt, C., Goldwirt, L., Pelton, K., Haidar, S., Levasseur, C., . . . Idbaih, A. (2016)., Preclinical efficacy of the MDM2 inhibitor RG7112 in MDM2-amplified and TP53 wild-type glioblastomas, Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 22(5), 1185-1196. doi:10.1158/1078-0432.CCR-15-1015 [doi]
    Harper, J., Lloyd, C., Dimasi, N., Toader, D., Marwood, R., Lewis, L., . . . Kamal, A. (2017)., Preclinical evaluation of MEDI0641, a pyrrolobenzodiazepine-conjugated antibody-drug conjugate targeting 5T4., Molecular Cancer Therapeutics, 16(8), 1576-1587. doi:10.1158/1535-7163.MCT-16-0825 [doi]
    Waters, A. M., Stewart, J. E., Atigadda, V. R., Mroczek-Musulman, E., Muccio, D. D., Grubbs, C. J., & Beierle, E. A. (2016)., Preclinical evaluation of UAB30 in pediatric renal and hepatic malignancies., Molecular Cancer Therapeutics, 15(5), 911-921. doi:10.1158/1535-7163.MCT-15-0521 [doi]
    Segatto, I., Massarut, S., Boyle, R., Baldassarre, G., Walker, D., & Belletti, B. (2016)., Preclinical validation of a novel compound targeting p70S6 kinase in breast cancer., Aging, 8(5), 958-976. doi:10.18632/aging.100954 [doi]
    Advani, S. J., Buckel, L., Chen, N. G., Scanderbeg, D. J., Geissinger, U., Zhang, Q., . . . Szalay, A. A. (2012)., Preferential replication of systemically delivered oncolytic vaccinia virus in focally irradiated glioma xenografts, Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 18(9), 2579-2590. doi:10.1158/1078-0432.CCR-11-2394 [doi]
    Avasarala, S., Van Scoyk, M., Karuppusamy Rathinam, M. K., Zerayesus, S., Zhao, X., Zhang, W., . . . Bikkavilli, R. K. (2015)., PRMT1 is a novel regulator of epithelial-mesenchymal-transition in non-small cell lung cancer, The Journal of Biological Chemistry, 290(21), 13479-13489. doi:10.1074/jbc.M114.636050 [doi]
    Zhang, Y., Thayele Purayil, H., Black, J. B., Fetto, F., Lynch, L. D., Masannat, J. N., & Daaka, Y. (2017)., Prostaglandin E2 receptor 4 mediates renal cell carcinoma intravasation and metastasis., Cancer Letters, 391, 50-58. doi:S0304-3835(17)30029-0 [pii]
    Dou, Liping; Yan, Fei; Pang, Jiuxia; Zheng, Dehua; Li, Dandan; Gao, Li; Wang, Lijun; Xu, Yihan; Shi, Jinlong; Wang, Qian; Zhou, Lei; Shen, Na; Singh, Puja; Wang, Lili; Li, Yonghui; Gao, Yvchi; Liu, Tao; Chen, Chongjian; Al-Kali, Aref; Litzow, Mark R; Chi, Young-In; Bode, Ann M; Liu, Chunhui; Huang, Haojie; Liu, Daihong; Marcucci, Guido; Liu, Shujun; Yu, Li;, Protein lysine 43 methylation by EZH1 promotes AML1-ETO transcriptional repression in leukemia., Nature communications Vol.10, 2019
    Tozzi M, Sørensen CE, Magni L, Christensen NM, Bouazzi R, Buch CM, Stefanini M, Duranti C, Arcangeli A, Novak I., Proton Pump Inhibitors Reduce Pancreatic Adenocarcinoma Progression by Selectively Targeting H(+), K(+)-ATPases in Pancreatic Cancer and Stellate Cells, Cancers (Basel). 2020 Mar 10;12(3):640. doi: 10.3390/cancers12030640.
    Mohammadabadi A, Huynh RN, Wadajkar AS, Lapidus RG, Kim AJ, Raub CB, Frenkel V., Pulsed focused ultrasound lowers interstitial fluid pressure and increases nanoparticle delivery and penetration in head and neck squamous cell carcinoma xenograft tumors, Phys Med Biol. 2020 Jun 22;65(12):125017. doi: 10.1088/1361-6560/ab9705.
    Kenny HA, Lal-Nag M, Shen M, Kara B, Nahotko DA, Wroblewski K, Fazal S, Chen S, Chiang CY, Chen YJ, Brimacombe KR, Marugan J, Ferrer M, Lengyel E., Quantitative High-Throughput Screening Using an Organotypic Model Identifies Compounds that Inhibit Ovarian Cancer Metastasis, Mol Cancer Ther. 2020 Jan;19(1):52-62. doi: 10.1158/1535-7163.MCT-19-0052. Epub 2019 Sep 27.
    Gupta K, Vuckovic I, Zhang S, Xiong Y, Carlson BL, Jacobs J, Olson I, Petterson XM, Macura SI, Sarkaria J, Burns TC., Radiation Induced Metabolic Alterations Associate With Tumor Aggressiveness and Poor Outcome in Glioblastoma, Front Oncol. 2020 May 5;10:535. doi: 10.3389/fonc.2020.00535. eCollection 2020.
    Deshayes, E., Ladjohounlou, R., Le Fur, P., Pichard, A., Lozza, C., Boudousq, V., . . . Pouget, J. P. (2018)., Radiolabeled antibodies against mullerian-inhibiting substance receptor, type II: New tools for a theranostic approach in ovarian cancer., Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, 59(8), 1234-1242. doi:10.2967/jnumed.118.208611 [doi]
    Jiang, D., Im, H. J., Sun, H., Valdovinos, H. F., England, C. G., Ehlerding, E. B., . . . Cai, W. (2017)., Radiolabeled pertuzumab for imaging of human epidermal growth factor receptor 2 expression in ovarian cancer., European Journal of Nuclear Medicine and Molecular Imaging, 44(8), 1296-1305. doi:10.1007/s00259-017-3663-y [doi]
    Albertoni, C., Leoni, B., Rosi, A., D'Alessio, V., Carollo, V., Spagnoli, L. G., . . . De Santis, R. (2015)., Radionuclide therapy of unresectable tumors with AvidinOX and (90)Y-biotinDOTA: Tongue cancer paradigm., Cancer Biotherapy & Radiopharmaceuticals, 30(7), 291-298. doi:10.1089/cbr.2015.1837 [doi]
    Schoenfeld, J. D., Sibenaller, Z. A., Mapuskar, K. A., Bradley, M. D., Wagner, B. A., Buettner, G. R., . . . Allen, B. G. (2018)., Redox active metals and H2O2 mediate the increased efficacy of pharmacological ascorbate in combination with gemcitabine or radiation in pre-clinical sarcoma models., Redox Biology, 14, 417-422. doi:S2213-2317(17)30582-7 [pii]
    Mantis, C., Kandela, I., Aird, F., & Reproducibility Project: Cancer Biology. (2017)., Replication study: Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs., Elife, 6, 10.7554/eLife.17584. doi:10.7554/eLife.17584 [doi]
    Ramachandran S, Srivastava SK., Repurposing Pimavanserin, an Anti-Parkinson Drug for Pancreatic Cancer Therapy, Mol Ther Oncolytics. 2020 Sep 2;19:19-32. doi: 10.1016/j.omto.2020.08.019. eCollection 2020 Dec 16.
    Kizilbash, S. H., Gupta, S. K., Chang, K., Kawashima, R., Parrish, K. E., Carlson, B. L., . . . Sarkaria, J. N. (2017)., Restricted delivery of talazoparib across the blood-brain barrier limits the sensitizing effects of PARP inhibition on temozolomide therapy in glioblastoma., Molecular Cancer Therapeutics, 16(12), 2735-2746. doi:10.1158/1535-7163.MCT-17-0365 [doi]
    Smith, Bryan D; Kaufman, Michael D; Lu, Wei-Ping; Gupta, Anu; Leary, Cynthia B; Wise, Scott C; Rutkoski, Thomas J; Ahn, Yu Mi; Al-Ani, Gada; Bulfer, Stacie L; Caldwell, Timothy M; Chun, Lawrence; Ensinger, Carol L; Hood, Molly M; McKinley, Arin; Patt, William C; Ruiz-Soto, Rodrigo; Su, Ying; Telikepalli, Hanumaiah; Town, Ajia; Turner, Benjamin A; Vogeti, Lakshminarayana; Vogeti, Subha; Yates, Karen; Janku, Filip; Abdul Razak, Albiruni Ryan; Rosen, Oliver; Heinrich, Michael C; Flynn, Daniel L;, Ripretinib (DCC-2618) Is a Switch Control Kinase Inhibitor of a Broad Spectrum of Oncogenic and Drug-Resistant KIT and PDGFRA Variants., Cancer cell Vol.35, 2019
    Mi, S., Lin, M., Brouwer-Visser, J., Heim, J., Smotkin, D., Hebert, T., . . . Huang, G. S. (2016), RNA-seq identification of RACGAP1 as a metastatic driver in uterine carcinosarcoma., Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 22(18), 4676-4686. doi:10.1158/1078-0432.CCR-15-2116 [doi]
    Cai, Demin; Wang, Junjian; Gao, Bei; Li, Jin; Wu, Feng; Zou, June X; Xu, Jianzhen; Jiang, Yuqian; Zou, Hongye; Huang, Zenghong; Borowsky, Alexander D; Bold, Richard J; Lara, Primo N; Li, Jian Jian; Chen, Xinbin; Lam, Kit S; To, Ka-Fai; Kung, Hsing-Jien; Fiehn, Oliver; Zhao, Ruqian; Evans, Ronald M; Chen, Hong-Wu;, ROR? is a targetable master regulator of cholesterol biosynthesis in a cancer subtype., Nature communications Vol.10, 2019
    Winter, U., Mena, H. A., Negrotto, S., Arana, E., Pascual-Pasto, G., Laurent, V., . . . Schaiquevich, P. (2016)., Schedule-dependent antiangiogenic and cytotoxic effects of chemotherapy on vascular endothelial and retinoblastoma cells., PloS One, 11(7), e0160094. doi:10.1371/journal.pone.0160094 [doi]
    Robles, A. J., Cai, S., Cichewicz, R. H., & Mooberry, S. L. (2016)., Selective activity of deguelin identifies therapeutic targets for androgen receptor-positive breast cancer., Breast Cancer Research and Treatment, 157(3), 475-488. doi:10.1007/s10549-016-3841-9 [doi]
    Yu, Z., He, S., Wang, D., Patel, H. K., Miller, C. P., Brown, J. L., . . . Saeh, J. C. (2017), Selective androgen receptor modulator RAD140 inhibits the growth of Androgen/Estrogen receptor-positive breast cancer models with a distinct mechanism of action., Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 23(24), 7608-7620. doi:10.1158/1078-0432.CCR-17-0670 [doi]
    Kausar, T., Schreiber, J. S., Karnak, D., Parsels, L. A., Parsels, J. D., Davis, M. A., . . . Morgan, M. A. (2015)., Sensitization of pancreatic cancers to gemcitabine chemoradiation by WEE1 kinase inhibition depends on homologous recombination repair, Neoplasia (New York, N.Y.), 17(10), 757-766. doi:10.1016/j.neo.2015.09.006 [doi]
    Kietzman, William B; Graham, Garrett T; Ory, Virginie; Sharif, Ghada M; Kushner, Max H; Gallanis, Gregory T; Kallakury, Bhaskar; Wellstein, Anton; Riegel, Anna T;, Short- and Long-Term Effects of CDK4/6 Inhibition on Early-Stage Breast Cancer., Molecular cancer therapeutics Vol.18, 2019
    Leelatian, N., Doxie, D. B., Greenplate, A. R., Mobley, B. C., Lehman, J. M., Sinnaeve, J., . . . Irish, J. M. (2017)., Single cell analysis of human tissues and solid tumors with mass cytometry., Cytometry.Part B, Clinical Cytometry, 92(1), 68-78. doi:10.1002/cyto.b.21481 [doi]
    Tchoghandjian, A., Jennewein, C., Eckhardt, I., Momma, S., Figarella-Branger, D., & Fulda, S. (2014)., Smac mimetic promotes glioblastoma cancer stem-like cell differentiation by activating NF-kappaB., Cell Death and Differentiation, 21(5), 735-747. doi:10.1038/cdd.2013.200 [doi]
    Yoshida, K., Toden, S., Weng, W., Shigeyasu, K., Miyoshi, J., Turner, J., . . . Goel, A. (2017)., SNORA21 - an oncogenic small nucleolar RNA, with a prognostic biomarker potential in human colorectal cancer., Ebiomedicine, 22, 68-77. doi:S2352-3964(17)30282-7 [pii]
    Bach, P., Abel, T., Hoffmann, C., Gal, Z., Braun, G., Voelker, I., . . . Buchholz, C. J. (2013)., Specific elimination of CD133+ tumor cells with targeted oncolytic measles virus., Cancer Research, 73(2), 865-874. doi:10.1158/0008-5472.CAN-12-2221 [doi]
    Li, X., Wu, J. B., Li, Q., Shigemura, K., Chung, L. W., & Huang, W. C. (2016), SREBP-2 promotes stem cell-like properties and metastasis by transcriptional activation of c-myc in prostate cancer., Oncotarget, 7(11), 12869-12884. doi:10.18632/oncotarget.7331 [doi]
    Gergen AK, Kohtz PD, Halpern AL, White AM, Meng X, Fullerton DA, Weyant MJ., Statins Inhibit Toll-Like Receptor 4-Mediated Growth of Human Esophageal Adenocarcinoma Cells, J Surg Res. 2020 Nov 30:S0022-4804(20)30754-X. doi: 10.1016/j.jss.2020.11.016. Online ahead of print.
    Trotta F, Avena P, Chimento A, Rago V, De Luca A, Sculco S, Nocito MC, Malivindi R, Fallo F, Pezzani R, Pilon C, Lasorsa FM, Barile SN, Palmieri L, Lerario AM, Pezzi V, Casaburi I, Sirianni R., Statins Reduce Intratumor Cholesterol Affecting Adrenocortical Cancer Growth, Mol Cancer Ther. 2020 Sep;19(9):1909-1921. doi: 10.1158/1535-7163.MCT-19-1063. Epub 2020 Jun 16.
    Gao, F., Alwhaibi, A., Sabbineni, H., Verma, A., Eldahshan, W., & Somanath, P. R. (2017)., Suppression of Akt1-beta-catenin pathway in advanced prostate cancer promotes TGFbeta1-mediated epithelial to mesenchymal transition and metastasis., Cancer Letters, 402, 177-189. doi:S0304-3835(17)30374-9 [pii]
    England RM, Moss JI, Gunnarsson A, Parker JS, Ashford MB., Synthesis and Characterization of Dendrimer-Based Polysarcosine Star Polymers: Well-Defined, Versatile Platforms Designed for Drug-Delivery Applications, Biomacromolecules. 2020 Aug 10;21(8):3332-3341. doi: 10.1021/acs.biomac.0c00768. Epub 2020 Jul 28.
    Vanderburgh, Joseph P; Kwakwa, Kristin A; Werfel, Thomas A; Merkel, Alyssa R; Gupta, Mukesh K; Johnson, Rachelle W; Guelcher, Scott A; Duvall, Craig L; Rhoades, Julie A;, Systemic delivery of a Gli inhibitor via polymeric nanocarriers inhibits tumor-induced bone disease, Journal of controlled release : official journal of the Controlled Release Society Vol.311-312, 2019
    Babae, N., Bourajjaj, M., Liu, Y., Van Beijnum, J. R., Cerisoli, F., Scaria, P. V., . . . Schiffelers, R. M. (2014)., Systemic miRNA-7 delivery inhibits tumor angiogenesis and growth in murine xenograft glioblastoma., Oncotarget, 5(16), 6687-6700. doi:2235 [pii]
    Rudnick-Glick, S., Corem-Salkmon, E., Grinberg, I., & Margel, S. (2016)., Targeted drug delivery of near IR fluorescent doxorubicin-conjugated poly(ethylene glycol) bisphosphonate nanoparticles for diagnosis and therapy of primary and metastatic bone cancer in a mouse model., Journal of Nanobiotechnology, 14(1), 80-016-0233-6. doi:10.1186/s12951-016-0233-6 [doi]
    Chan, C. M., Jing, X., Pike, L. A., Zhou, Q., Lim, D. J., Sams, S. B., . . . Schweppe, R. E. (2012)., Targeted inhibition of src kinase with dasatinib blocks thyroid cancer growth and metastasis., . Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 18(13), 3580-3591. doi:10.1158/1078-0432.CCR-11-3359 [doi]
    Sen, T., Tong, P., Diao, L., Li, L., Fan, Y., Hoff, J., . . . Byers, L. A. (2017)., Targeting AXL and mTOR pathway overcomes primary and acquired resistance to WEE1 inhibition in small-cell lung cancer, Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 23(20), 6239-6253. doi:10.1158/1078-0432.CCR-17-1284 [doi]
    Lallous, N., Leblanc, E., Munuganti, R. S., Hassona, M. D., Nakouzi, N. A., Awrey, S., . . . Cherkasov, A. (2016)., Targeting binding function-3 of the androgen receptor blocks its co-chaperone interactions, nuclear translocation, and activation., Molecular Cancer Therapeutics, 15(12), 2936-2945. doi:1535-7163.MCT-16-0354 [pii]
    Pittala, S., Krelin, Y., & Shoshan-Barmatz, V. (2018), Targeting liver cancer and associated pathologies in mice with a mitochondrial VDAC1-based peptide., Neoplasia (New York, N.Y.), 20(6), 594-609. doi:S1476-5586(17)30508-0 [pii]
    de Lucas, A. G., Schuhmacher, A. J., Oteo, M., Romero, E., Camara, J. A., de Martino, A., . . . Mulero, F. (2016), Targeting MT1-MMP as an ImmunoPET-based strategy for imaging gliomas., PloS One, 11(7), e0158634. doi:10.1371/journal.pone.0158634 [doi]
    Stafman, L. L., Mruthyunjayappa, S., Waters, A. M., Garner, E. F., Aye, J. M., Stewart, J. E., . . . Beierle, E. A. (2018)., Targeting PIM kinase as a therapeutic strategy in human hepatoblastoma., Oncotarget, 9(32), 22665-22679. doi:10.18632/oncotarget.25205 [doi]
    Stafman, Laura L; Williams, Adele P; Garner, Evan F; Aye, Jamie M; Stewart, Jerry E; Yoon, Karina J; Whelan, Kimberly; Beierle, Elizabeth A;, Targeting PIM Kinases Affects Maintenance of CD133 Tumor Cell Population in Hepatoblastoma., Translational oncology Vol.12, 2019
    de Boer, D. V., Martens-de Kemp, S. R., Buijze, M., Stigter-van Walsum, M., Bloemena, E., Dietrich, R., . . . Brakenhoff, R. H. (2017)., Targeting PLK1 as a novel chemopreventive approach to eradicate preneoplastic mucosal changes in the head and neck., Oncotarget, 8(58), 97928-97940. doi:10.18632/oncotarget.17880 [doi]
    Alimova, I., Pierce, A. M., Harris, P., Donson, A., Birks, D. K., Prince, E., . . . Vibhakar, R. (2017)., Targeting polo-like kinase 1 in SMARCB1 deleted atypical teratoid rhabdoid tumor, Oncotarget, 8(57), 97290-97303. doi:10.18632/oncotarget.21932 [doi]
    Sen, M., Joyce, S., Panahandeh, M., Li, C., Thomas, S. M., Maxwell, J., . . . Grandis, J. R. (2012), Targeting Stat3 abrogates EGFR inhibitor resistance in cancer., Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 18(18), 4986-4996. doi:10.1158/1078-0432.CCR-12-0792 [doi]
    Jimbo, M., Blanco, F. F., Huang, Y. H., Telonis, A. G., Screnci, B. A., Cosma, G. L., . . . Brody, J. R. (2015), Targeting the mRNA-binding protein HuR impairs malignant characteristics of pancreatic ductal adenocarcinoma cells, Oncotarget, 6(29), 27312-27331. doi:10.18632/oncotarget.4743 [doi]
    Sinha S, Dwivedi N, Tao S, Jamadar A, Kakade VR, Neil MO, Weiss RH, Enders J, Calvet JP, Thomas SM, Rao R., Targeting the vasopressin type-2 receptor for renal cell carcinoma therapy, Oncogene. 2020 Feb;39(6):1231-1245. doi: 10.1038/s41388-019-1059-0. Epub 2019 Oct 15.
    Capone E, Lamolinara A, Pastorino F, Gentile R, Ponziani S, Di Vittorio G, D'Agostino D, Bibbò S, Rossi C, Piccolo E, Iacobelli V, Lattanzio R, Panella V, Sallese M, De Laurenzi V, Giansanti F, Sala A, Iezzi M, Ponzoni M, Ippoliti R, Iacobelli S, Sala G., Targeting Vesicular LGALS3BP by an Antibody-Drug Conjugate as Novel Therapeutic Strategy for Neuroblastoma, Cancers (Basel). 2020 Oct 15;12(10):2989. doi: 10.3390/cancers12102989.
    Jin, U. H., Lee, S. O., Pfent, C., & Safe, S. (2014)., The aryl hydrocarbon receptor ligand omeprazole inhibits breast cancer cell invasion and metastasis., BMC Cancer, 14, 498-2407-14-498. doi:10.1186/1471-2407-14-498 [doi]
    Morell, C., Bort, A., Vara, D., Ramos-Torres, A., Rodriguez-Henche, N., & Diaz-Laviada, I. (2016)., The cannabinoid WIN 55,212-2 prevents neuroendocrine differentiation of LNCaP prostate cancer cells., Prostate Cancer and Prostatic Diseases, 19(3), 248-257. doi:10.1038/pcan.2016.19 [doi]
    van Senten, Jeffrey R; Bebelman, Maarten P; Fan, Tian Shu; Heukers, Raimond; Bergkamp, Nick D; van Gasselt, Puck; Langemeijer, Ellen V; Slinger, Erik; Lagerweij, Tonny; Rahbar, Afsar; Stigter-van Walsum, Marijke; Maussang, David; Leurs, Rob; Musters, René J P; van Dongen, Guus A M S; Söderberg-Nauclér, Cecilia; Würdinger, Thomas; Siderius, Marco; Smit, Martine J;, The human cytomegalovirus-encoded G protein-coupled receptor UL33 exhibits oncomodulatory properties, . The Journal of biological chemistry Vol.294, 2019
    Laprevotte, E., Cochaud, S., du Manoir, S., Lapierre, M., Dejou, C., Philippe, M., . . . Bonnefoy, N. (2017)., The IL-17B-IL-17 receptor B pathway promotes resistance to paclitaxel in breast tumors through activation of the ERK1/2 pathway, Oncotarget, 8(69), 113360-113372. doi:10.18632/oncotarget.23008 [doi]
    Canon, J., Osgood, T., Olson, S. H., Saiki, A. Y., Robertson, R., Yu, D., . . . Radinsky, R. (2015)., The MDM2 inhibitor AMG 232 demonstrates robust antitumor efficacy and potentiates the activity of p53-inducing cytotoxic agents, Molecular Cancer Therapeutics, 14(3), 649-658. doi:10.1158/1535-7163.MCT-14-0710 [doi]
    Canon, J., Osgood, T., Olson, S. H., Saiki, A. Y., Robertson, R., Yu, D., . . . Radinsky, R. (2015), The MDM2 inhibitor AMG 232 demonstrates robust antitumor efficacy and potentiates the activity of p53-inducing cytotoxic agents., Molecular Cancer Therapeutics, 14(3), 649-658. doi:10.1158/1535-7163.MCT-14-0710 [doi]
    Schuller, A. G., Barry, E. R., Jones, R. D., Henry, R. E., Frigault, M. M., Beran, G., . . . D'Cruz, C. M. (2015), The MET inhibitor AZD6094 (savolitinib, HMPL-504) induces regression in papillary renal cell carcinoma patient-derived xenograft models., Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 21(12), 2811-2819. doi:10.1158/1078-0432.CCR-14-2685 [doi]
    Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology Vol.48, 2019, The novel capsazepine analog, CIDD-99, significantly inhibits oral squamous cell carcinoma in vivo through a TRPV1-independent induction of ER stress, mitochondrial dysfunction, and apoptosis., De La Chapa, Jorge J; Singha, Prajjal K; Self, Kristen K; Sallaway, McKay L; McHardy, Stanton F; Hart, Matthew J; McGuff, Howard Stan; Valdez, Matthew C; Ruiz, Francisco; Polusani, Srikanth R; Gonzales, Cara B;
    Martin-Fernandez, M., Valencia, K., Zandueta, C., Ormazabal, C., Martinez-Canarias, S., Lecanda, F., & de la Piedra, C. (2017), The usefulness of bone biomarkers for monitoring treatment disease: A comparative study in osteolytic and osteosclerotic bone metastasis models., Translational Oncology, 10(2), 255-261. doi:S1936-5233(16)30223-6 [pii]
    Barbhuiya, M. A., Mirando, A. C., Simons, B. W., Lemtiri-Chlieh, G., Green, J. J., Popel, A. S., . . . Tran, P. T. (2017)., Therapeutic potential of an anti-angiogenic multimodal biomimetic peptide in hepatocellular carcinoma, Oncotarget, 8(60), 101520-101534. doi:10.18632/oncotarget.21148 [doi]
    Gadkari K, Kolhatkar U, Hemani R, Campanelli G, Cai Q, Kumar A, Levenson AS., Therapeutic Potential of Gnetin C in Prostate Cancer: A Pre-Clinical Study, Nutrients. 2020 Nov 26;12(12):3631. doi: 10.3390/nu12123631.
    Redko, B., Tuchinsky, H., Segal, T., Tobi, D., Luboshits, G., Ashur-Fabian, O., . . . Gellerman, G. (2017)., Toward the development of a novel non-RGD cyclic peptide drug conjugate for treatment of human metastatic melanoma, Oncotarget, 8(1), 757-768. doi:10.18632/oncotarget.12748 [doi]
    Kiesel, B. F., Parise, R. A., Guo, J., Huryn, D. M., Johnston, P. A., Colombo, R., . . . Eiseman, J. L. (2016)., Toxicity, pharmacokinetics and metabolism of a novel inhibitor of IL-6-induced STAT3 activation., Cancer Chemotherapy and Pharmacology, 78(6), 1225-1235. doi:10.1007/s00280-016-3181-9 [doi]
    Zhang, Z., Li, Z., Wu, X., Zhang, C. F., Calway, T., He, T. C., . . . Yuan, C. S. (2015)., TRAIL pathway is associated with inhibition of colon cancer by protopanaxadiol., Journal of Pharmacological Sciences, 127(1), 83-91. doi:10.1016/j.jphs.2014.11.003 [doi]
    Zhu, Jiajun; Berisa, Mirela; Schwörer, Simon; Qin, Weige; Cross, Justin R; Thompson, Craig B;, Transsulfuration Activity Can Support Cell Growth upon Extracellular Cysteine Limitation, Cell metabolism Vol.30, 2019
    Theunissen, J. W., Cai, A. G., Bhatti, M. M., Cooper, A. B., Avery, A. D., Dorfman, R., . . . Migone, T. S. (2018)., Treating tissue factor-positive cancers with antibody-drug conjugates that do not affect blood clotting., Molecular Cancer Therapeutics, doi:molcanther.0471.2018 [pii]
    Ostler, K. R., Yang, Q., Looney, T. J., Zhang, L., Vasanthakumar, A., Tian, Y., . . . Godley, L. A. (2012)., Truncated DNMT3B isoform DNMT3B7 suppresses growth, induces differentiation, and alters DNA methylation in human neuroblastoma., Cancer Research, 72(18), 4714-4723. doi:10.1158/0008-5472.CAN-12-0886 [doi]
    Dziegielewska, B., Casarez, E. V., Yang, W. Z., Gray, L. S., Dziegielewski, J., & Slack-Davis, J. K. (2016), T-type Ca2+ channel inhibition sensitizes ovarian cancer to carboplatin., Molecular Cancer Therapeutics, 15(3), 460-470. doi:10.1158/1535-7163.MCT-15-0456 [doi]
    Lingasamy P, Tobi A, Kurm K, Kopanchuk S, Sudakov A, Salumäe M, Rätsep T, Asser T, Bjerkvig R, Teesalu T., Tumor-penetrating peptide for systemic targeting of Tenascin-C, Sci Rep. 2020 Apr 2;10(1):5809. doi: 10.1038/s41598-020-62760-y.
    Emmenegger, U., Francia, G., Chow, A., Shaked, Y., Kouri, A., Man, S., & Kerbel, R. S. (2011)., Tumors that acquire resistance to low-dose metronomic cyclophosphamide retain sensitivity to maximum tolerated dose cyclophosphamide, Neoplasia (New York, N.Y.), 13(1), 40-48.
    Brunetti, J., Pillozzi, S., Falciani, C., Depau, L., Tenori, E., Scali, S., . . . Bracci, L. (2015)., Tumor-selective peptide-carrier delivery of paclitaxel increases in vivo activity of the drug, Scientific Reports, 5, 17736. doi:10.1038/srep17736 [doi]
    Yuan, B., Cheng, L., Gupta, K., Chiang, H. C., Gupta, H. B., Sareddy, G. R., . . . Li, R. (2016)., Tyrosine phosphorylation regulates ERbeta ubiquitination, protein turnover, and inhibition of breast cancer., Oncotarget, 7(27), 42585-42597. doi:10.18632/oncotarget.10018 [doi]
    Williams, Adele P; Garner, Evan F; Stafman, Laura L; Aye, Jamie M; Quinn, Colin H; Marayati, Raoud; Stewart, Jerry E; Atigadda, Venkatram R; Mroczek-Musulman, Elizabeth; Moore, Blake P; Beierle, Elizabeth A; Friedman, Gregory K;, UAB30, A Novel Rexinoid Agonist, Decreases Stemness In Group 3 Medulloblastoma Human Cell Line Xenografts., Translational oncology Vol.12, 2019
    Nguyen, Tu; Kirsch, Brian James; Asaka, Ryoichi; Nabi, Karim; Quinones, Addison; Tan, Jessica; Antonio, Marjorie Justine; Camelo, Felipe; Li, Ting; Nguyen, Stephanie; Hoang, Giang; Nguyen, Kiet; Udupa, Sunag; Sazeides, Christos; Shen, Yao-An; Elgogary, Amira; Reyes, Juvenal; Zhao, Liang; Kleensang, Andre; Chaichana, Kaisorn Lee; Hartung, Thomas; Betenbaugh, Michael J; Marie, Suely K; Jung, Jin G; Wang, Tian-Li; Gabrielson, Edward; Le, Anne;, Uncovering the Role of N-Acetyl-Aspartyl-Glutamate as a Glutamate Reservoir in Cance, Cell reports Vol.27, 2019
    Richter, K., Paakkola, T., Mennerich, D., Kubaichuk, K., Konzack, A., Kippari, H. A., . . . Kietzmann, T. (2018), USP28 deficiency promotes breast and liver carcinogenesis as well as tumor angiogenesis in a HIF-independent manner., Molecular Cancer Research : MCR, 16(6), 1000-1012. doi:10.1158/1541-7786.MCR-17-0452 [doi]
    Gholami, S., Chen, C. H., Lou, E., Belin, L. J., Fujisawa, S., Longo, V. A., . . . Fong, Y. (2014), Vaccinia virus GLV-1h153 in combination with 131I shows increased efficiency in treating triple-negative breast cancer., FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology, 28(2), 676-682. doi:10.1096/fj.13-237222 [doi]
    Gruslova, A., Cavazos, D. A., Miller, J. R., Breitbart, E., Cohen, Y. C., Bangio, L., . . . Brenner, A. J. (2015)., VB-111: A novel anti-vascular therapeutic for glioblastoma multiforme, Journal of Neuro-Oncology, 124(3), 365-372. doi:10.1007/s11060-015-1853-7 [doi]
    O'Steen, S., Green, D. J., Gopal, A. K., Orozco, J. J., Kenoyer, A. L., Lin, Y., . . . Press, O. W. (2017)., Venetoclax synergizes with radiotherapy for treatment of B-cell lymphomas., Cancer Research, 77(14), 3885-3893. doi:10.1158/0008-5472.CAN-17-0082 [doi]
    Patil, S. S., Gentschev, I., Adelfinger, M., Donat, U., Hess, M., Weibel, S., . . . Szalay, A. A. (2012)., Virotherapy of canine tumors with oncolytic vaccinia virus GLV-1h109 expressing an anti-VEGF single-chain antibody, PloS One, 7(10), e47472. doi:10.1371/journal.pone.0047472 [doi]
    Kim SI, Chaurasiya S, Park AK, Kang S, Lu J, Woo Y, Yin HH, Yin Z, Fong Y, Warner SG., Vitamin D as a Primer for Oncolytic Viral Therapy in Colon Cancer Models, Int J Mol Sci. 2020 Oct 3;21(19):7326. doi: 10.3390/ijms21197326.
    Stein, A. P., Swick, A. D., Smith, M. A., Blitzer, G. C., Yang, R. Z., Saha, S., . . . Kimple, R. J. (2015)., Xenograft assessment of predictive biomarkers for standard head and neck cancer therapies, Cancer Medicine, 4(5), 699-712. doi:10.1002/cam4.387 [doi]
    Zhang, Q., Sun, X., Yang, J., Ding, H., LeBrun, D., Ding, K., . . . Li, M. (2015)., ZIP4 silencing improves bone loss in pancreatic cancer., Oncotarget, 6(28), 26041-26051. doi:10.18632/oncotarget.4667 [doi]
    Cam M, Charan M, Welker AM, Dravid P, Studebaker AW, Leonard JR, Pierson CR, Nakano I, Beattie CE, Hwang EI, Kambhampati M, Nazarian J, Finlay JL, Cam H., ΔNp73/ETS2 complex drives glioblastoma pathogenesis- targeting downstream mediators by rebastinib prolongs survival in preclinical models of glioblastoma, Neuro Oncol. 2020 Mar 5;22(3):345-356. doi: 10.1093/neuonc/noz190.
    Tu C, Du Z, Zhang H, Feng Y, Qi Y, Zheng Y, Liu J, Wang J., Endocytic pathway inhibition attenuates extracellular vesicle-induced reduction of chemosensitivity to bortezomib in multiple myeloma cells., Theranostics 2021; 11(5):2364-2380. doi:10.7150/thno.47996.
    Huang, Weimei; Yang, Yunchu; Wu, Jingfang; Niu, Yuchun; Yao, Yao; Zhang, Jian; Huang, Xiaoxian; Liang, Shumei; Chen, Rui; Chen, Size; Guo, Linlang., Circular RNA cESRP1 sensitises small cell lung cancer cells to chemotherapy by sponging miR-93-5p to inhibit TGF-β signalling, Cell death and differentiation Vol.27, 2020
    Chen, Wancheng; Wang, Xuefei; Zhao, Bingxia; Zhang, Rongjun; Xie, Zhen; He, Yi; Chen, Ali; Xie, Xiaofang; Yao, Kaitai; Zhong, Mei; Yuan, Miaomiao., CuS-MnS2 nano-flowers for magnetic resonance imaging guided photothermal/photodynamic therapy of ovarian cancer through necroptosis., Nanoscale Vol.11, 2019
    Xiao, Xinhua; Li, Huiliang; Jin, Huizi; Jin, Jin; Yu, Miao; Ma, Chunmin; Tong, Yin; Zhou, Li; Lei, Hu; Xu, Hanzhang; Zhang, Weidong; Liu, Wei; Wu, Yingli., Identification of 11(13)-dehydroivaxillin as a potent therapeutic agent against non-Hodgkins lymphoma., Cell death & disease Vol.8, 2017
    Wang, Dan; Chen, Yao; Fang, Houshun; Zheng, Liang; Li, Ying; Yang, Fan; Xu, Yan; Du, Lijuan; Zhou, Bin-Bing S; Li, Hui., Increase of PRPP enhances chemosensitivity of PRPS1 mutant acute lymphoblastic leukemia cells to 5-Fluorouracil., Journal of cellular and molecular medicine Vol.22, 2018
    Sun, Yu; Sun, Ye; Yan, Kun; Li, Zhuxuan; Xu, Cheng; Geng, Yibo; Pan, Changcun; Chen, Xin; Zhang, Liwei; Xi, Qiaoran., Potent anti-tumor efficacy of palbociclib in treatment-naïve H3.3K27M-mutant diffuse intrinsic pontine glioma, EBioMedicine Vol.43, 2019
    Gong, Jianhua; Guo, Feihu; Cheng, Weihua; Fan, Hongqiang; Miao, Qingfang; Yang, Jigang., Preliminary biological evaluation of 123I-labelled anti-CD30-LDM in CD30-positive lymphomas murine models., Artificial cells, nanomedicine, and biotechnology Vol.48, 2020
    Lei, Hu; Tu, Yaoyao; Yang, Li; Jin, Jin; Luo, Hao; Xu, Hanzhang; Kang, Jingwu; Zhou, Li; Wu, Yingli., Quinacrine Depletes BCR-ABL and Suppresses Ph-Positive Leukemia Cells., Cancer investigation Vol.37, 2019
    Chen, Hua-Dong; Huang, Chen-Song; Xu, Qiong-Cong; Li, Fuxi; Huang, Xi-Tai; Wang, Jie-Qin; Li, Shi-Jin; Zhao, Wei; Yin, Xiao-Yu., Therapeutic Targeting of CDK7 Suppresses Tumor Progression in Intrahepatic Cholangiocarcinoma., International journal of biological sciences Vol.16, 2020
    Wu, Rihui; Mei, Xueting; Ye, Yibiao; Xue, Ting; Wang, Jiasheng; Sun, Wenjia; Lin, Caixia; Xue, Ruoxue; Zhang, Jiabao; Xu, Donghui., Zn(II)-curcumin solid dispersion impairs hepatocellular carcinoma growth and enhances chemotherapy by modulating gut microbiota-mediated zinc homeostasis., Pharmacological research Vol.150, 2019
    Sridharan, V., Tripathi, P., Sharma, S. K., Moros, E. G., Corry, P. M., Lieblong, B. J., . . . Boerma, M. (2012)., Cardiac inflammation after local irradiation is influenced by the kallikrein-kinin system., Cancer Research, 72(19), 4984-4992. doi:10.1158/0008-5472.CAN-12-1831 [doi]
    Huang, G., Wilson, N. A., Reese, S. R., Jacobson, L. M., Zhong, W., & Djamali, A. (2014)., Characterization of transfusion-elicited acute antibody-mediated rejection in a rat model of kidney transplantation., American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 14(5), 1061-1072. doi:10.1111/ajt.12674 [doi]
    Nilsson, R., Eriksson, S. E., Sjogren, H. O., & Tennvall, J. (2011)., Different toxicity profiles for drug- versus radionuclide-conjugated BR96 monoclonal antibodies in a syngeneic rat colon carcinoma model., Acta Oncologica (Stockholm, Sweden), 50(5), 711-718. doi:10.3109/0284186X.2010.547215 [doi]
    Maselli, J., Hales, B. F., Chan, P., & Robaire, B. (2012)., Exposure to bleomycin, etoposide, and cis-platinum alters rat sperm chromatin integrity and sperm head protein profile., Biology of Reproduction, 86(5), 166, 1-10. doi:10.1095/biolreprod.111.098616 [doi]
    Martensson, L., Nilsson, R., Ohlsson, T., Sjogren, H. O., Strand, S. E., & Tennvall, J. (2010)., High-dose radioimmunotherapy combined with extracorporeal depletion in a syngeneic rat tumor model: Evaluation of toxicity, therapeutic effect, and tumor model., Cancer, 116(4 Suppl), 1043-1052. doi:10.1002/cncr.24791 [doi]
    Sini, P., Samarzija, I., Baffert, F., Littlewood-Evans, A., Schnell, C., Theuer, A., . . . Hynes, N. E. (2008)., Inhibition of multiple vascular endothelial growth factor receptors (VEGFR) blocks lymph node metastases but inhibition of VEGFR-2 is sufficient to sensitize tumor cells to platinum-based chemotherapeutics., Cancer Research, 68(5), 1581-1592. doi:10.1158/0008-5472.CAN-06-4685 [doi]
    Elgstrom, E., Eriksson, S. E., Ohlsson, T. G., Tennvall, J., & Nilsson, R. (2012)., Pattern of antigen expression in metastases after radioimmunotherapy of a syngeneic rat colon carcinoma utilizing the BR96 antibody., Experimental Hematology & Oncology, 1(1), 34-3619-1-34. doi:10.1186/2162-3619-1-34 [doi]
    Elgstrom, E., Eriksson, S. E., Ohlsson, T. G., Tennvall, J., & Nilsson, R. (2012)., Pattern of antigen expression in metastases after radioimmunotherapy of a syngeneic rat colon carcinoma utilizing the BR96 antibody., Experimental Hematology & Oncology, 1(1), 34-3619-1-34. doi:10.1186/2162-3619-1-34 [doi]
    Tanaka, Y., Shigemura, N., Kawamura, T., Noda, K., Isse, K., Stolz, D. B., . . . Nakao, A. (2012)., Profiling molecular changes induced by hydrogen treatment of lung allografts prior to procurement., Biochemical and Biophysical Research Communications, 425(4), 873-879. doi:10.1016/j.bbrc.2012.08.005 [doi]
    Delbes, G., Chan, D., Hales, B. F., Trasler, J. M., & Robaire, B. (2013)., Selective induction of glutathione S-transferases in round spermatids from the brown-norway rat by the chemotherapeutic regimen for testicular cancer., Reproductive Toxicology (Elmsford, N.Y.), 36, 24-32. doi:10.1016/j.reprotox.2012.10.012 [doi]
    Eriksson, S. E., Back, T., Elgstrom, E., Jensen, H., Nilsson, R., Lindegren, S., & Tennvall, J. (2013)., Successful radioimmunotherapy of established syngeneic rat colon carcinoma with 211At-mAb., EJNMMI Research, 3(1), 23-219X-3-23. doi:10.1186/2191-219X-3-23 [doi]
    Ten Hagen, T. L., Seynhaeve, A. L., de Wiel-Ambagtsheer, G., de Bruijn, E. A., van Tiel, S. T., Ruegg, C., . . . Eggermont, A. M. (2013)., The alphaVbeta3/alphaVbeta5 integrin inhibitor cilengitide augments tumor response to melphalan isolated limb perfusion in a sarcoma model. International Journal of Cancer., Journal International Du Cancer, 132(11), 2694-2704. doi:10.1002/ijc.27940 [doi]
    Nilsson, R., Martensson, L., Eriksson, S. E., Sjogren, H. O., & Tennvall, J. (2010)., Toxicity-reducing potential of extracorporeal affinity adsorption treatment in combination with the auristatin-conjugated monoclonal antibody BR96 in a syngeneic rat tumor model., Cancer, 116(4 Suppl), 1033-1042. doi:10.1002/cncr.24790 [doi]
    Eriksson, S. E., Ohlsson, T., Nilsson, R., & Tennvall, J. (2012)., Treatment with unlabeled mAb BR96 after radioimmunotherapy with 177Lu-DOTA-BR96 in a syngeneic rat colon carcinoma model., Cancer Biotherapy & Radiopharmaceuticals, 27(3), 175-182. doi:10.1089/cbr.2011.1132 [doi]
    Colletti, J. A.,2nd, Leland-Wavrin, K. M., Kurz, S. G., Hickman, M. P., Seiler, N. L., Samanas, N. B., . . . Shull, J. D. (2014)., Validation of six genetic determinants of susceptibility to estrogen-induced mammary cancer in the rat and assessment of their relevance to breast cancer risk in humans., G3 (Bethesda, Md.), 4(8), 1385-1394. doi:10.1534/g3.114.011163 [doi]
    Healy, M. E., Chow, J. D., Byrne, F. L., Breen, D. S., Leitinger, N., Li, C., . . . Hoehn, K. L. (2015)., Dietary effects on liver tumor burden in mice treated with the hepatocellular carcinogen diethylnitrosamine., Journal of Hepatology, 62(3), 599-606. doi:10.1016/j.jhep.2014.10.024 [doi]
    Healy, M. E., Lahiri, S., Hargett, S. R., Chow, J. D., Byrne, F. L., Breen, D. S., . . . Hoehn, K. L. (2016)., Dietary sugar intake increases liver tumor incidence in female mice., Scientific Reports, 6, 22292. doi:10.1038/srep22292 [doi]
    Bransi, A., Salgado, O. C., Beffinger, M., Milo, K., Silina, K., Yagita, H., . . . van den Broek, M. (2015)., Rational combination of immunotherapies with clinical efficacy in mice with advanced cancer., Cancer Immunology Research, 3(11), 1279-1288. doi:10.1158/2326-6066.CIR-15-0103-T [doi]
    Barrett, J. A., Cai, H., Miao, J., Khare, P. D., Gonzalez, P., Dalsing-Hernandez, J., . . . Lebel, F. (2018)., Regulated intratumoral expression of IL-12 using a RheoSwitch therapeutic system((R)) (RTS((R))) gene switch as gene therapy for the treatment of glioma., Cancer Gene Therapy, 25(5-6), 106-116. doi:10.1038/s41417-018-0019-0 [doi]
    Suckow, M. A., Wolter, W. R., & Duffield, G. E. (2017)., The impact of environmental light intensity on experimental tumor growth., Anticancer Research, 37(9), 4967-4971. doi:37/9/4967 [pii]
    Patel, A., Anderson, J., Kraft, D., Finnon, R., Finnon, P., Scudamore, C. L., . . . Badie, C. (2016), The influence of the CTIP polymorphism, Q418P, on homologous recombination and predisposition to radiation-induced tumorigenesis (mainly rAML) in mice., Radiation Research, 186(6), 638-649. doi:10.1667/RR14495.1 [doi]
    Brighenti, E., Giannone, F. A., Fornari, F., Onofrillo, C., Govoni, M., Montanaro, L., . . . Derenzini, M. (2016)., Therapeutic dosages of aspirin counteract the IL-6 induced pro-tumorigenic effects by slowing down the ribosome biogenesis rate., Oncotarget, 7(39), 63226-63241. doi:10.18632/oncotarget.11441 [doi]
    O'Rourke, K. P., Loizou, E., Livshits, G., Schatoff, E. M., Baslan, T., Manchado, E., . . . Lowe, S. W. (2017)., Transplantation of engineered organoids enables rapid generation of metastatic mouse models of colorectal cancer., Nature Biotechnology, 35(6), 577-582. doi:10.1038/nbt.3837 [doi]
    Andersen CL, Liu M, Wang Z, Ye X, Xiao S., Chemotherapeutic agent doxorubicin alters uterine gene expression in response to estrogen in ovariectomized CD-1 adult mice†, Biol Reprod. 2019 Apr 1;100(4):869-871. doi: 10.1093/biolre/ioy259.
    Ruban, A., Berkutzki, T., Cooper, I., Mohar, B., & Teichberg, V. I. (2012)., Blood glutamate scavengers prolong the survival of rats and mice with brain-implanted gliomas., Investigational New Drugs, 30(6), 2226-2235. doi:10.1007/s10637-012-9799-5 [doi]
    Lev-Ari, S., Starr, A., Katzburg, S., Berkovich, L., Rimmon, A., Ben-Yosef, R., . . . Earon, G. (2014)., Curcumin induces apoptosis and inhibits growth of orthotopic human non-small cell lung cancer xenografts., The Journal of Nutritional Biochemistry, 25(8), 843-850. doi:10.1016/j.jnutbio.2014.03.014 [doi]
    Carosio, R., Pistoia, V., Orienti, I., Formelli, F., Cavadini, E., Mangraviti, S., . . . Zuccari, G. (2012)., Enhanced anti-neuroblastoma activity of a fenretinide complexed form after intravenous administration., The Journal of Pharmacy and Pharmacology, 64(2), 228-236. doi:10.1111/j.2042-7158.2011.01403.x [doi]
    Yan, S. B., Peek, V. L., Ajamie, R., Buchanan, S. G., Graff, J. R., Heidler, S. A., . . . Walgren, R. A. (2013)., LY2801653 is an orally bioavailable multi-kinase inhibitor with potent activity against MET, MST1R, and other oncoproteins, and displays anti-tumor activities in mouse xenograft models., Investigational New Drugs, 31(4), 833-844. doi:10.1007/s10637-012-9912-9 [doi]
    Konson, A., Pradeep, S., & Seger, R. (2010)., Phosphomimetic mutants of pigment epithelium-derived factor with enhanced antiangiogenic activity as potent anticancer agents., Cancer Research, 70(15), 6247-6257. doi:10.1158/0008-5472.CAN-10-0434 [doi]
    Portella, L., Vitale, R., De Luca, S., D'Alterio, C., Ierano, C., Napolitano, M., . . . Scala, S. (2013)., Preclinical development of a novel class of CXCR4 antagonist impairing solid tumors growth and metastases., PloS One, 8(9), e74548. doi:10.1371/journal.pone.0074548 [doi]
    Adi Harel, S., Bossel Ben-Moshe, N., Aylon, Y., Bublik, D. R., Moskovits, N., Toperoff, G., . . . Oren, M. (2015)., Reactivation of epigenetically silenced miR-512 and miR-373 sensitizes lung cancer cells to cisplatin and restricts tumor growth., Cell Death and Differentiation, 22(8), 1328-1340. doi:10.1038/cdd.2014.221 [doi]
    Dal Bello, M. G., Alama, A., Barletta, G., Coco, S., Truini, A., Vanni, I., . . . Grossi, F. (2015)., Sequential use of vinorelbine followed by gefitinib enhances the antitumor effect in NSCLC cell lines poorly responsive to reversible EGFR tyrosine kinase inhibitors., International Journal of Cancer.Journal International Du Cancer, doi:10.1002/ijc.29647 [doi]
    Barnea, I., Ben-Yosef, R., Karaush, V., Benhar, I., & Vexler, A. (2013)., Targeting EGFR-positive cancer cells with cetuximab-ZZ-PE38: Results of in vitro and in vivo studies., Head & Neck, 35(8), 1171-1177. doi:10.1002/hed.23093 [doi]
    Barnea, I., Haif, S., Keshet, R., Karaush, V., Lev-Ari, S., Khafif, A., . . . Ben Yosef, R. (2013)., Targeting ErbB-1 and ErbB-4 in irradiated head and neck cancer: Results of in vitro and in vivo studies., Head & Neck, 35(3), 399-407. doi:10.1002/hed.22967 [doi]
    Tsao, N., Chanda, M., Yu, D. F., Kurihara, H., Zhang, Y. H., Mendez, R., & Yang, D. J. (2013)., 99mTc-N4amG: Synthesis biodistribution and imaging in breast tumor-bearing rodents, Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for use in Agriculture, Industry and Medicine, 72, 105-113. doi:10.1016/j.apradiso.2012.07.018 [doi]
    Ouyang, N., Ji, P., & Williams, J. L. (2013)., A novel NSAID derivative, phospho-ibuprofen, prevents AOM-induced colon cancer in rats., International Journal of Oncology, 42(2), 643-650. doi:10.3892/ijo.2012.1756 [doi]
    Yang, D. J., Pham, L., Liao, M. H., Kong, F. L., Uemura, H., & Shih, Y. Y. (2014), Advances in molecular pathway-directed cancer systems imaging and therapy., BioMed Research International, 2014, 639475. doi:10.1155/2014/639475 [doi]
    Bielefeld, E. C., Tanaka, C., Chen, G. D., Coling, D., Li, M., Henderson, D., & Fetoni, A. R. (2013), An src-protein tyrosine kinase inhibitor to reduce cisplatin ototoxicity while preserving its antitumor effect., Anti-Cancer Drugs, 24(1), 43-51. doi:10.1097/CAD.0b013e32835739fd [doi]
    Remeniuk, B., Sukhtankar, D., Okun, A., Navratilova, E., Xie, J. Y., King, T., & Porreca, F. (2015)., Behavioral and neurochemical analysis of ongoing bone cancer pain in rats, Pain, 156(10), 1864-1873. doi:10.1097/j.pain.0000000000000218 [doi]
    Lubet, R. A., Clapper, M. L., McCormick, D. L., Pereira, M. A., Chang, W. C., Steele, V. E., . . . Grubbs, C. J. (2012)., Chemopreventive efficacy of targretin in rodent models of urinary bladder, colon/intestine, head and neck and mammary cancers., Oncology Reports, 27(5), 1400-1406. doi:10.3892/or.2012.1673 [doi]
    Mohammed, Altaf; Miller, Mark Steven; Lubet, Ronald A; Suen, Chen S; Sei, Shizuko; Shoemaker, Robert H; Juliana, Margaret M; Moeinpour, Fariba L; Grubbs, Clinton J, Combination of erlotinib and naproxen employing pulsatile or intermittent dosing profoundly inhibits urinary bladder cancers, Cancer prevention research (Philadelphia, Pa.) Vol.69, 2019
    Vellimana, A. K., Recinos, V. R., Hwang, L., Fowers, K. D., Li, K. W., Zhang, Y., . . . Tyler, B. M. (2013)., Combination of paclitaxel thermal gel depot with temozolomide and radiotherapy significantly prolongs survival in an experimental rodent glioma model, Journal of Neuro-Oncology, 111(3), 229-236. doi:10.1007/s11060-012-1014-1 [doi]
    Hoff, B. A., Bhojani, M. S., Rudge, J., Chenevert, T. L., Meyer, C. R., Galban, S., . . . Galban, C. J. (2012)., DCE and DW-MRI monitoring of vascular disruption following VEGF-trap treatment of a rat glioma model, NMR in Biomedicine, 25(7), 935-942. doi:10.1002/nbm.1814 [doi]
    Men, H., & Bryda, E. C. (2013), Derivation of a germline competent transgenic fischer 344 embryonic stem cell line., PloS One, 8(2), e56518. doi:10.1371/journal.pone.0056518 [doi]
    Sims-Mourtada, J., Yang, D., Tworowska, I., Larson, R., Smith, D., Tsao, N., . . . Woodward, W. (2012)., Detection of canonical hedgehog signaling in breast cancer by 131-iodine-labeled derivatives of the sonic hedgehog protein., Journal of Biomedicine & Biotechnology, 2012, 639562. doi:10.1155/2012/639562 [doi]
    Kong, F. L., Zhang, Y., Young, D. P., Yu, D. F., & Yang, D. J. (2013)., Development of (99m)tc-EC-tyrosine for early detection of breast cancer tumor response to the anticancer drug melphalan, Academic Radiology, 20(1), 41-51. doi:10.1016/j.acra.2012.08.005 [doi]
    Ali, M. S., Kong, F. L., Rollo, A., Mendez, R., Kohanim, S., Smith, D. L., & Yang, D. J. (2012), Development of (99m)tc-N4-NIM for molecular imaging of tumor hypoxia., Journal of Biomedicine & Biotechnology, 2012, 828139. doi:10.1155/2012/828139 [doi]
    Kong, F. L., Ali, M. S., Rollo, A., Smith, D. L., Zhang, Y., Yu, D. F., & Yang, D. J. (2012)., Development of tyrosine-based radiotracer 99mTc-N4-tyrosine for breast cancer imaging., Journal of Biomedicine & Biotechnology, 2012, 671708. doi:10.1155/2012/671708 [doi]
    Shi, N., Riedl, K. M., Schwartz, S. J., Zhang, X., Clinton, S. K., & Chen, T. (2016)., Efficacy comparison of lyophilised black raspberries and combination of celecoxib and PBIT in prevention of carcinogen-induced oesophageal cancer in rats, Journal of Functional Foods, 27, 84-94. doi:10.1016/j.jff.2016.08.044 [doi]
    Towner, R. A., Jensen, R. L., Colman, H., Vaillant, B., Smith, N., Casteel, R., . . . Wren, J. D. (2013)., ELTD1, a potential new biomarker for gliomas., Neurosurgery, 72(1), 77-90; discussion 91. doi:10.1227/NEU.0b013e318276b29d [doi]
    Stypula-Cyrus, Y., Mutyal, N. N., Dela Cruz, M., Kunte, D. P., Radosevich, A. J., Wali, R., . . . Backman, V. (2014), End-binding protein 1 (EB1) up-regulation is an early event in colorectal carcinogenesis, FEBS Letters, 588(5), 829-835. doi:10.1016/j.febslet.2014.01.046 [doi]
    Thangappan, R., Eandi, J. A., Modi, J., & Kurzrock, E. A. (2012)., Epithelium-free bladder wall graft: Epithelial ingrowth and regeneration--clinical implications for partial cystectomy., The Journal of Urology, 187(4), 1450-1457. doi:10.1016/j.juro.2011.12.014 [doi]
    Ljubimova, J. Y., Kleinman, M. T., Karabalin, N. M., Inoue, S., Konda, B., Gangalum, P., . . . Black, K. L. (2013)., Gene expression changes in rat brain after short and long exposures to particulate matter in los angeles basin air: Comparison with human brain tumors, Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie, 65(7-8), 1063-1071. doi:10.1016/j.etp.2013.04.002 [doi]
    Stypula-Cyrus, Y., Damania, D., Kunte, D. P., Cruz, M. D., Subramanian, H., Roy, H. K., & Backman, V. (2013)., HDAC up-regulation in early colon field carcinogenesis is involved in cell tumorigenicity through regulation of chromatin structure., PloS One, 8(5), e64600. doi:10.1371/journal.pone.0064600 [doi]
    Gradilone, S. A., Radtke, B. N., Bogert, P. S., Huang, B. Q., Gajdos, G. B., & LaRusso, N. F. (2013)., HDAC6 inhibition restores ciliary expression and decreases tumor growth., Cancer Research, 73(7), 2259-2270. doi:10.1158/0008-5472.CAN-12-2938 [doi]
    Willson, C. J., Herbert, R. A., & Cline, J. M. (2015)., Hormone receptor expression in spontaneous uterine adenocarcinoma in fischer 344 rats., Toxicologic Pathology, 43(6), 865-871. doi:10.1177/0192623315591839 [doi]
    Foster, B. A., Gangavarapu, K. J., Mathew, G., Azabdaftari, G., Morrison, C. D., Miller, A., & Huss, W. J. (2013)., Human prostate side population cells demonstrate stem cell properties in recombination with urogenital sinus mesenchyme., PloS One, 8(1), e55062. doi:10.1371/journal.pone.0055062 [doi]
    Doblas, S., He, T., Saunders, D., Hoyle, J., Smith, N., Pye, Q., . . . Towner, R. A. (2012)., In vivo characterization of several rodent glioma models by 1H MRS, NMR in Biomedicine, 25(4), 685-694. doi:10.1002/nbm.1785 [doi]
    Oghumu, S., Casto, B. C., Ahn-Jarvis, J., Weghorst, L. C., Maloney, J., Geuy, P., . . . Knobloch, T. J. (2017), Inhibition of pro-inflammatory and anti-apoptotic biomarkers during experimental oral cancer chemoprevention by dietary black raspberries, Frontiers in Immunology, 8, 1325. doi:10.3389/fimmu.2017.01325 [doi]
    Pan, P., Peiffer, D. S., Huang, Y. W., Oshima, K., Stoner, G. D., & Wang, L. S. (2018), Inhibition of the development of N-nitrosomethylbenzylamine-induced esophageal tumors in rats by strawberries and aspirin, alone and in combination., Journal of Berry Research, 8(2), 137-146. doi:10.3233/JBR-170291 [doi]
    Lee, W. H., Warrington, J. P., Sonntag, W. E., & Lee, Y. W. (2012)., Irradiation alters MMP-2/TIMP-2 system and collagen type IV degradation in brain, International Journal of Radiation Oncology, Biology, Physics, 82(5), 1559-1566. doi:10.1016/j.ijrobp.2010.12.032 [doi]
    Bow, H., Hwang, L. S., Schildhaus, N., Xing, J., Murray, L., Salditch, Q., . . . Tyler, B. (2014), Local delivery of angiogenesis-inhibitor minocycline combined with radiotherapy and oral temozolomide chemotherapy in 9L glioma., Journal of Neurosurgery, 120(3), 662-669. doi:10.3171/2013.11.JNS13556 [doi]
    Havelin, J., Imbert, I., Sukhtankar, D., Remeniuk, B., Pelletier, I., Gentry, J., . . . King, T. E. (2017), Mediation of movement-induced breakthrough cancer pain by IB4-binding nociceptors in rats., he Journal of Neuroscience : The Official Journal of the Society for Neuroscience, 37(20), 5111-5122. doi:10.1523/JNEUROSCI.1212-16.2017 [doi]
    Klempin, F., Marr, R. A., & Peterson, D. A. (2012)., Modification of pax6 and olig2 expression in adult hippocampal neurogenesis selectively induces stem cell fate and alters both neuronal and glial populations., Stem Cells (Dayton, Ohio), 30(3), 500-509. doi:10.1002/stem.1005 [doi]
    Zhang, H., Tian, M., Carrio, I., Civelek, A. C., & Fujibayashi, Y. (2014)., Molecular image-guided theranostic and personalized medicine 2013., BioMed Research International, 2014, 682527. doi:10.1155/2014/682527 [doi]
    Zhang, Y. H., Bryant, J., Kong, F. L., Yu, D. F., Mendez, R., Edmund Kim, E., & Yang, D. J. (2012)., Molecular imaging of mesothelioma with (99m)tc-ECG and (68)ga-ECG, Journal of Biomedicine & Biotechnology, 2012, 232863. doi:10.1155/2012/232863 [doi]
    He, T., Smith, N., Saunders, D., Pittman, B. P., Lerner, M., Lightfoot, S., . . . Towner, R. A. (2013)., Molecular MRI differentiation of VEGF receptor-2 levels in C6 and RG2 glioma models., American Journal of Nuclear Medicine and Molecular Imaging, 3(4), 300-311.
    Srinivasan, S., Manchanda, R., Fernandez-Fernandez, A., Lei, T., & McGoron, A. J. (2013), Near-infrared fluorescing IR820-chitosan conjugate for multifunctional cancer theranostic applications., Journal of Photochemistry and Photobiology.B, Biology, 119, 52-59. doi:10.1016/j.jphotobiol.2012.12.008 [doi]
    Li, Chengyue; Xu, Xiaochun; McMahon, Nathan; Alhaj Ibrahim, Omar; Sattar, Husain A; Tichauer, Kenneth M;, Paired-Agent Fluorescence Molecular Imaging of Sentinel Lymph Nodes Using Indocyanine Green as a Control Agent for Antibody-Based Targeted Agents., Contrast media & molecular imaging Vol.2019, 2019
    Smith, D., Kong, F., Yang, D., Larson, R., Sims-Mourtada, J., & Woodward, W. A. (2014), Patched targeting peptides for imaging and treatment of hedgehog positive breast tumors., BioMed Research International, 2014, 525680. doi:10.1155/2014/525680 [doi]
    Kang, J. Y., Eggert, M., Mouli, S., Aljuffali, I., Fu, X., Nie, B., . . . Arnold, R. D. (2015), Pharmacokinetics, antitumor and cardioprotective effects of liposome-encapsulated phenylaminoethyl selenide in human prostate cancer rodent models., Pharmaceutical Research, 32(3), 852-862. doi:10.1007/s11095-014-1501-5 [doi]
    Cadamuro, Massimiliano; Brivio, Simone; Mertens, Joachim; Vismara, Marta; Moncsek, Anja; Milani, Chiara; Fingas, Christian; Cristina Malerba, Maria; Nardo, Giorgia; DallOlmo, Luigi; Milani, Eleonora; Mariotti, Valeria; Stecca, Tommaso; Massani, Marco; Spirli, Carlo; Fiorotto, Romina; Indraccolo, Stefano; Strazzabosco, Mario; Fabris, Luca;, Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma., Journal of hepatology Vol.70, 2019
    Fingas, C. D., Mertens, J. C., Razumilava, N., Sydor, S., Bronk, S. F., Christensen, J. D., . . . Gores, G. J. (2013)., Polo-like kinase 2 is a mediator of hedgehog survival signaling in cholangiocarcinoma., Hepatology (Baltimore, Md.), 58(4), 1362-1374. doi:10.1002/hep.26484 [doi]
    Janakiram, N. B., Mohammed, A., Bryant, T., Zhang, Y., Brewer, M., Duff, A., . . . Rao, C. V. (2016)., Potentiating NK cell activity by combination of rosuvastatin and difluoromethylornithine for effective chemopreventive efficacy against colon cancer., Scientific Reports, 6, 37046. doi:10.1038/srep37046 [doi]
    Stakleff, K. S., Sloan, T., Blanco, D., Marcanthony, S., Booth, T. D., & Bishayee, A. (2012)., Resveratrol exerts differential effects in vitro and in vivo against ovarian cancer cells, Asian Pacific Journal of Cancer Prevention : APJCP, 13(4), 1333-1340.
    Cao, S., Durrani, F. A., Toth, K., & Rustum, Y. M. (2014), Se-methylselenocysteine offers selective protection against toxicity and potentiates the antitumour activity of anticancer drugs in preclinical animal models., British Journal of Cancer, 110(7), 1733-1743. doi:10.1038/bjc.2014.85 [doi]
    Mansini, Adrian P; Peixoto, Estanislao; Jin, Sujeong; Richard, Seth; Gradilone, Sergio A;, The Chemosensory Function of Primary Cilia Regulates Cholangiocyte Migration, Invasion, and Tumor Growth, Hepatology (Baltimore, Md.) Vol.69, 2019
    Jackson, S., Anders, N. M., Mangraviti, A., Wanjiku, T. M., Sankey, E. W., Liu, A., . . . Grossman, S. A. (2016), The effect of regadenoson-induced transient disruption of the blood-brain barrier on temozolomide delivery to normal rat brain, Journal of Neuro-Oncology, 126(3), 433-439. doi:10.1007/s11060-015-1998-4 [doi]
    Han, A., Abuhabsah, R., Miller, R. J., Sarwate, S., & O'Brien, W. D.,Jr. (2013), The measurement of ultrasound backscattering from cell pellet biophantoms and tumors ex vivo, The Journal of the Acoustical Society of America, 134(1), 686-693. doi:10.1121/1.4807576 [doi]
    Zhang, F., Mastorakos, P., Mishra, M. K., Mangraviti, A., Hwang, L., Zhou, J., . . . Kannan, R. M. (2015)., Uniform brain tumor distribution and tumor associated macrophage targeting of systemically administered dendrimers., Biomaterials, 52, 507-516. doi:10.1016/j.biomaterials.2015.02.053 [doi]
    Ouyang, N., Ji, P., & Williams, J. L. (2013)., A novel NSAID derivative, phospho-ibuprofen, prevents AOM-induced colon cancer in rats., International Journal of Oncology, 42(2), 643-650. doi:10.3892/ijo.2012.1756 [doi]
    Yang, D. J., Pham, L., Liao, M. H., Kong, F. L., Uemura, H., & Shih, Y. Y. (2014), Advances in molecular pathway-directed cancer systems imaging and therapy., BioMed Research International, 2014, 639475. doi:10.1155/2014/639475 [doi]
    Bielefeld, E. C., Tanaka, C., Chen, G. D., Coling, D., Li, M., Henderson, D., & Fetoni, A. R. (2013), An src-protein tyrosine kinase inhibitor to reduce cisplatin ototoxicity while preserving its antitumor effect., Anti-Cancer Drugs, 24(1), 43-51. doi:10.1097/CAD.0b013e32835739fd [doi]
    Remeniuk, B., Sukhtankar, D., Okun, A., Navratilova, E., Xie, J. Y., King, T., & Porreca, F. (2015)., Behavioral and neurochemical analysis of ongoing bone cancer pain in rats, Pain, 156(10), 1864-1873. doi:10.1097/j.pain.0000000000000218 [doi]
    Lubet, R. A., Clapper, M. L., McCormick, D. L., Pereira, M. A., Chang, W. C., Steele, V. E., . . . Grubbs, C. J. (2012)., Chemopreventive efficacy of targretin in rodent models of urinary bladder, colon/intestine, head and neck and mammary cancers., Oncology Reports, 27(5), 1400-1406. doi:10.3892/or.2012.1673 [doi]
    Mohammed, Altaf; Miller, Mark Steven; Lubet, Ronald A; Suen, Chen S; Sei, Shizuko; Shoemaker, Robert H; Juliana, Margaret M; Moeinpour, Fariba L; Grubbs, Clinton J, Combination of erlotinib and naproxen employing pulsatile or intermittent dosing profoundly inhibits urinary bladder cancers, Cancer prevention research (Philadelphia, Pa.) Vol.69, 2019
    Vellimana, A. K., Recinos, V. R., Hwang, L., Fowers, K. D., Li, K. W., Zhang, Y., . . . Tyler, B. M. (2013)., Combination of paclitaxel thermal gel depot with temozolomide and radiotherapy significantly prolongs survival in an experimental rodent glioma model, Journal of Neuro-Oncology, 111(3), 229-236. doi:10.1007/s11060-012-1014-1 [doi]
    Hoff, B. A., Bhojani, M. S., Rudge, J., Chenevert, T. L., Meyer, C. R., Galban, S., . . . Galban, C. J. (2012)., DCE and DW-MRI monitoring of vascular disruption following VEGF-trap treatment of a rat glioma model, NMR in Biomedicine, 25(7), 935-942. doi:10.1002/nbm.1814 [doi]
    Liaw K, Zhang F, Mangraviti A, Kannan S, Tyler B, Kannan RM., Dendrimer size effects on the selective brain tumor targeting in orthotopic tumor models upon systemic administration, Bioeng Transl Med. 2020 Apr 14;5(2):e10160. doi: 10.1002/btm2.10160. eCollection 2020 May.
    Men, H., & Bryda, E. C. (2013), Derivation of a germline competent transgenic fischer 344 embryonic stem cell line., PloS One, 8(2), e56518. doi:10.1371/journal.pone.0056518 [doi]
    Sims-Mourtada, J., Yang, D., Tworowska, I., Larson, R., Smith, D., Tsao, N., . . . Woodward, W. (2012)., Detection of canonical hedgehog signaling in breast cancer by 131-iodine-labeled derivatives of the sonic hedgehog protein., Journal of Biomedicine & Biotechnology, 2012, 639562. doi:10.1155/2012/639562 [doi]
    Kong, F. L., Zhang, Y., Young, D. P., Yu, D. F., & Yang, D. J. (2013)., Development of (99m)tc-EC-tyrosine for early detection of breast cancer tumor response to the anticancer drug melphalan, Academic Radiology, 20(1), 41-51. doi:10.1016/j.acra.2012.08.005 [doi]
    Ali, M. S., Kong, F. L., Rollo, A., Mendez, R., Kohanim, S., Smith, D. L., & Yang, D. J. (2012), Development of (99m)tc-N4-NIM for molecular imaging of tumor hypoxia., Journal of Biomedicine & Biotechnology, 2012, 828139. doi:10.1155/2012/828139 [doi]
    Kong, F. L., Ali, M. S., Rollo, A., Smith, D. L., Zhang, Y., Yu, D. F., & Yang, D. J. (2012)., Development of tyrosine-based radiotracer 99mTc-N4-tyrosine for breast cancer imaging., Journal of Biomedicine & Biotechnology, 2012, 671708. doi:10.1155/2012/671708 [doi]
    Shi, N., Riedl, K. M., Schwartz, S. J., Zhang, X., Clinton, S. K., & Chen, T. (2016)., Efficacy comparison of lyophilised black raspberries and combination of celecoxib and PBIT in prevention of carcinogen-induced oesophageal cancer in rats, Journal of Functional Foods, 27, 84-94. doi:10.1016/j.jff.2016.08.044 [doi]
    Towner, R. A., Jensen, R. L., Colman, H., Vaillant, B., Smith, N., Casteel, R., . . . Wren, J. D. (2013)., ELTD1, a potential new biomarker for gliomas., Neurosurgery, 72(1), 77-90; discussion 91. doi:10.1227/NEU.0b013e318276b29d [doi]
    Stypula-Cyrus, Y., Mutyal, N. N., Dela Cruz, M., Kunte, D. P., Radosevich, A. J., Wali, R., . . . Backman, V. (2014), End-binding protein 1 (EB1) up-regulation is an early event in colorectal carcinogenesis, FEBS Letters, 588(5), 829-835. doi:10.1016/j.febslet.2014.01.046 [doi]
    Thangappan, R., Eandi, J. A., Modi, J., & Kurzrock, E. A. (2012)., Epithelium-free bladder wall graft: Epithelial ingrowth and regeneration--clinical implications for partial cystectomy., The Journal of Urology, 187(4), 1450-1457. doi:10.1016/j.juro.2011.12.014 [doi]
    Ljubimova, J. Y., Kleinman, M. T., Karabalin, N. M., Inoue, S., Konda, B., Gangalum, P., . . . Black, K. L. (2013)., Gene expression changes in rat brain after short and long exposures to particulate matter in los angeles basin air: Comparison with human brain tumors, Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie, 65(7-8), 1063-1071. doi:10.1016/j.etp.2013.04.002 [doi]
    Stypula-Cyrus, Y., Damania, D., Kunte, D. P., Cruz, M. D., Subramanian, H., Roy, H. K., & Backman, V. (2013)., HDAC up-regulation in early colon field carcinogenesis is involved in cell tumorigenicity through regulation of chromatin structure., PloS One, 8(5), e64600. doi:10.1371/journal.pone.0064600 [doi]
    Gradilone, S. A., Radtke, B. N., Bogert, P. S., Huang, B. Q., Gajdos, G. B., & LaRusso, N. F. (2013)., HDAC6 inhibition restores ciliary expression and decreases tumor growth., Cancer Research, 73(7), 2259-2270. doi:10.1158/0008-5472.CAN-12-2938 [doi]
    Willson, C. J., Herbert, R. A., & Cline, J. M. (2015)., Hormone receptor expression in spontaneous uterine adenocarcinoma in fischer 344 rats., Toxicologic Pathology, 43(6), 865-871. doi:10.1177/0192623315591839 [doi]
    Foster, B. A., Gangavarapu, K. J., Mathew, G., Azabdaftari, G., Morrison, C. D., Miller, A., & Huss, W. J. (2013)., Human prostate side population cells demonstrate stem cell properties in recombination with urogenital sinus mesenchyme., PloS One, 8(1), e55062. doi:10.1371/journal.pone.0055062 [doi]
    Doblas, S., He, T., Saunders, D., Hoyle, J., Smith, N., Pye, Q., . . . Towner, R. A. (2012)., In vivo characterization of several rodent glioma models by 1H MRS, NMR in Biomedicine, 25(4), 685-694. doi:10.1002/nbm.1785 [doi]
    Oghumu, S., Casto, B. C., Ahn-Jarvis, J., Weghorst, L. C., Maloney, J., Geuy, P., . . . Knobloch, T. J. (2017), Inhibition of pro-inflammatory and anti-apoptotic biomarkers during experimental oral cancer chemoprevention by dietary black raspberries, Frontiers in Immunology, 8, 1325. doi:10.3389/fimmu.2017.01325 [doi]
    Pan, P., Peiffer, D. S., Huang, Y. W., Oshima, K., Stoner, G. D., & Wang, L. S. (2018), Inhibition of the development of N-nitrosomethylbenzylamine-induced esophageal tumors in rats by strawberries and aspirin, alone and in combination., Journal of Berry Research, 8(2), 137-146. doi:10.3233/JBR-170291 [doi]
    Lee, W. H., Warrington, J. P., Sonntag, W. E., & Lee, Y. W. (2012)., Irradiation alters MMP-2/TIMP-2 system and collagen type IV degradation in brain, International Journal of Radiation Oncology, Biology, Physics, 82(5), 1559-1566. doi:10.1016/j.ijrobp.2010.12.032 [doi]
    Bow, H., Hwang, L. S., Schildhaus, N., Xing, J., Murray, L., Salditch, Q., . . . Tyler, B. (2014), Local delivery of angiogenesis-inhibitor minocycline combined with radiotherapy and oral temozolomide chemotherapy in 9L glioma., Journal of Neurosurgery, 120(3), 662-669. doi:10.3171/2013.11.JNS13556 [doi]
    Havelin, J., Imbert, I., Sukhtankar, D., Remeniuk, B., Pelletier, I., Gentry, J., . . . King, T. E. (2017), Mediation of movement-induced breakthrough cancer pain by IB4-binding nociceptors in rats., he Journal of Neuroscience : The Official Journal of the Society for Neuroscience, 37(20), 5111-5122. doi:10.1523/JNEUROSCI.1212-16.2017 [doi]
    Klempin, F., Marr, R. A., & Peterson, D. A. (2012)., Modification of pax6 and olig2 expression in adult hippocampal neurogenesis selectively induces stem cell fate and alters both neuronal and glial populations., Stem Cells (Dayton, Ohio), 30(3), 500-509. doi:10.1002/stem.1005 [doi]
    Zhang, H., Tian, M., Carrio, I., Civelek, A. C., & Fujibayashi, Y. (2014)., Molecular image-guided theranostic and personalized medicine 2013., BioMed Research International, 2014, 682527. doi:10.1155/2014/682527 [doi]
    Zhang, Y. H., Bryant, J., Kong, F. L., Yu, D. F., Mendez, R., Edmund Kim, E., & Yang, D. J. (2012)., Molecular imaging of mesothelioma with (99m)tc-ECG and (68)ga-ECG, Journal of Biomedicine & Biotechnology, 2012, 232863. doi:10.1155/2012/232863 [doi]
    He, T., Smith, N., Saunders, D., Pittman, B. P., Lerner, M., Lightfoot, S., . . . Towner, R. A. (2013)., Molecular MRI differentiation of VEGF receptor-2 levels in C6 and RG2 glioma models., American Journal of Nuclear Medicine and Molecular Imaging, 3(4), 300-311.
    Tsao, N., Chanda, M., Yu, D. F., Kurihara, H., Zhang, Y. H., Mendez, R., & Yang, D. J. (2013)., mTc-N4amG: Synthesis biodistribution and imaging in breast tumor-bearing rodents, Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for use in Agriculture, Industry and Medicine, 72, 105-113. doi:10.1016/j.apradiso.2012.07.018 [doi]
    Srinivasan, S., Manchanda, R., Fernandez-Fernandez, A., Lei, T., & McGoron, A. J. (2013), Near-infrared fluorescing IR820-chitosan conjugate for multifunctional cancer theranostic applications., Journal of Photochemistry and Photobiology.B, Biology, 119, 52-59. doi:10.1016/j.jphotobiol.2012.12.008 [doi]
    Li, Chengyue; Xu, Xiaochun; McMahon, Nathan; Alhaj Ibrahim, Omar; Sattar, Husain A; Tichauer, Kenneth M;, Paired-Agent Fluorescence Molecular Imaging of Sentinel Lymph Nodes Using Indocyanine Green as a Control Agent for Antibody-Based Targeted Agents., Contrast media & molecular imaging Vol.2019, 2019
    Smith, D., Kong, F., Yang, D., Larson, R., Sims-Mourtada, J., & Woodward, W. A. (2014), Patched targeting peptides for imaging and treatment of hedgehog positive breast tumors., BioMed Research International, 2014, 525680. doi:10.1155/2014/525680 [doi]
    Kang, J. Y., Eggert, M., Mouli, S., Aljuffali, I., Fu, X., Nie, B., . . . Arnold, R. D. (2015), Pharmacokinetics, antitumor and cardioprotective effects of liposome-encapsulated phenylaminoethyl selenide in human prostate cancer rodent models., Pharmaceutical Research, 32(3), 852-862. doi:10.1007/s11095-014-1501-5 [doi]
    Cadamuro, Massimiliano; Brivio, Simone; Mertens, Joachim; Vismara, Marta; Moncsek, Anja; Milani, Chiara; Fingas, Christian; Cristina Malerba, Maria; Nardo, Giorgia; DallOlmo, Luigi; Milani, Eleonora; Mariotti, Valeria; Stecca, Tommaso; Massani, Marco; Spirli, Carlo; Fiorotto, Romina; Indraccolo, Stefano; Strazzabosco, Mario; Fabris, Luca;, Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma., Journal of hepatology Vol.70, 2019
    Fingas, C. D., Mertens, J. C., Razumilava, N., Sydor, S., Bronk, S. F., Christensen, J. D., . . . Gores, G. J. (2013)., Polo-like kinase 2 is a mediator of hedgehog survival signaling in cholangiocarcinoma., Hepatology (Baltimore, Md.), 58(4), 1362-1374. doi:10.1002/hep.26484 [doi]
    Janakiram, N. B., Mohammed, A., Bryant, T., Zhang, Y., Brewer, M., Duff, A., . . . Rao, C. V. (2016)., Potentiating NK cell activity by combination of rosuvastatin and difluoromethylornithine for effective chemopreventive efficacy against colon cancer., Scientific Reports, 6, 37046. doi:10.1038/srep37046 [doi]
    Stakleff, K. S., Sloan, T., Blanco, D., Marcanthony, S., Booth, T. D., & Bishayee, A. (2012)., Resveratrol exerts differential effects in vitro and in vivo against ovarian cancer cells, Asian Pacific Journal of Cancer Prevention : APJCP, 13(4), 1333-1340.
    Cao, S., Durrani, F. A., Toth, K., & Rustum, Y. M. (2014), Se-methylselenocysteine offers selective protection against toxicity and potentiates the antitumour activity of anticancer drugs in preclinical animal models., British Journal of Cancer, 110(7), 1733-1743. doi:10.1038/bjc.2014.85 [doi]
    Mansini, Adrian P; Peixoto, Estanislao; Jin, Sujeong; Richard, Seth; Gradilone, Sergio A;, The Chemosensory Function of Primary Cilia Regulates Cholangiocyte Migration, Invasion, and Tumor Growth, Hepatology (Baltimore, Md.) Vol.69, 2019
    Jackson, S., Anders, N. M., Mangraviti, A., Wanjiku, T. M., Sankey, E. W., Liu, A., . . . Grossman, S. A. (2016), The effect of regadenoson-induced transient disruption of the blood-brain barrier on temozolomide delivery to normal rat brain, Journal of Neuro-Oncology, 126(3), 433-439. doi:10.1007/s11060-015-1998-4 [doi]
    Han, A., Abuhabsah, R., Miller, R. J., Sarwate, S., & O'Brien, W. D.,Jr. (2013), The measurement of ultrasound backscattering from cell pellet biophantoms and tumors ex vivo, The Journal of the Acoustical Society of America, 134(1), 686-693. doi:10.1121/1.4807576 [doi]
    Mohammed SI, Torres-Luquis O, Zhou W, Lanman NA, Espina V, Liotta L., Tumor-Draining Lymph Secretome En Route to the Regional Lymph Node in Breast Cancer Metastasis, Breast Cancer (Dove Med Press). 2020 Mar 25;12:57-67. doi: 10.2147/BCTT.S236168. eCollection 2020.
    Zhang, F., Mastorakos, P., Mishra, M. K., Mangraviti, A., Hwang, L., Zhou, J., . . . Kannan, R. M. (2015)., Uniform brain tumor distribution and tumor associated macrophage targeting of systemically administered dendrimers., Biomaterials, 52, 507-516. doi:10.1016/j.biomaterials.2015.02.053 [doi]
    Pal R, Villarreal P, Yu X, Qiu S, Vargas G., Multimodal widefield fluorescence imaging with nonlinear optical microscopy workflow for noninvasive oral epithelial neoplasia detection: a preclinical study, J Biomed Opt. 2020 Nov;25(11):116008. doi: 10.1117/1.JBO.25.11.116008.
    Woo Y, Reid V, Kelly KJ, Carlson D, Yu Z, Fong Y., Oncolytic Herpes Simplex Virus Prevents Premalignant Lesions from Progressing to Cancer, Mol Ther Oncolytics. 2019 Dec 6;16:1-6. doi: 10.1016/j.omto.2019.11.003. eCollection 2020 Mar 27.
    de la Fuente, M., Jones, M. C., Santander-Ortega, M. J., Mirenska, A., Marimuthu, P., Uchegbu, I., & Schatzlein, A. (2015)., A nano-enabled cancer-specific ITCH RNAi chemotherapy booster for pancreatic cancer., Nanomedicine : Nanotechnology, Biology, and Medicine, 11(2), 369-377. doi:10.1016/j.nano.2014.09.010 [doi]
    Qiu, X., Liang, Y., Sellers, R. S., Perez-Soler, R., & Zou, Y. (2014)., Aerosol azacytidine inhibits orthotopic lung cancers in mice through its DNA demethylation and gene reactivation effects., PloS One, 9(10), e109874. doi:10.1371/journal.pone.0109874 [doi]
    Frosina, G., Profumo, A., Marubbi, D., Marcello, D., Ravetti, J. L., & Daga, A. (2018)., ATR kinase inhibitors NVP-BEZ235 and AZD6738 effectively penetrate the brain after systemic administration, Radiation Oncology (London, England), 13(1), 76-018-1020-3. doi:10.1186/s13014-018-1020-3 [doi]
    Oliveira, H., Lopes, T., Almeida, T., Pereira Mde, L., & Santos, C. (2012), Cadmium-induced genetic instability in mice testis, Human & Experimental Toxicology, 31(12), 1228-1236. doi:10.1177/0960327112445937 [doi]
    Smith, M. C., Mader, M. M., Cook, J. A., Iversen, P., Ajamie, R., Perkins, E., . . . Wacheck, V. (2016)., Characterization of LY3023414, a novel PI3K/mTOR dual inhibitor eliciting transient target modulation to impede tumor growth, Molecular Cancer Therapeutics, 15(10), 2344-2356. doi:1535-7163.MCT-15-0996 [pii]
    Aviello, G., Romano, B., Borrelli, F., Capasso, R., Gallo, L., Piscitelli, F., . . . Izzo, A. A. (2012)., Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer., Journal of Molecular Medicine (Berlin, Germany), 90(8), 925-934. doi:10.1007/s00109-011-0856-x [doi]
    Gridley, D. S., Freeman, T. L., Makinde, A. Y., Wroe, A. J., Luo-Owen, X., Tian, J., . . . Pecaut, M. J. (2011), Comparison of proton and electron radiation effects on biological responses in liver, spleen and blood., International Journal of Radiation Biology, 87(12), 1173-1181. doi:10.3109/09553002.2011.624393 [doi]
    Arantes-Rodrigues, R., Pinto-Leite, R., da Costa, R. G., Colaco, A., Lopes, C., & Oliveira, P. (2013)., Cytogenetic characterization of an N-butyl-N-(4-hydroxybutyl) nitrosamine-induced mouse papillary urothelial carcinoma., Tumour Biology : The Journal of the International Society for Oncodevelopmental Biology and Medicine, 34(5), 2691-2696. doi:10.1007/s13277-013-0820-1 [doi]
    Santos, N. P., Oliveira, P. A., Arantes-Rodrigues, R., Faustino-Rocha, A. I., Colaco, A., Lopes, C., & Gil da Costa, R. M. (2014)., Cytokeratin 7/19 expression in N-diethylnitrosamine-induced mouse hepatocellular lesions: Implications for histogenesis., International Journal of Experimental Pathology, 95(3), 191-198. doi:10.1111/iep.12082 [doi]
    Sengar, P., Juarez, P., Verdugo-Meza, A., Arellano, D. L., Jain, A., Chauhan, K., . . . Fournier, P. G. J. (2018)., Development of a functionalized UV-emitting nanocomposite for the treatment of cancer using indirect photodynamic therapy., Journal of Nanobiotechnology, 16(1), 19-018-0344-3. doi:10.1186/s12951-018-0344-3 [doi]
    Nachliely, Matan; Trachtenberg, Aviram; Khalfin, Boris; Nalbandyan, Karen; Cohen-Lahav, Merav; Yasuda, Kaori; Sakaki, Toshiyuki; Kutner, Andrzej; Danilenko, Michael;, Dimethyl fumarate and vitamin D derivatives cooperatively enhance VDR and Nrf2 signaling in differentiating AML cells in vitro and inhibit leukemia progression in a xenograft mouse model., The Journal of steroid biochemistry and molecular biology Vol.188, 2019
    Beziere, N., Lozano, N., Nunes, A., Salichs, J., Queiros, D., Kostarelos, K., & Ntziachristos, V. (2015)., Dynamic imaging of PEGylated indocyanine green (ICG) liposomes within the tumor microenvironment using multi-spectral optoacoustic tomography (MSOT), Biomaterials, 37, 415-424. doi:10.1016/j.biomaterials.2014.10.014 [doi]
    Vasconcelos-Nobrega, C., Costa, C., Vala, H., Colaco, A., Santos, L., Lopes, C., & Oliveira, P. A. (2013), E-cadherin and beta-catenin expression during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl) nitrosamine in mice., Urologia Internationalis, 91(4), 462-466. doi:10.1159/000348329 [doi]
    Cho, J., Rho, O., Junco, J. J., Carbajal, S., Siegel, D., Slaga, T. J., & DiGiovanni, J. (2015)., Effect of combined treatment with ursolic acid and resveratrol on skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate., Cancer Prevention Research (Philadelphia, Pa.), doi:canprevres.0098.2015 [pii]
    Cho, J., Rho, O., Junco, J., Carbajal, S., Siegel, D., Slaga, T. J., & DiGiovanni, J. (2015)., Effect of combined treatment with ursolic acid and resveratrol on skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate., Cancer Prevention Research (Philadelphia, Pa.), 8(9), 817-825. doi:10.1158/1940-6207.CAPR-15-0098 [doi]
    Dogan, S., Johannsen, A. C., Grande, J. P., & Cleary, M. P. (2011)., Effects of intermittent and chronic calorie restriction on mammalian target of rapamycin (mTOR) and IGF-I signaling pathways in mammary fat pad tissues and mammary tumors., Nutrition and Cancer, 63(3), 389-401. doi:10.1080/01635581.2011.535968 [doi]
    Hao, E., Lee, S. H., & Levine, F. (2013)., Efficient beta-cell regeneration by a combination of neogenesis and replication following beta-cell ablation and reversal of pancreatic duct ligation., Stem Cells (Dayton, Ohio), 31(11), 2388-2395. doi:10.1002/stem.1492 [doi]
    Moore, T., Beltran, L., Carbajal, S., Hursting, S. D., & DiGiovanni, J. (2012)., Energy balance modulates mouse skin tumor promotion through altered IGF-1R and EGFR crosstalk., Cancer Prevention Research (Philadelphia, Pa.), 5(10), 1236-1246. doi:10.1158/1940-6207.CAPR-12-0234 [doi]
    Holtz, B. J., Lodewyk, K. B., Sebolt-Leopold, J. S., Ernst, S. A., & Williams, J. A. (2014)., ERK activation is required for CCK-mediated pancreatic adaptive growth in mice., American Journal of Physiology.Gastrointestinal and Liver Physiology, 307(7), G700-10. doi:10.1152/ajpgi.00163.2014 [doi]
    Vasconcelos-Nobrega, C., Colaco, A., Santos, L., Vala, H., Palomino, L. F., Lopes, C., & Oliveira, P. A. (2011)., Experimental study of the anticancer effect of gemcitabine combined with sirolimus on chemically induced urothelial lesions., Anticancer Research, 31(5), 1637-1642. doi:31/5/1637 [pii]
    Celik, H., Bulut, G., Han, J., Graham, G. T., Minas, T. Z., Conn, E. J., . . . Uren, A. (2016)., Ezrin inhibition up-regulates stress response gene expression., The Journal of Biological Chemistry, 291(25), 13257-13270. doi:10.1074/jbc.M116.718189 [doi]
    Oren, R., Addadi, Y., Narunsky Haziza, L., Dafni, H., Rotkopf, R., Meir, G., . . . Neeman, M. (2016)., Fibroblast recruitment as a tool for ovarian cancer detection and targeted therapy., International Journal of Cancer, 139(8), 1788-1798. doi:10.1002/ijc.30209 [doi]
    Nakagawa, R., Vukovic, M., Tarafdar, A., Cosimo, E., Dunn, K., McCaig, A. M., . . . Michie, A. M. (2015)., Generation of a poor prognostic chronic lymphocytic leukemia-like disease model: PKCalpha subversion induces up-regulation of PKCbetaII expression in B lymphocytes., Haematologica, 100(4), 499-510. doi:10.3324/haematol.2014.112276 [doi]
    Piao, L., Li, H., Teng, L., Yung, B. C., Sugimoto, Y., Brueggemeier, R. W., & Lee, R. J. (2013), Human serum albumin-coated lipid nanoparticles for delivery of siRNA to breast cancer., Nanomedicine : Nanotechnology, Biology, and Medicine, 9(1), 122-129. doi:10.1016/j.nano.2012.03.008 [doi]
    Krivokrysenko, V. I., Shakhov, A. N., Singh, V. K., Bone, F., Kononov, Y., Shyshynova, I., . . . Feinstein, E. (2012)., Identification of granulocyte colony-stimulating factor and interleukin-6 as candidate biomarkers of CBLB502 efficacy as a medical radiation countermeasure., The Journal of Pharmacology and Experimental Therapeutics, 343(2), 497-508. doi:10.1124/jpet.112.196071 [doi]
    Vasconcelos-Nobrega, C., Pinto-Leite, R., Arantes-Rodrigues, R., Ferreira, R., Brochado, P., Cardoso, M. L., . . . Oliveira, P. A. (2013)., In vivo and in vitro effects of RAD001 on bladder cancer., Urologic Oncology, 31(7), 1212-1221. doi:10.1016/j.urolonc.2011.11.002 [doi]
    Romano, B., Borrelli, F., Pagano, E., Cascio, M. G., Pertwee, R. G., & Izzo, A. A. (2014)., Inhibition of colon carcinogenesis by a standardized cannabis sativa extract with high content of cannabidiol., Phytomedicine : International Journal of Phytotherapy and Phytopharmacology, 21(5), 631-639. doi:10.1016/j.phymed.2013.11.006 [doi]
    Tremmel, Lisa; Rho, Okkyung; Slaga, Thomas J; DiGiovanni, John;, Inhibition of skin tumor promotion by TPA using a combination of topically applied ursolic acid and curcumin., Molecular carcinogenesis Vol.58, 2019
    Koh, R. Y., Lim, C. L., Uhal, B. D., Abdullah, M., Vidyadaran, S., Ho, C. C., & Seow, H. F. (2015), Inhibition of transforming growth factor-beta via the activin receptor-like kinase-5 inhibitor attenuates pulmonary fibrosis., Molecular Medicine Reports, 11(5), 3808-3813. doi:10.3892/mmr.2015.3193 [doi]
    Yu, B., Hsu, S. H., Zhou, C., Wang, X., Terp, M. C., Wu, Y., . . . Lee, L. J. (2012)., Lipid nanoparticles for hepatic delivery of small interfering RNA., Biomaterials, 33(25), 5924-5934. doi:10.1016/j.biomaterials.2012.05.002 [doi]
    Wu, Y., Crawford, M., Yu, B., Mao, Y., Nana-Sinkam, S. P., & Lee, L. J. (2011)., MicroRNA delivery by cationic lipoplexes for lung cancer therapy, Molecular Pharmaceutics, 8(4), 1381-1389. doi:10.1021/mp2002076 [doi]
    Miyake, Makito; Furuya, Hideki; Onishi, Sayuri; Hokutan, Kanani; Anai, Satoshi; Chan, Owen; Shi, Sixiang; Fujimoto, Kiyohide; Goodison, Steve; Cai, Weibo; Rosser, Charles J;, Monoclonal Antibody against CXCL1 (HL2401) as a Novel Agent in Suppressing IL6 Expression and Tumoral Growth., . Theranostics Vol.9, 2019
    Ryall, C. L., Viloria, K., Lhaf, F., Walker, A. J., King, A., Jones, P., . . . Hill, N. J. (2014)., Novel role for matricellular proteins in the regulation of islet beta cell survival: The effect of SPARC on survival, proliferation, and signaling, The Journal of Biological Chemistry, 289(44), 30614-30624. doi:10.1074/jbc.M114.573980 [doi]
    Bilousova, G., Jun du, H., King, K. B., De Langhe, S., Chick, W. S., Torchia, E. C., . . . Majka, S. M. (2011)., Osteoblasts derived from induced pluripotent stem cells form calcified structures in scaffolds both in vitro and in vivo., Stem Cells (Dayton, Ohio), 29(2), 206-216. doi:10.1002/stem.566 [doi]
    Yang, J., Ahn, S., Wu, Z., Hwang, D. J., Miller, D. D., & Dalton, J. T. (2012)., Pharmacokinetics, pharmacodynamics and metabolism of a novel anticancer agent for prostate cancer., International Journal of Oncology, 41(1), 337-344. doi:10.3892/ijo.2012.1442 [doi]
    Velupillai, P., Sung, C. K., Andrews, E., Moran, J., Beier, D., Kagan, J., & Benjamin, T. (2012)., Polymorphisms in toll-like receptor 4 underlie susceptibility to tumor induction by the mouse polyomavirus., Journal of Virology, 86(21), 11541-11547. doi:10.1128/JVI.01614-12 [doi]
    Stallons, Tania A Rozgaja; Saidi, Amal; Tworowska, Izabela; Delpassand, Ebrahim S; Torgue, Julien J;, Preclinical Investigation of 212Pb-DOTAMTATE for Peptide Receptor Radionuclide Therapy in a Neuroendocrine Tumor Model, Molecular cancer therapeutics Vol.18, 2019
    Kimler, B. F., Briley, S. M., Johnson, B. W., Armstrong, A. G., Jasti, S., & Duncan, F. E. (2018)., Radiation-induced ovarian follicle loss occurs without overt stromal changes., Reproduction (Cambridge, England), 155(6), 553-562. doi:10.1530/REP-18-0089 [doi]
    Strupp, C., Bomann, W., Cohen, S. M., & Weber, K. (2016)., Relationship of metabolism and cell proliferation to the mode of action of fluensulfone-induced mouse lung tumors. II: Additional mechanistic studies., Toxicological Sciences : An Official Journal of the Society of Toxicology, 154(2), 296-308. doi:kfw168 [pii]
    Smith, B., Hsu, Y. H., Flores, R., Gagea, M., Craig, S., & Hung, M. C. (2018), Single oral dose acute and subacute toxicity of a c-MET tyrosine kinase inhibitor and CDK 4/6 inhibitor combination drug therapy., American Journal of Cancer Research, 8(1), 183-191.
    Mayzlish-Gati, E., Laufer, D., Grivas, C. F., Shaknof, J., Sananes, A., Bier, A., . . . Koltai, H. (2015)., Strigolactone analogs act as new anti-cancer agents in inhibition of breast cancer in xenograft model., Cancer Biology & Therapy, 16(11), 1682-1688. doi:10.1080/15384047.2015.1070982 [doi]
    Zhang, Y., Hong, H., Sun, B., Carter, K., Qin, Y., Wei, W., . . . Lovell, J. F. (2017)., Surfactant-stripped naphthalocyanines for multimodal tumor theranostics with upconversion guidance cream., Nanoscale, 9(10), 3391-3398. doi:10.1039/c6nr09321c [doi]
    Romano, B., Fasolino, I., Pagano, E., Capasso, R., Pace, S., De Rosa, G., . . . Borrelli, F. (2014)., The chemopreventive action of bromelain, from pineapple stem (ananas comosus L.), on colon carcinogenesis is related to antiproliferative and proapoptotic effects., Molecular Nutrition & Food Research, 58(3), 457-465. doi:10.1002/mnfr.201300345 [doi]
    Henriques, A., Arantes-Rodrigues, R., I Faustino-Rocha, A., I Teixeira-Guedes, C., Pinho-Oliveira, J., Talhada, D., . . . A Oliveira, P. (2014), The effects of whole green tea infusion on mouse urinary bladder chemical carcinogenesis., Iranian Journal of Basic Medical Sciences, 17(2), 145-148.
    Lee, S. H., Hao, E., Kiselyuk, A., Shapiro, J., Shields, D. J., Lowy, A., . . . Itkin-Ansari, P. (2011)., The Id3/E47 axis mediates cell-cycle control in human pancreatic ducts and adenocarcinoma., Molecular Cancer Research : MCR, 9(6), 782-790. doi:10.1158/1541-7786.MCR-10-0535 [doi]
    Da Costa, R. M., Paula-Santos, N., Rocha, A. F., Colaco, A., Lopes, C., & Oliveira, P. A. (2014)., The N-nitrosodiethylamine mouse model: Sketching a timeline of evolution of chemically-induced hepatic lesions., Anticancer Research, 34(12), 7029-7037. doi:34/12/7029 [pii]
    Shelton, D. N., Fornalik, H., Neff, T., Park, S. Y., Bender, D., DeGeest, K., . . . Goodheart, M. J. (2012)., The role of LEF1 in endometrial gland formation and carcinogenesis, PloS One, 7(7), e40312. doi:10.1371/journal.pone.0040312 [doi]
    Zhang, P., Suidasari, S., Hasegawa, T., Yanaka, N., & Kato, N. (2014), Vitamin B(6) activates p53 and elevates p21 gene expression in cancer cells and the mouse colon., Oncology Reports, 31(5), 2371-2376. doi:10.3892/or.2014.3073 [doi]
    Tremmel, Lisa; Rho, Okkyung; Slaga, Thomas J; DiGiovanni, John;, Inhibition of skin tumor promotion by TPA using a combination of topically applied ursolic acid and curcumin., Molecular carcinogenesis Vol.58, 2019
    de la Fuente, M., Jones, M. C., Santander-Ortega, M. J., Mirenska, A., Marimuthu, P., Uchegbu, I., & Schatzlein, A. (2015)., A nano-enabled cancer-specific ITCH RNAi chemotherapy booster for pancreatic cancer., Nanomedicine : Nanotechnology, Biology, and Medicine, 11(2), 369-377. doi:10.1016/j.nano.2014.09.010 [doi]
    Qiu, X., Liang, Y., Sellers, R. S., Perez-Soler, R., & Zou, Y. (2014)., Aerosol azacytidine inhibits orthotopic lung cancers in mice through its DNA demethylation and gene reactivation effects., PloS One, 9(10), e109874. doi:10.1371/journal.pone.0109874 [doi]
    Frosina, G., Profumo, A., Marubbi, D., Marcello, D., Ravetti, J. L., & Daga, A. (2018)., ATR kinase inhibitors NVP-BEZ235 and AZD6738 effectively penetrate the brain after systemic administration, Radiation Oncology (London, England), 13(1), 76-018-1020-3. doi:10.1186/s13014-018-1020-3 [doi]
    Oliveira, H., Lopes, T., Almeida, T., Pereira Mde, L., & Santos, C. (2012), Cadmium-induced genetic instability in mice testis, Human & Experimental Toxicology, 31(12), 1228-1236. doi:10.1177/0960327112445937 [doi]
    Smith, M. C., Mader, M. M., Cook, J. A., Iversen, P., Ajamie, R., Perkins, E., . . . Wacheck, V. (2016)., Characterization of LY3023414, a novel PI3K/mTOR dual inhibitor eliciting transient target modulation to impede tumor growth, Molecular Cancer Therapeutics, 15(10), 2344-2356. doi:1535-7163.MCT-15-0996 [pii]
    Aviello, G., Romano, B., Borrelli, F., Capasso, R., Gallo, L., Piscitelli, F., . . . Izzo, A. A. (2012)., Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer., Journal of Molecular Medicine (Berlin, Germany), 90(8), 925-934. doi:10.1007/s00109-011-0856-x [doi]
    Gridley, D. S., Freeman, T. L., Makinde, A. Y., Wroe, A. J., Luo-Owen, X., Tian, J., . . . Pecaut, M. J. (2011), Comparison of proton and electron radiation effects on biological responses in liver, spleen and blood., International Journal of Radiation Biology, 87(12), 1173-1181. doi:10.3109/09553002.2011.624393 [doi]
    Arantes-Rodrigues, R., Pinto-Leite, R., da Costa, R. G., Colaco, A., Lopes, C., & Oliveira, P. (2013)., Cytogenetic characterization of an N-butyl-N-(4-hydroxybutyl) nitrosamine-induced mouse papillary urothelial carcinoma., Tumour Biology : The Journal of the International Society for Oncodevelopmental Biology and Medicine, 34(5), 2691-2696. doi:10.1007/s13277-013-0820-1 [doi]
    Santos, N. P., Oliveira, P. A., Arantes-Rodrigues, R., Faustino-Rocha, A. I., Colaco, A., Lopes, C., & Gil da Costa, R. M. (2014)., Cytokeratin 7/19 expression in N-diethylnitrosamine-induced mouse hepatocellular lesions: Implications for histogenesis., International Journal of Experimental Pathology, 95(3), 191-198. doi:10.1111/iep.12082 [doi]
    Sengar, P., Juarez, P., Verdugo-Meza, A., Arellano, D. L., Jain, A., Chauhan, K., . . . Fournier, P. G. J. (2018)., Development of a functionalized UV-emitting nanocomposite for the treatment of cancer using indirect photodynamic therapy., Journal of Nanobiotechnology, 16(1), 19-018-0344-3. doi:10.1186/s12951-018-0344-3 [doi]
    Nachliely, Matan; Trachtenberg, Aviram; Khalfin, Boris; Nalbandyan, Karen; Cohen-Lahav, Merav; Yasuda, Kaori; Sakaki, Toshiyuki; Kutner, Andrzej; Danilenko, Michael;, Dimethyl fumarate and vitamin D derivatives cooperatively enhance VDR and Nrf2 signaling in differentiating AML cells in vitro and inhibit leukemia progression in a xenograft mouse model., The Journal of steroid biochemistry and molecular biology Vol.188, 2019
    Beziere, N., Lozano, N., Nunes, A., Salichs, J., Queiros, D., Kostarelos, K., & Ntziachristos, V. (2015)., Dynamic imaging of PEGylated indocyanine green (ICG) liposomes within the tumor microenvironment using multi-spectral optoacoustic tomography (MSOT), Biomaterials, 37, 415-424. doi:10.1016/j.biomaterials.2014.10.014 [doi]
    Vasconcelos-Nobrega, C., Costa, C., Vala, H., Colaco, A., Santos, L., Lopes, C., & Oliveira, P. A. (2013), E-cadherin and beta-catenin expression during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl) nitrosamine in mice., Urologia Internationalis, 91(4), 462-466. doi:10.1159/000348329 [doi]
    Cho, J., Rho, O., Junco, J. J., Carbajal, S., Siegel, D., Slaga, T. J., & DiGiovanni, J. (2015)., Effect of combined treatment with ursolic acid and resveratrol on skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate., Cancer Prevention Research (Philadelphia, Pa.), doi:canprevres.0098.2015 [pii]
    Cho, J., Rho, O., Junco, J., Carbajal, S., Siegel, D., Slaga, T. J., & DiGiovanni, J. (2015)., Effect of combined treatment with ursolic acid and resveratrol on skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate., Cancer Prevention Research (Philadelphia, Pa.), 8(9), 817-825. doi:10.1158/1940-6207.CAPR-15-0098 [doi]
    Dogan, S., Johannsen, A. C., Grande, J. P., & Cleary, M. P. (2011)., Effects of intermittent and chronic calorie restriction on mammalian target of rapamycin (mTOR) and IGF-I signaling pathways in mammary fat pad tissues and mammary tumors., Nutrition and Cancer, 63(3), 389-401. doi:10.1080/01635581.2011.535968 [doi]
    Hao, E., Lee, S. H., & Levine, F. (2013)., Efficient beta-cell regeneration by a combination of neogenesis and replication following beta-cell ablation and reversal of pancreatic duct ligation., Stem Cells (Dayton, Ohio), 31(11), 2388-2395. doi:10.1002/stem.1492 [doi]
    Moore, T., Beltran, L., Carbajal, S., Hursting, S. D., & DiGiovanni, J. (2012)., Energy balance modulates mouse skin tumor promotion through altered IGF-1R and EGFR crosstalk., Cancer Prevention Research (Philadelphia, Pa.), 5(10), 1236-1246. doi:10.1158/1940-6207.CAPR-12-0234 [doi]
    Holtz, B. J., Lodewyk, K. B., Sebolt-Leopold, J. S., Ernst, S. A., & Williams, J. A. (2014)., ERK activation is required for CCK-mediated pancreatic adaptive growth in mice., American Journal of Physiology.Gastrointestinal and Liver Physiology, 307(7), G700-10. doi:10.1152/ajpgi.00163.2014 [doi]
    Vasconcelos-Nobrega, C., Colaco, A., Santos, L., Vala, H., Palomino, L. F., Lopes, C., & Oliveira, P. A. (2011)., Experimental study of the anticancer effect of gemcitabine combined with sirolimus on chemically induced urothelial lesions., Anticancer Research, 31(5), 1637-1642. doi:31/5/1637 [pii]
    Celik, H., Bulut, G., Han, J., Graham, G. T., Minas, T. Z., Conn, E. J., . . . Uren, A. (2016)., Ezrin inhibition up-regulates stress response gene expression., The Journal of Biological Chemistry, 291(25), 13257-13270. doi:10.1074/jbc.M116.718189 [doi]
    Oren, R., Addadi, Y., Narunsky Haziza, L., Dafni, H., Rotkopf, R., Meir, G., . . . Neeman, M. (2016)., Fibroblast recruitment as a tool for ovarian cancer detection and targeted therapy., International Journal of Cancer, 139(8), 1788-1798. doi:10.1002/ijc.30209 [doi]
    Nakagawa, R., Vukovic, M., Tarafdar, A., Cosimo, E., Dunn, K., McCaig, A. M., . . . Michie, A. M. (2015)., Generation of a poor prognostic chronic lymphocytic leukemia-like disease model: PKCalpha subversion induces up-regulation of PKCbetaII expression in B lymphocytes., Haematologica, 100(4), 499-510. doi:10.3324/haematol.2014.112276 [doi]
    Piao, L., Li, H., Teng, L., Yung, B. C., Sugimoto, Y., Brueggemeier, R. W., & Lee, R. J. (2013), Human serum albumin-coated lipid nanoparticles for delivery of siRNA to breast cancer., Nanomedicine : Nanotechnology, Biology, and Medicine, 9(1), 122-129. doi:10.1016/j.nano.2012.03.008 [doi]
    Krivokrysenko, V. I., Shakhov, A. N., Singh, V. K., Bone, F., Kononov, Y., Shyshynova, I., . . . Feinstein, E. (2012)., Identification of granulocyte colony-stimulating factor and interleukin-6 as candidate biomarkers of CBLB502 efficacy as a medical radiation countermeasure., The Journal of Pharmacology and Experimental Therapeutics, 343(2), 497-508. doi:10.1124/jpet.112.196071 [doi]
    Vasconcelos-Nobrega, C., Pinto-Leite, R., Arantes-Rodrigues, R., Ferreira, R., Brochado, P., Cardoso, M. L., . . . Oliveira, P. A. (2013)., In vivo and in vitro effects of RAD001 on bladder cancer., Urologic Oncology, 31(7), 1212-1221. doi:10.1016/j.urolonc.2011.11.002 [doi]
    Romano, B., Borrelli, F., Pagano, E., Cascio, M. G., Pertwee, R. G., & Izzo, A. A. (2014)., Inhibition of colon carcinogenesis by a standardized cannabis sativa extract with high content of cannabidiol., Phytomedicine : International Journal of Phytotherapy and Phytopharmacology, 21(5), 631-639. doi:10.1016/j.phymed.2013.11.006 [doi]
    Koh, R. Y., Lim, C. L., Uhal, B. D., Abdullah, M., Vidyadaran, S., Ho, C. C., & Seow, H. F. (2015), Inhibition of transforming growth factor-beta via the activin receptor-like kinase-5 inhibitor attenuates pulmonary fibrosis., Molecular Medicine Reports, 11(5), 3808-3813. doi:10.3892/mmr.2015.3193 [doi]
    Yu, B., Hsu, S. H., Zhou, C., Wang, X., Terp, M. C., Wu, Y., . . . Lee, L. J. (2012)., Lipid nanoparticles for hepatic delivery of small interfering RNA., Biomaterials, 33(25), 5924-5934. doi:10.1016/j.biomaterials.2012.05.002 [doi]
    Wu, Y., Crawford, M., Yu, B., Mao, Y., Nana-Sinkam, S. P., & Lee, L. J. (2011)., MicroRNA delivery by cationic lipoplexes for lung cancer therapy, Molecular Pharmaceutics, 8(4), 1381-1389. doi:10.1021/mp2002076 [doi]
    Miyake, Makito; Furuya, Hideki; Onishi, Sayuri; Hokutan, Kanani; Anai, Satoshi; Chan, Owen; Shi, Sixiang; Fujimoto, Kiyohide; Goodison, Steve; Cai, Weibo; Rosser, Charles J;, Monoclonal Antibody against CXCL1 (HL2401) as a Novel Agent in Suppressing IL6 Expression and Tumoral Growth., . Theranostics Vol.9, 2019
    Abas E , Pena-Martinez R , Aguirre-Ramírez D , Rodriguez-Dieguez A , Laguna M , Grasa L ., New selective thiolate gold(i) complexes inhibit the proliferation of different human cancer cells and induce apoptosis in primary cultures of mouse colon tumors, Dalton Trans. 2020 Feb 11;49(6):1915-1927. doi: 10.1039/c9dt04423j.
    Ryall, C. L., Viloria, K., Lhaf, F., Walker, A. J., King, A., Jones, P., . . . Hill, N. J. (2014)., Novel role for matricellular proteins in the regulation of islet beta cell survival: The effect of SPARC on survival, proliferation, and signaling, The Journal of Biological Chemistry, 289(44), 30614-30624. doi:10.1074/jbc.M114.573980 [doi]
    Bilousova, G., Jun du, H., King, K. B., De Langhe, S., Chick, W. S., Torchia, E. C., . . . Majka, S. M. (2011)., Osteoblasts derived from induced pluripotent stem cells form calcified structures in scaffolds both in vitro and in vivo., Stem Cells (Dayton, Ohio), 29(2), 206-216. doi:10.1002/stem.566 [doi]
    Yang, J., Ahn, S., Wu, Z., Hwang, D. J., Miller, D. D., & Dalton, J. T. (2012)., Pharmacokinetics, pharmacodynamics and metabolism of a novel anticancer agent for prostate cancer., International Journal of Oncology, 41(1), 337-344. doi:10.3892/ijo.2012.1442 [doi]
    Velupillai, P., Sung, C. K., Andrews, E., Moran, J., Beier, D., Kagan, J., & Benjamin, T. (2012)., Polymorphisms in toll-like receptor 4 underlie susceptibility to tumor induction by the mouse polyomavirus., Journal of Virology, 86(21), 11541-11547. doi:10.1128/JVI.01614-12 [doi]
    Stallons, Tania A Rozgaja; Saidi, Amal; Tworowska, Izabela; Delpassand, Ebrahim S; Torgue, Julien J;, Preclinical Investigation of 212Pb-DOTAMTATE for Peptide Receptor Radionuclide Therapy in a Neuroendocrine Tumor Model, Molecular cancer therapeutics Vol.18, 2019
    Kimler, B. F., Briley, S. M., Johnson, B. W., Armstrong, A. G., Jasti, S., & Duncan, F. E. (2018)., Radiation-induced ovarian follicle loss occurs without overt stromal changes., Reproduction (Cambridge, England), 155(6), 553-562. doi:10.1530/REP-18-0089 [doi]
    Strupp, C., Bomann, W., Cohen, S. M., & Weber, K. (2016)., Relationship of metabolism and cell proliferation to the mode of action of fluensulfone-induced mouse lung tumors. II: Additional mechanistic studies., Toxicological Sciences : An Official Journal of the Society of Toxicology, 154(2), 296-308. doi:kfw168 [pii]
    Toussaint M, Deuther-Conrad W, Kranz M, Fischer S, Ludwig FA, Juratli TA, Patt M, Wünsch B, Schackert G, Sabri O, Brust P., Sigma-1 Receptor Positron Emission Tomography: A New Molecular Imaging Approach Using (S)-(-)-[(18)F]Fluspidine in Glioblastoma, Molecules. 2020 May 6;25(9):2170. doi: 10.3390/molecules25092170.
    Smith, B., Hsu, Y. H., Flores, R., Gagea, M., Craig, S., & Hung, M. C. (2018), Single oral dose acute and subacute toxicity of a c-MET tyrosine kinase inhibitor and CDK 4/6 inhibitor combination drug therapy., American Journal of Cancer Research, 8(1), 183-191.
    Mayzlish-Gati, E., Laufer, D., Grivas, C. F., Shaknof, J., Sananes, A., Bier, A., . . . Koltai, H. (2015)., Strigolactone analogs act as new anti-cancer agents in inhibition of breast cancer in xenograft model., Cancer Biology & Therapy, 16(11), 1682-1688. doi:10.1080/15384047.2015.1070982 [doi]
    Zhang, Y., Hong, H., Sun, B., Carter, K., Qin, Y., Wei, W., . . . Lovell, J. F. (2017)., Surfactant-stripped naphthalocyanines for multimodal tumor theranostics with upconversion guidance cream., Nanoscale, 9(10), 3391-3398. doi:10.1039/c6nr09321c [doi]
    Romano, B., Fasolino, I., Pagano, E., Capasso, R., Pace, S., De Rosa, G., . . . Borrelli, F. (2014)., The chemopreventive action of bromelain, from pineapple stem (ananas comosus L.), on colon carcinogenesis is related to antiproliferative and proapoptotic effects., Molecular Nutrition & Food Research, 58(3), 457-465. doi:10.1002/mnfr.201300345 [doi]
    Henriques, A., Arantes-Rodrigues, R., I Faustino-Rocha, A., I Teixeira-Guedes, C., Pinho-Oliveira, J., Talhada, D., . . . A Oliveira, P. (2014), The effects of whole green tea infusion on mouse urinary bladder chemical carcinogenesis., Iranian Journal of Basic Medical Sciences, 17(2), 145-148.
    Lee, S. H., Hao, E., Kiselyuk, A., Shapiro, J., Shields, D. J., Lowy, A., . . . Itkin-Ansari, P. (2011)., The Id3/E47 axis mediates cell-cycle control in human pancreatic ducts and adenocarcinoma., Molecular Cancer Research : MCR, 9(6), 782-790. doi:10.1158/1541-7786.MCR-10-0535 [doi]
    Da Costa, R. M., Paula-Santos, N., Rocha, A. F., Colaco, A., Lopes, C., & Oliveira, P. A. (2014)., The N-nitrosodiethylamine mouse model: Sketching a timeline of evolution of chemically-induced hepatic lesions., Anticancer Research, 34(12), 7029-7037. doi:34/12/7029 [pii]
    Lemberg KM, Zhao L, Wu Y, Veeravalli V, Alt J, Aguilar JMH, Dash RP, Lam J, Tenora L, Rodriguez C, Nedelcovych MT, Brayton C, Majer P, Blakeley JO, Rais R, Slusher BS., The Novel Glutamine Antagonist Prodrug JHU395 Has Antitumor Activity in Malignant Peripheral Nerve Sheath Tumor, Mol Cancer Ther. 2020 Feb;19(2):397-408. doi: 10.1158/1535-7163.MCT-19-0319. Epub 2019 Oct 8.
    Shelton, D. N., Fornalik, H., Neff, T., Park, S. Y., Bender, D., DeGeest, K., . . . Goodheart, M. J. (2012)., The role of LEF1 in endometrial gland formation and carcinogenesis, PloS One, 7(7), e40312. doi:10.1371/journal.pone.0040312 [doi]
    Emadi A, Kapadia B, Bollino D, Bhandary B, Baer MR, Niyongere S, Strovel ET, Kaizer H, Chang E, Choi EY, Ma X, Tighe KM, Carter-Cooper B, Moses BS, Civin CI, Mahurkar A, Shetty AC, Gartenhaus RB, Kamangar F, Lapidus RG., Venetoclax and pegcrisantaspase for complex karyotype acute myeloid leukemia, Leukemia. 2020 Nov 16. doi: 10.1038/s41375-020-01080-6. Online ahead of print.
    Zhang, P., Suidasari, S., Hasegawa, T., Yanaka, N., & Kato, N. (2014), Vitamin B(6) activates p53 and elevates p21 gene expression in cancer cells and the mouse colon., Oncology Reports, 31(5), 2371-2376. doi:10.3892/or.2014.3073 [doi]
    Puntel, M., Muhammad, A. K., Candolfi, M., Salem, A., Yagiz, K., Farrokhi, C., . . . Castro, M. G. (2010)., A novel bicistronic high-capacity gutless adenovirus vector that drives constitutive expression of herpes simplex virus type 1 thymidine kinase and tet-inducible expression of Flt3L for glioma therapeutics., Journal of Virology, 84(12), 6007-6017. doi:10.1128/JVI.00398-10 [doi]
    King, G. D., Muhammad, A. K., Larocque, D., Kelson, K. R., Xiong, W., Liu, C., . . . Lowenstein, P. R. (2011)., Combined Flt3L/TK gene therapy induces immunological surveillance which mediates an immune response against a surrogate brain tumor neoantigen., Molecular Therapy : The Journal of the American Society of Gene Therapy, 19(10), 1793-1801. doi:10.1038/mt.2011.77 [doi]
    King, G. D., Muhammad, A. K., Curtin, J. F., Barcia, C., Puntel, M., Liu, C., . . . Castro, M. G. (2008)., Flt3L and TK gene therapy eradicate multifocal glioma in a syngeneic glioblastoma model., Neuro-Oncology, 10(1), 19-31. doi:15228517-2007-045 [pii]
    King, G. D., Kroeger, K. M., Bresee, C. J., Candolfi, M., Liu, C., Manalo, C. M., . . . Castro, M. G. (2008)., Flt3L in combination with HSV1-TK-mediated gene therapy reverses brain tumor-induced behavioral deficits., Molecular Therapy : The Journal of the American Society of Gene Therapy, 16(4), 682-690. doi:10.1038/mt.2008.18 [doi]
    Baker, G. J., Yadav, V. N., Motsch, S., Koschmann, C., Calinescu, A. A., Mineharu, Y., . . . Lowenstein, P. R. (2014), Mechanisms of glioma formation: Iterative perivascular glioma growth and invasion leads to tumor progression, VEGF-independent vascularization, and resistance to antiangiogenic therapy., Neoplasia (New York, N.Y.), 16(7), 543-561. doi:10.1016/j.neo.2014.06.003 [doi]
    Pool, S. E., ten Hagen, T. L., Koelewijn, S., de Jong, M., & Koning, G. A. (2012)., Multimodality imaging of somatostatin receptor-positive tumors with nuclear and bioluminescence imaging., Molecular Imaging, 11(1), 27-32.
    Baker, G. J., Chockley, P., Yadav, V. N., Doherty, R., Ritt, M., Sivaramakrishnan, S., . . . Lowenstein, P. R. (2014)., Natural killer cells eradicate galectin-1-deficient glioma in the absence of adaptive immunity., Cancer Research, 74(18), 5079-5090. doi:10.1158/0008-5472.CAN-14-1203 [doi]
    Bison, S. M., Pool, S. E., Koelewijn, S. J., van der Graaf, L. M., Groen, H. C., Melis, M., & de Jong, M. (2014)., Peptide receptor radionuclide therapy (PRRT) with [(177)lu-DOTA(0),tyr(3)]octreotate in combination with RAD001 treatment: Further investigations on tumor metastasis and response in the rat pancreatic CA20948 tumor model., EJNMMI Research, 4, 21-014-0021-y. eCollection 2014. doi:10.1186/s13550-014-0021-y [doi]
    Bison, S. M., Pool, S. E., Koelewijn, S. J., van der Graaf, L. M., Groen, H. C., Melis, M., & de Jong, M. (2014)., Peptide receptor radionuclide therapy (PRRT) with [(177)lu-DOTA(0),tyr(3)]octreotate in combination with RAD001 treatment: Further investigations on tumor metastasis and response in the rat pancreatic CA20948 tumor model., EJNMMI Research, 4, 21-014-0021-y. eCollection 2014. doi:10.1186/s13550-014-0021-y [doi]
    Jacobs, V. L., Landry, R. P., Liu, Y., Romero-Sandoval, E. A., & De Leo, J. A. (2012)., Propentofylline decreases tumor growth in a rodent model of glioblastoma multiforme by a direct mechanism on microglia., Neuro-Oncology, 14(2), 119-131. doi:10.1093/neuonc/nor194 [doi]
    Poli, A., Wang, J., Domingues, O., Planaguma, J., Yan, T., Rygh, C. B., . . . Chekenya, M. (2013)., Targeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survival., Oncotarget, 4(9), 1527-1546. doi:1291 [pii]
    Müller WEG, Ackermann M, Al-Nawas B, Righesso LAR, Muñoz-Espí R, Tolba E, Neufurth M, Schröder HC, Wang X., Amplified morphogenetic and bone forming activity of amorphous versus crystalline calcium phosphate/polyphosphate, Acta Biomater. 2020 Dec;118:233-247. doi: 10.1016/j.actbio.2020.10.023. Epub 2020 Oct 17.
    Kemmerling, R., Alinger, B., Dietze, O., Bosmuller, H. C., Ocker, M., Wolkersdorfer, G. W., . . . Kiesslich, T. (2012)., Association of stem cell marker expression pattern and survival in human biliary tract cancer., International Journal of Oncology, 41(2), 511-522. doi:10.3892/ijo.2012.1477 [doi]
    Frandsen, S. K., Gissel, H., Hojman, P., Tramm, T., Eriksen, J., & Gehl, J. (2012)., Direct therapeutic applications of calcium electroporation to effectively induce tumor necrosis., Cancer Research, 72(6), 1336-1341. doi:10.1158/0008-5472.CAN-11-3782 [doi]
    Garcia-Garcia, C., Ibrahim, Y. H., Serra, V., Calvo, M. T., Guzman, M., Grueso, J., . . . Scaltriti, M. (2012)., Dual mTORC1/2 and HER2 blockade results in antitumor activity in preclinical models of breast cancer resistant to anti-HER2 therapy., Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 18(9), 2603-2612. doi:10.1158/1078-0432.CCR-11-2750 [doi]
    Knauer, S. K., Unruhe, B., Karczewski, S., Hecht, R., Fetz, V., Bier, C., . . . Stauber, R. H. (2013)., Functional characterization of novel mutations affecting survivin (BIRC5)-mediated therapy resistance in head and neck cancer patients., Human Mutation, 34(2), 395-404. doi:10.1002/humu.22249 [doi]
    Tritten, L., Nwosu, U., Vargas, M., & Keiser, J. (2012)., In vitro and in vivo efficacy of tribendimidine and its metabolites alone and in combination against the hookworms heligmosomoides bakeri and ancylostoma ceylanicum., Acta Tropica, 122(1), 101-107. doi:10.1016/j.actatropica.2011.12.008 [doi]
    Hantel, C., Lewrick, F., Reincke, M., Suss, R., & Beuschlein, F. (2012)., Liposomal doxorubicin-based treatment in a preclinical model of adrenocortical carcinoma., The Journal of Endocrinology, 213(2), 155-161. doi:10.1530/JOE-11-0427 [doi]
    Hantel, C., Jung, S., Mussack, T., Reincke, M., & Beuschlein, F. (2014)., Liposomal polychemotherapy improves adrenocortical carcinoma treatment in a preclinical rodent model., Endocrine-Related Cancer, 21(3), 383-394. doi:10.1530/ERC-13-0439 [doi]
    Pool, S. E., Bison, S., Koelewijn, S. J., van der Graaf, L. M., Melis, M., Krenning, E. P., & de Jong, M. (2013)., mTOR inhibitor RAD001 promotes metastasis in a rat model of pancreatic neuroendocrine cancer., Cancer Research, 73(1), 12-18. doi:10.1158/0008-5472.CAN-11-2089 [doi]
    Wang, C. F., Sarparanta, M. P., Makila, E. M., Hyvonen, M. L., Laakkonen, P. M., Salonen, J. J., . . . Santos, H. A. (2015)., Multifunctional porous silicon nanoparticles for cancer theranostics., Biomaterials, 48, 108-118. doi:10.1016/j.biomaterials.2015.01.008 [doi]
    Ibrahim, Y. H., Garcia-Garcia, C., Serra, V., He, L., Torres-Lockhart, K., Prat, A., . . . Baselga, J. (2012)., PI3K inhibition impairs BRCA1/2 expression and sensitizes BRCA-proficient triple-negative breast cancer to PARP inhibition., Cancer Discovery, 2(11), 1036-1047. doi:10.1158/2159-8290.CD-11-0348 [doi]
    Serra, V., Eichhorn, P. J., Garcia-Garcia, C., Ibrahim, Y. H., Prudkin, L., Sanchez, G., . . . Baselga, J. (2013)., RSK3/4 mediate resistance to PI3K pathway inhibitors in breast cancer., The Journal of Clinical Investigation, 123(6), 2551-2563. doi:10.1172/JCI66343 [doi]
    Boven, E., Schipper, H., Erkelens, C. A., Hatty, S. A., & Pinedo, H. M. (1993)., The influence of the schedule and the dose of gemcitabine on the anti-tumour efficacy in experimental human cancer., British Journal of Cancer, 68(1), 52-56.
    Van Impe, K., Bethuyne, J., Cool, S., Impens, F., Ruano-Gallego, D., De Wever, O., . . . Gettemans, J. (2013), A nanobody targeting the F-actin capping protein CapG restrains breast cancer metastasis., Breast Cancer Research : BCR, 15(6), R116. doi:10.1186/bcr3585 [doi]
    Falah, Mizied; Rayan, Mahmoud; Rayan, Anwar, A Novel Paclitaxel Conjugate with Higher Efficiency and Lower Toxicity: A New Drug Candidate for Cancer Treatment., International journal of molecular sciences Vol.20, 2019
    Hoogi, Shiran; Eisenberg, Vasyl; Mayer, Shimrit; Shamul, Astar; Barliya, Tilda; Cohen, Cyrille J, A TIGIT-based chimeric co-stimulatory switch receptor improves T-cell anti-tumor function, Journal for immunotherapy of cancer Vol.7, 2019
    Zarrinkar, P. P., Gunawardane, R. N., Cramer, M. D., Gardner, M. F., Brigham, D., Belli, B., . . . Bhagwat, S. S. (2009), AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML)., Blood, 114(14), 2984-2992. doi:10.1182/blood-2009-05-222034 [doi]
    Bruckheimer, E. M., Fazenbaker, C. A., Gallagher, S., Mulgrew, K., Fuhrmann, S., Coffman, K. T., . . . Coats, S. (2009)., Antibody-dependent cell-mediated cytotoxicity effector-enhanced EphA2 agonist monoclonal antibody demonstrates potent activity against human tumors., Neoplasia (New York, N.Y.), 11(6), 509-17, 2 p following 517.
    Yen, W. C., Fischer, M. M., Hynes, M., Wu, J., Kim, E., Beviglia, L., . . . Hoey, T. (2012), Anti-DLL4 has broad spectrum activity in pancreatic cancer dependent on targeting DLL4-notch signaling in both tumor and vasculature cells., Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 18(19), 5374-5386. doi:10.1158/1078-0432.CCR-12-0736 [doi]
    Damelin, M., Bankovich, A., Park, A., Aguilar, J., Anderson, W., Santaguida, M., . . . Dylla, S. J. (2015)., Anti-EFNA4 calicheamicin conjugates effectively target triple-negative breast and ovarian tumor-initiating cells to result in sustained tumor regressions, Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 21(18), 4165-4173. doi:10.1158/1078-0432.CCR-15-0695 [doi]
    Hassler, M. R., Klisaroska, A., Kollmann, K., Steiner, I., Bilban, M., Schiefer, A. I., . . . Egger, G. (2012)., Antineoplastic activity of the DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine in anaplastic large cell lymphoma., Biochimie, 94(11), 2297-2307. doi:10.1016/j.biochi.2012.05.029 [doi]
    Dold, C., Rodriguez Urbiola, C., Wollmann, G., Egerer, L., Muik, A., Bellmann, L., . . . von Laer, D. (2016)., Application of interferon modulators to overcome partial resistance of human ovarian cancers to VSV-GP oncolytic viral therapy., Molecular Therapy Oncolytics, 3, 16021. doi:10.1038/mto.2016.21 [doi]
    Cosco, D., Paolino, D., De Angelis, F., Cilurzo, F., Celia, C., Di Marzio, L., . . . Fresta, M. (2015), Aqueous-core PEG-coated PLA nanocapsules for an efficient entrapment of water soluble anticancer drugs and a smart therapeutic response, European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik e.V, 89, 30-39. doi:10.1016/j.ejpb.2014.11.012 [doi]
    Was, H., Barszcz, K., Czarnecka, J., Kowalczyk, A., Bernas, T., Uzarowska, E., . . . Sikora, E. (2017)., Bafilomycin A1 triggers proliferative potential of senescent cancer cells in vitro and in NOD/SCID mice., Oncotarget, 8(6), 9303-9322. doi:10.18632/oncotarget.14066 [doi]
    Londono-Joshi, A. I., Oliver, P. G., Li, Y., Lee, C. H., Forero-Torres, A., LoBuglio, A. F., & Buchsbaum, D. J. (2012)., Basal-like breast cancer stem cells are sensitive to anti-DR5 mediated cytotoxicity, Breast Cancer Research and Treatment, 133(2), 437-445. doi:10.1007/s10549-011-1763-0 [doi]
    Wang, L., Park, P., Zhang, H., La Marca, F., Claeson, A., Than, K., . . . Lin, C. Y. (2012)., BMP-2 inhibits tumor growth of human renal cell carcinoma and induces bone formation, International Journal of Cancer.Journal International Du Cancer, 131(8), 1941-1950. doi:10.1002/ijc.27444 [doi]
    Wang, L., Park, P., La Marca, F., Than, K., Rahman, S., & Lin, C. Y. (2013)., Bone formation induced by BMP-2 in human osteosarcoma cells., International Journal of Oncology, 43(4), 1095-1102. doi:10.3892/ijo.2013.2030 [doi]
    Gaudio, E., Tarantelli, C., Ponzoni, M., Odore, E., Rezai, K., Bernasconi, E., . . . Bertoni, F. (2016)., Bromodomain inhibitor OTX015 (MK-8628) combined with targeted agents shows strong in vivo antitumor activity in lymphoma, Oncotarget, 7(36), 58142-58147. doi:10.18632/oncotarget.10983 [doi]
    Sharma, Sambad; Wu, Shih-Ying; Jimenez, Hugo; Xing, Fei; Zhu, Dongqin; Liu, Yin; Wu, Kerui; Tyagi, Abhishek; Zhao, Dan; Lo, Hui-Wen; Metheny-Barlow, Linda; Sun, Peiqing; Bourland, John D; Chan, Michael D; Thomas, Alexandra; Barbault, Alexandre; DAgostino, Ralph B; Whitlow, Christopher T; Kirchner, Volker; Blackman, Carl; Pasche, Boris; Watabe, Kounosuke;, Ca2+ and CACNA1H mediate targeted suppression of breast cancer brain metastasis by AM RF EMF., EBioMedicine Vol.44, 2019
    Gatt, S., & Dagan, A. (2012), Cancer and sphingolipid storage disease therapy using novel synthetic analogs of sphingolipids, Chemistry and Physics of Lipids, 165(4), 462-474. doi:10.1016/j.chemphyslip.2012.02.006 [doi]
    Zaoui, K., Bossow, S., Grossardt, C., Leber, M. F., Springfeld, C., Plinkert, P. K., . . . Ungerechts, G. (2012)., Chemovirotherapy for head and neck squamous cell carcinoma with EGFR-targeted and CD/UPRT-armed oncolytic measles virus., Cancer Gene Therapy, 19(3), 181-191. doi:10.1038/cgt.2011.75 [doi]
    Feng, Yashu; Zhang, Ling; Wu, Jieying; Khadka, Bijay; Fang, Zhigang; Gu, Jiaming; Tang, Baoqiang; Xiao, Ruozhi; Pan, Guangjin; Liu, Jiajun;, CircRNA circ_0000190 inhibits the progression of multiple myeloma through modulating miR-767-5p/MAPK4 pathway., Journal of experimental & clinical cancer research : CR Vol.38, 2019
    Sun, L., Zhang, L., Qian, J., Yang, J., Yi, Q., Dong, W., & Wang, M. (2012)., Combination of atiprimod and the proteasome inhibitor bortezomib induces apoptosis of mantle cell lymphoma in vitro and in vivo., Leukemia Research, 36(3), 363-368. doi:10.1016/j.leukres.2011.09.014 [doi]
    Gaudio, E., Tarantelli, C., Kwee, I., Barassi, C., Bernasconi, E., Rinaldi, A., . . . Bertoni, F. (2016)., Combination of the MEK inhibitor pimasertib with BTK or PI3K-delta inhibitors is active in preclinical models of aggressive lymphomas., Annals of Oncology : Official Journal of the European Society for Medical Oncology, 27(6), 1123-1128. doi:10.1093/annonc/mdw131 [doi]
    Benguigui, Madeleine; Weitz, Iris S; Timaner, Michael; Kan, Tal; Shechter, Dvir; Perlman, Or; Sivan, Sarit; Raviv, Ziv; Azhari, Haim; Shaked, Yuval;, Copper oxide nanoparticles inhibit pancreatic tumor growth primarily by targeting tumor initiating cells., Scientific reports Vol.9, 2019
    Cosco, D., Cilurzo, F., Maiuolo, J., Federico, C., Di Martino, M. T., Cristiano, M. C., . . . Paolino, D. (2015)., Delivery of miR-34a by chitosan/PLGA nanoplexes for the anticancer treatment of multiple myeloma., Scientific Reports, 5, 17579. doi:10.1038/srep17579 [doi]
    Aasen, Synnøve Nymark; Parajuli, Himalaya; Hoang, Tuyen; Feng, Zichao; Stokke, Krister; Wang, Jiwei; Roy, Kislay; Bjerkvig, Rolf; Knappskog, Stian; Thorsen, Frits;, Effective Treatment of Metastatic Melanoma by Combining MAPK and PI3K Signaling Pathway Inhibitors., International journal of molecular sciences Vol.20, 2019
    Shir, A., Ogris, M., Roedl, W., Wagner, E., & Levitzki, A. (2011), EGFR-homing dsRNA activates cancer-targeted immune response and eliminates disseminated EGFR-overexpressing tumors in mice, Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 17(5), 1033-1043. doi:10.1158/1078-0432.CCR-10-1140 [doi]
    Krishnamoorthy, Gnana P; Davidson, Natalie R; Leach, Steven D; Zhao, Zhen; Lowe, Scott W; Lee, Gina; Landa, I?igo; Nagarajah, James; Saqcena, Mahesh; Singh, Kamini; Wendel, Hans-Guido; Dogan, Snjezana; Tamarapu, Prasanna P; Blenis, John; Ghossein, Ronald A; Knauf, Jeffrey A; Rätsch, Gunnar; Fagin, James A, EIF1AX and RAS Mutations Cooperate to Drive Thyroid Tumorigenesis through ATF4 and c-MYC., Cancer discovery Vol.9, 2019
    La Rocca, Francesco; Airoldi, Irma; Di Carlo, Emma; Marotta, Pina; Falco, Geppino; Simeon, Vittorio; Laurenzana, Ilaria; Trino, Stefania; De Luca, Luciana; Todoerti, Katia; Villani, Oreste; Lackmann, Martin; DAuria, Fiorella; Frassoni, Francesco; Neri, Antonino; Del Vecchio, Luigi; Musto, Pellegrino; Cilloni, Daniela; Caivano, Antonella;, EphA3 targeting reduces in vitro adhesion and invasion and in vivo growth and angiogenesis of multiple myeloma cells., Cellular oncology (Dordrecht) Vol.40, 2017
    Zong X, Wang W, Ozes A, Fang F, Sandusky GE, Nephew KP., EZH2-Mediated Downregulation of the Tumor Suppressor DAB2IP Maintains Ovarian Cancer Stem Cells, Cancer Res. 2020 Oct 15;80(20):4371-4385. doi: 10.1158/0008-5472.CAN-20-0458. Epub 2020 Aug 19.
    Ronca R, Ghedini GC, Maccarinelli F, Sacco A, Locatelli SL, Foglio E, Taranto S, Grillo E, Matarazzo S, Castelli R, Paganini G, Desantis V, Cattane N, Cattaneo A, Mor M, Carlo-Stella C, Belotti A, Roccaro AM, Presta M, Giacomini A., FGF Trapping Inhibits Multiple Myeloma Growth through c-Myc Degradation-Induced Mitochondrial Oxidative Stress, Cancer Res. 2020 Jun 1;80(11):2340-2354. doi: 10.1158/0008-5472.CAN-19-2714. Epub 2020 Feb 24.
    Paolino, D., Licciardi, M., Celia, C., Giammona, G., Fresta, M., & Cavallaro, G. (2012)., Folate-targeted supramolecular vesicular aggregates as a new frontier for effective anticancer treatment in in vivo model., European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik e.V, 82(1), 94-102. doi:10.1016/j.ejpb.2012.06.001 [doi]
    Paolino, D., Cosco, D., Celano, M., Moretti, S., Puxeddu, E., Russo, D., & Fresta, M. (2013)., Gemcitabine-loaded biocompatible nanocapsules for the effective treatment of human cancer, Nanomedicine (London, England), 8(2), 193-201. doi:10.2217/nnm.12.101 [doi]
    Solimando AG, Da Vià MC, Leone P, Borrelli P, Croci GA, Tabares P, Brandl A, Di Lernia G, Bianchi FP, Tafuri S, Steinbrunn T, Balduini A, Melaccio A, De Summa S, Argentiero A, Rauert-Wunderlich H, Frassanito MA, Ditonno P, Henke E, Klapper W, Ria R, Terragna C, Rasche L, Rosenwald A, Kortüm KM, Cavo M, Ribatti D, Racanelli V, Einsele H, Vacca A, Beilhack A., Halting the vicious cycle within the multiple myeloma ecosystem: blocking JAM-A on bone marrow endothelial cells restores the angiogenic homeostasis and suppresses tumor progression, Haematologica. 2020 Apr 30:haematol.2019.239913. doi: 10.3324/haematol.2019.239913. Online ahead of print.
    Litzenburger, B. C., Creighton, C. J., Tsimelzon, A., Chan, B. T., Hilsenbeck, S. G., Wang, T., . . . Lee, A. V. (2011), High IGF-IR activity in triple-negative breast cancer cell lines and tumorgrafts correlates with sensitivity to anti-IGF-IR therapy., Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 17(8), 2314-2327. doi:10.1158/1078-0432.CCR-10-1903 [doi]
    Shin, D. Y., Kim, A., Kang, H. J., Park, S., Kim, D. W., & Lee, S. S. (2015)., Histone deacetylase inhibitor romidepsin induces efficient tumor cell lysis via selective down-regulation of LMP1 and c-myc expression in EBV-positive diffuse large B-cell lymphoma, Cancer Letters, 364(2), 89-97. doi:10.1016/j.canlet.2015.03.016 [doi]
    Lu, Y., Liu, Y., Oeck, S., & Glazer, P. M. (2018)., Hypoxia promotes resistance to EGFR inhibition in NSCLC cells via the histone demethylases, LSD1 and PLU-1., Molecular Cancer Research : MCR, 16(10), 1458-1469. doi:10.1158/1541-7786.MCR-17-0637 [doi]
    Stewart, R., Morrow, M., Hammond, S. A., Mulgrew, K., Marcus, D., Poon, E., . . . McCourt, M. (2015)., Identification and characterization of MEDI4736, an antagonistic anti-PD-L1 monoclonal antibody., Cancer Immunology Research, 3(9), 1052-1062. doi:10.1158/2326-6066.CIR-14-0191 [doi]
    Buoncervello, M., Romagnoli, G., Buccarelli, M., Fragale, A., Toschi, E., Parlato, S., . . . Gabriele, L. (2016), IFN-alpha potentiates the direct and immune-mediated antitumor effects of epigenetic drugs on both metastatic and stem cells of colorectal cancer., Oncotarget, 7(18), 26361-26373. doi:10.18632/oncotarget.8379 [doi]
    Airoldi, I., Di Carlo, E., Cocco, C., Caci, E., Cilli, M., Sorrentino, C., . . . Pistoia, V. (2009)., IL-12 can target human lung adenocarcinoma cells and normal bronchial epithelial cells surrounding tumor lesions., PloS One, 4(7), e6119. doi:10.1371/journal.pone.0006119 [doi]
    Aasen, Synnøve Nymark; Espedal, Heidi; Holte, Christopher Florian; Keunen, Olivier; Karlsen, Tine Veronika; Tenstad, Olav; Maherally, Zaynah; Miletic, Hrvoje; Hoang, Tuyen; Eikeland, Anne Vaag; Baghirov, Habib; Olberg, Dag Erlend; Pilkington, Geoffrey John; Sarkar, Gobinda; Jenkins, Robert B; Sundstr??m, Terje; Bjerkvig, Rolf; Thorsen, Frits;, Improved Drug Delivery to Brain Metastases by Peptide-Mediated Permeabilization of the Blood-Brain Barrier., Molecular cancer therapeutics Vol.18, 2019
    Di Martino, M. T., Gulla, A., Gallo Cantafio, M. E., Altomare, E., Amodio, N., Leone, E., . . . Tassone, P. (2014, In vitro and in vivo activity of a novel locked nucleic acid (LNA)-inhibitor-miR-221 against multiple myeloma cells., PloS One, 9(2), e89659. doi:10.1371/journal.pone.0089659 [doi]
    Hofmann, M., McCormack, E., Mujic, M., Rossberg, M., Bernd, A., Bereiter-Hahn, J., . . . Kippenberger, S. (2009)., Increased plasma colloid osmotic pressure facilitates the uptake of therapeutic macromolecules in a xenograft tumor model, Neoplasia (New York, N.Y.), 11(8), 812-822.
    Otto, Marius; Blatt, Sebastian; Pabst, Andreas; Mandic, Robert; Schwarz, Johanna; Neff, Andreas; Ziebart, Thomas;, Influence of buffy coat-derived putative endothelial progenitor cells on tumor growth and neovascularization in oral squamous cell carcinoma xenografts., Clinical oral investigations Vol.23, 2019
    Boer, J. C., Domanska, U. M., Timmer-Bosscha, H., Boer, I. G., de Haas, C. J., Joseph, J. V., . . . Walenkamp, A. M. (2013), Inhibition of formyl peptide receptor in high-grade astrocytoma by CHemotaxis inhibitory protein of S. aureus., British Journal of Cancer, 108(3), 587-596. doi:10.1038/bjc.2012.603 [doi]
    Lamanuzzi, A., Saltarella, I., Desantis, V., Frassanito, M. A., Leone, P., Racanelli, V., . . . Ria, R. (2018)., Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma., Oncotarget, 9(29), 20563-20577. doi:10.18632/oncotarget.25003 [doi]
    Rodriguez-Barrueco, R., Yu, J., Saucedo-Cuevas, L. P., Olivan, M., Llobet-Navas, D., Putcha, P., . . . Silva, J. M. (2015)., Inhibition of the autocrine IL-6-JAK2-STAT3-calprotectin axis as targeted therapy for HR-/HER2+ breast cancers, Genes & Development, 29(15), 1631-1648. doi:10.1101/gad.262642.115 [doi]
    Burns, T. F., Dobromilskaya, I., Murphy, S. C., Gajula, R. P., Thiyagarajan, S., Chatley, S. N., . . . Rudin, C. M. (2013)., Inhibition of TWIST1 leads to activation of oncogene-induced senescence in oncogene-driven non-small cell lung cancer, Molecular Cancer Research : MCR, 11(4), 329-338. doi:10.1158/1541-7786.MCR-12-0456 [doi]
    Wang T, Gnanaprakasam JNR, Chen X, Kang S, Xu X, Sun H, Liu L, Rodgers H, Miller E, Cassel TA, Sun Q, Vicente-Muñoz S, Warmoes MO, Lin P, Piedra-Quintero ZL, Guerau-de-Arellano M, Cassady KA, Zheng SG, Yang J, Lane AN, Song X, Fan TW, Wang R., Inosine is an alternative carbon source for CD8(+)-T-cell function under glucose restriction, Nat Metab. 2020 Jul;2(7):635-647. doi: 10.1038/s42255-020-0219-4. Epub 2020 Jun 15.
    Haas, T. L., Sciuto, M. R., Brunetto, L., Valvo, C., Signore, M., Fiori, M. E., . . . De Maria, R. (2017)., Integrin alpha7 is a functional marker and potential therapeutic target in glioblastoma, Cell Stem Cell, 21(1), 35-50.e9. doi:S1934-5909(17)30137-6 [pii]
    Cocco, C., Giuliani, N., Di Carlo, E., Ognio, E., Storti, P., Abeltino, M., . . . Airoldi, I. (2010), Interleukin-27 acts as multifunctional antitumor agent in multiple myeloma., Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 16(16), 4188-4197. doi:10.1158/1078-0432.CCR-10-0173 [doi]
    Airoldi, I., Tupone, M. G., Esposito, S., Russo, M. V., Barbarito, G., Cipollone, G., & Di Carlo, E. (2015)., Interleukin-27 re-educates intratumoral myeloid cells and down-regulates stemness genes in non-small cell lung cancer., Oncotarget, 6(6), 3694-3708. doi:2797 [pii]
    Lapenta, Caterina; Donati, Simona; Spadaro, Francesca; Lattanzi, Laura; Urbani, Francesca; Macchia, Iole; Sestili, Paola; Spada, Massimo; Cox, Maria Christina; Belardelli, Filippo; Santini, Stefano M, Lenalidomide improves the therapeutic effect of an interferon-α-dendritic cell-based lymphoma vaccine., Cancer immunology, immunotherapy : CII Vol.68, 2019
    Balvers, R. K., Belcaid, Z., van den Hengel, S. K., Kloezeman, J., de Vrij, J., Wakimoto, H., . . . Lamfers, M. L. (2014)., Locally-delivered T-cell-derived cellular vehicles efficiently track and deliver adenovirus delta24-RGD to infiltrating glioma., Viruses, 6(8), 3080-3096. doi:10.3390/v6083080 [doi]
    Sato H, Schoenfeld AJ, Siau E, Lu YC, Tai H, Suzawa K, Kubota D, Lui AJW, Qeriqi B, Mattar M, Offin M, Sakaguchi M, Toyooka S, Drilon A, Rosen NX, Kris MG, Solit D, De Stanchina E, Davare MA, Riely GJ, Ladanyi M, Somwar R., MAPK Pathway Alterations Correlate with Poor Survival and Drive Resistance to Therapy in Patients with Lung Cancers Driven by ROS1 Fusions, Clin Cancer Res. 2020 Jun 15;26(12):2932-2945. doi: 10.1158/1078-0432.CCR-19-3321. Epub 2020 Mar 2.
    Novoplansky, Ofra; Fury, Matthew; Prasad, Manu; Yegodayev, Ksenia; Zorea, Jonathan; Cohen, Limor; Pelossof, Raphael; Cohen, Liz; Katabi, Nora; Cecchi, Fabiola; Joshua, Ben-Zion; Popovtzer, Aron; Baselga, Jose; Scaltriti, Maurizio; Elkabets, Moshe;, MET activation confers resistance to cetuximab, and prevents HER2 and HER3 upregulation in head and neck cancer, International journal of cancer Vol.145, 2019
    Lynam-Lennon, N., Heavey, S., Sommerville, G., Bibby, B. A., Ffrench, B., Quinn, J., . . . Maher, S. G. (2017)., MicroRNA-17 is downregulated in esophageal adenocarcinoma cancer stem-like cells and promotes a radioresistant phenotype, Oncotarget, 8(7), 11400-11413. doi:10.18632/oncotarget.13940 [doi]
    Baertsch, M. A., Leber, M. F., Bossow, S., Singh, M., Engeland, C. E., Albert, J., . . . Ungerechts, G. (2014), MicroRNA-mediated multi-tissue detargeting of oncolytic measles virus., Cancer Gene Therapy, 21(9), 373-380. doi:10.1038/cgt.2014.40 [doi]
    Liu, R., Shi, P., Nie, Z., Liang, H., Zhou, Z., Chen, W., . . . Chen, C. (2016)., Mifepristone suppresses basal triple-negative breast cancer stem cells by down-regulating KLF5 expression., Theranostics, 6(4), 533-544. doi:10.7150/thno.14315 [doi]
    Parvin, Salma; Ramirez-Labrada, Ariel; Aumann, Shlomzion; Lu, XiaoQing; Weich, Natalia; Santiago, Gabriel; Cortizas, Elena M; Sharabi, Eden; Zhang, Yu; Sanchez-Garcia, Isidro; Gentles, Andrew J; Roberts, Evan; Bilbao-Cortes, Daniel; Vega, Francisco; Chapman, Jennifer R; Verdun, Ramiro E; Lossos, Izidore S;, MO2 Confers Synthetic Lethality to PARP Inhibition in DLBCL, Cancer cell Vol.36, 2019
    Wennier, S. T., Liu, J., Li, S., Rahman, M. M., Mona, M., & McFadden, G. (2012)., Myxoma virus sensitizes cancer cells to gemcitabine and is an effective oncolytic virotherapeutic in models of disseminated pancreatic cancer., Molecular Therapy : The Journal of the American Society of Gene Therapy, 20(4), 759-768. doi:10.1038/mt.2011.293 [doi]
    Sionov, Ronit Vogt; Fainsod-Levi, Tanya; Zelter, Tamir; Polyansky, Lola; Pham, Christine T; Granot, Zvi;, Neutrophil Cathepsin G and Tumor Cell RAGE Facilitate Neutrophil Anti-Tumor Cytotoxicity., Oncoimmunology Vol.8, 2019
    Chao, M. W., Chu, P. C., Chuang, H. C., Shen, F. H., Chou, C. C., Hsu, E. C., . . . Chen, C. S. (2016)., Non-epigenetic function of HDAC8 in regulating breast cancer stem cells by maintaining Notch1 protein stability., Oncotarget, 7(2), 1796-1807. doi:10.18632/oncotarget.6427 [doi]
    Giovannini, C., Baglioni, M., Baron Toaldo, M., Ventrucci, C., D'Adamo, S., Cipone, M., . . . Bolondi, L. (2013)., Notch3 inhibition enhances sorafenib cytotoxic efficacy by promoting GSK3b phosphorylation and p21 down-regulation in hepatocellular carcinoma., Oncotarget, 4(10), 1618-1631. doi:1221 [pii]
    Moschetta, M., Basile, A., Ferrucci, A., Frassanito, M. A., Rao, L., Ria, R., . . . Vacca, A. (2013)., Novel targeting of phospho-cMET overcomes drug resistance and induces antitumor activity in multiple myeloma., Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 19(16), 4371-4382. doi:10.1158/1078-0432.CCR-13-0039 [doi]
    Garg, G., Gibbs, J., Belt, B., Powell, M. A., Mutch, D. G., Goedegebuure, P., . . . Spitzer, D. (2014)., Novel treatment option for MUC16-positive malignancies with the targeted TRAIL-based fusion protein meso-TR3., BMC Cancer, 14, 35-2407-14-35. doi:10.1186/1471-2407-14-35 [doi]
    Santoro, Angela; Vlachou, Thalia; Luzi, Lucilla; Melloni, Giorgio; Mazzarella, Luca; DElia, Errico; Aobuli, Xieraili; Pasi, Cristina Elisabetta; Reavie, Linsey; Bonetti, Paola; Punzi, Simona; Casoli, Lucia; Sab??, Arianna; Moroni, Maria Cristina; Dellino, Gaetano Ivan; Amati, Bruno; Nicassio, Francesco; Lanfrancone, Luisa; Pelicci, Pier Giuseppe;, p53 Loss in Breast Cancer Leads to Myc Activation, Increased Cell Plasticity, and Expression of a Mitotic Signature with Prognostic Value, Cell reports Vol.26, 2019
    Pleniceanu, O., Shukrun, R., Omer, D., Vax, E., Kanter, I., Dziedzic, K., . . . Dekel, B. (2017)., Peroxisome proliferator-activated receptor gamma (PPARgamma) is central to the initiation and propagation of human angiomyolipoma, suggesting its potential as a therapeutic target, EMBO Molecular Medicine, 9(4), 508-530. doi:10.15252/emmm.201506111 [doi]
    Zhu, C., Cheng, K. W., Ouyang, N., Huang, L., Sun, Y., Constantinides, P., & Rigas, B. (2012)., Phosphosulindac (OXT-328) selectively targets breast cancer stem cells in vitro and in human breast cancer xenografts., Stem Cells (Dayton, Ohio), 30(10), 2065-2075. doi:10.1002/stem.1139 [doi]
    Kolev, V. N., Wright, Q. G., Vidal, C. M., Ring, J. E., Shapiro, I. M., Ricono, J., . . . Xu, Q. (2015)., PI3K/mTOR dual inhibitor VS-5584 preferentially targets cancer stem cells., null
    Di Meo, C., Cilurzo, F., Licciardi, M., Scialabba, C., Sabia, R., Paolino, D., . . . Matricardi, P. (2015)., Polyaspartamide-doxorubicin conjugate as potential prodrug for anticancer therapy., Pharmaceutical Research, 32(5), 1557-1569. doi:10.1007/s11095-014-1557-2 [doi]
    Deb G, Wingelhofer B, Amaral FMR, Maiques-Diaz A, Chadwick JA, Spencer GJ, Williams EL, Leong HS, Maes T, Somervaille TCP., Pre-clinical activity of combined LSD1 and mTORC1 inhibition in MLL-translocated acute myeloid leukaemia, Leukemia. 2020 May;34(5):1266-1277. doi: 10.1038/s41375-019-0659-6. Epub 2019 Nov 28.
    Torres-Guzman, R., Calsina, B., Hermoso, A., Baquero, C., Alvarez, B., Amat, J., . . . Lallena, M. J. (2017)., Preclinical characterization of abemaciclib in hormone receptor positive breast cancer., Oncotarget, 8(41), 69493-69507. doi:10.18632/oncotarget.17778 [doi]
    Friedrich, M., Henn, A., Raum, T., Bajtus, M., Matthes, K., Hendrich, L., . . . Rattel, B. (2014)., Preclinical characterization of AMG 330, a CD3/CD33-bispecific T-cell-engaging antibody with potential for treatment of acute myelogenous leukemia., Molecular Cancer Therapeutics, 13(6), 1549-1557. doi:10.1158/1535-7163.MCT-13-0956 [doi]
    Hammer S, Hagemann UB, Zitzmann-Kolbe S, Larsen A, Ellingsen C, Geraudie S, Grant D, Indrevoll B, Smeets R, von Ahsen O, Kristian A, Lejeune P, Hennekes H, Karlsson J, Bjerke RM, Ryan OB, Cuthbertson AS, Mumberg D., Preclinical Efficacy of a PSMA-Targeted Thorium-227 Conjugate (PSMA-TTC), a Targeted Alpha Therapy for Prostate Cancer, Clin Cancer Res. 2020 Apr 15;26(8):1985-1996. doi: 10.1158/1078-0432.CCR-19-2268. Epub 2019 Dec 12.
    Hammer, Stefanie; Hagemann, Urs B; Zitzmann-Kolbe, Sabine; Larsen, Aasmund; Ellingsen, Christine; Geraudie, Solene; Grant, Derek; Indrevoll, Baard; Smeets, Roger; von Ahsen, Oliver; Kristian, Alexander; Lejeune, Pascale; Hennekes, Hartwig; Karlsson, Jenny; Bjerke, Roger M; Ryan, Olav B; Cuthbertson, Alan S; Mumberg, Dominik;, Preclinical efficacy of a PSMA-targeted thorium-227 conjugate (PSMA-TTC), a targeted alpha therapy for prostate cancer., Clinical cancer research : an official journal of the American Association for Cancer Research Vol.9, 2019
    Sommer, A., Kopitz, C., Schatz, C. A., Nising, C. F., Mahlert, C., Lerchen, H. G., . . . Kreft, B. (2016)., Preclinical efficacy of the auristatin-based antibody-drug conjugate BAY 1187982 for the treatment of FGFR2-positive solid tumors, Cancer Research, 76(21), 6331-6339. doi:0008-5472.CAN-16-0180 [pii]
    Smit, J. K., Faber, H., Niemantsverdriet, M., Baanstra, M., Bussink, J., Hollema, H., . . . Coppes, R. P. (2013)., Prediction of response to radiotherapy in the treatment of esophageal cancer using stem cell markers., Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology, 107(3), 434-441. doi:10.1016/j.radonc.2013.03.027 [doi]
    Kim, S., Jin, H., Seo, H. R., Lee, H. J., & Lee, Y. S. (2018)., Regulating BRCA1 protein stability by cathepsin S-mediated ubiquitin degradation., Cell Death and Differentiation, doi:10.1038/s41418-018-0153-0 [doi]
    Amodio, Nicola; Gallo Cantafio, Maria Eugenia; Botta, Cirino; Agosti, Valter; Federico, Cinzia; Caracciolo, Daniele; Ronchetti, Domenica; Rossi, Marco; Driessen, Christoph; Neri, Antonino; Tagliaferri, Pierosandro; Tassone, Pierfrancesco;, Replacement of miR-155 Elicits Tumor Suppressive Activity and Antagonizes Bortezomib Resistance in Multiple Myeloma, Cancers Vol.11, 2019
    Badarni, Mai; Prasad, Manu; Balaban, Noa; Zorea, Jonathan; Yegodayev, Ksenia M; Joshua, Ben-Zion; Dinur, Anat Bahat; Grénman, Reidar; Rotblat, Barak; Cohen, Limor; Elkabets, Moshe, Repression of AXL expression by AP-1/JNK blockage overcomes resistance to PI3Ka therapy, JCI insight Vol.5, 2019
    Liapis E, Klemm U, Karlas A, Reber J, Ntziachristos V., Resolution of Spatial and Temporal Heterogeneity in Bevacizumab-Treated Breast Tumors by Eigenspectra Multispectral Optoacoustic Tomography, Cancer Res. 2020 Dec 1;80(23):5291-5304. doi: 10.1158/0008-5472.CAN-20-1011. Epub 2020 Sep 29.
    Smith BD, Kaufman MD, Lu WP, Gupta A, Leary CB, Wise SC, Rutkoski TJ, Ahn YM, Al-Ani G, Bulfer SL, Caldwell TM, Chun L, Ensinger CL, Hood MM, McKinley A, Patt WC, Ruiz-Soto R, Su Y, Telikepalli H, Town A, Turner BA, Vogeti L, Vogeti S, Yates K, Janku F, Abdul Razak AR, Rosen O, Heinrich MC, Flynn DL., Ripretinib (DCC-2618) Is a Switch Control Kinase Inhibitor of a Broad Spectrum of Oncogenic and Drug-Resistant KIT and PDGFRA Variants., Cancer Cell. 2019 May 13;35(5):738-751.e9
    Dahlmann, M., & Stein, U. (2015)., RNA interference for antimetastatic therapy., Methods in Molecular Biology (Clifton, N.J.), 1317, 153-165. doi:10.1007/978-1-4939-2727-2_10 [doi]
    D'Alesio, C., Punzi, S., Cicalese, A., Fornasari, L., Furia, L., Riva, L., . . . Lanfrancone, L. (2016)., RNAi screens identify CHD4 as an essential gene in breast cancer growth, Oncotarget, 7(49), 80901-80915. doi:10.18632/oncotarget.12646 [doi]
    Fischer, M. M., Yeung, V. P., Cattaruzza, F., Hussein, R., Yen, W. C., Murriel, C., . . . Hoey, T. (2017)., RSPO3 antagonism inhibits growth and tumorigenicity in colorectal tumors harboring common wnt pathway mutations., Scientific Reports, 7(1), 15270-017-15704-y. doi:10.1038/s41598-017-15704-y [doi]
    Spriano, Filippo; Tarantelli, Chiara; Gaudio, Eugenio; Gerlach, Magdalena M; Priebe, Valdemar; Cascione, Luciano; Bernasconi, Elena; Targa, Altea; Mascia, Michele; Dirnhofer, Stefan; Stathis, Anastasios; Zucca, Emanuele; Bertoni, Francesco;, Single and combined BTK and PI3Kδ inhibition with acalabrutinib and ACP-319 in pre-clinical models of aggressive lymphomas., British journal of haematology Vol.187, 2019
    He, M., Tan, B., Vasan, K., Yuan, H., Cheng, F., Ramos da Silva, S., . . . Gao, S. J. (2017)., SIRT1 and AMPK pathways are essential for the proliferation and survival of primary effusion lymphoma cells, The Journal of Pathology, 242(3), 309-321. doi:10.1002/path.4905 [doi]
    Li, X., Wu, J. B., Li, Q., Shigemura, K., Chung, L. W., & Huang, W. C. (2016)., SREBP-2 promotes stem cell-like properties and metastasis by transcriptional activation of c-myc in prostate cancer., Oncotarget, 7(11), 12869-12884. doi:10.18632/oncotarget.7331 [doi]
    Patyna, S., Laird, A. D., Mendel, D. B., O'farrell, A. M., Liang, C., Guan, H., . . . Hu-Lowe, D. (2006)., SU14813: A novel multiple receptor tyrosine kinase inhibitor with potent antiangiogenic and antitumor activity, Molecular Cancer Therapeutics, 5(7), 1774-1782. doi:5/7/1774 [pii]
    Melis, M. H., Simpson, K. L., Dovedi, S. J., Welman, A., MacFarlane, M., Dive, C., . . . Illidge, T. M. (2013)., Sustained tumour eradication after induced caspase-3 activation and synchronous tumour apoptosis requires an intact host immune response, Cell Death and Differentiation, 20(5), 765-773. doi:10.1038/cdd.2013.8 [doi]
    Galuppo, R., Maynard, E., Shah, M., Daily, M. F., Chen, C., Spear, B. T., & Gedaly, R. (2014)., Synergistic inhibition of HCC and liver cancer stem cell proliferation by targeting RAS/RAF/MAPK and WNT/beta-catenin pathways, Anticancer Research, 34(4), 1709-1713. doi:34/4/1709 [pii]
    Rao, L., De Veirman, K., Giannico, D., Saltarella, I., Desantis, V., Frassanito, M. A., . . . Vacca, A. (2018)., Targeting angiogenesis in multiple myeloma by the VEGF and HGF blocking DARPin((R)) protein MP0250: A preclinical study, Oncotarget, 9(17), 13366-13381. doi:10.18632/oncotarget.24351 [doi]
    Leone, E., Morelli, E., Di Martino, M. T., Amodio, N., Foresta, U., Gulla, A., . . . Tassone, P. (2013)., Targeting miR-21 inhibits in vitro and in vivo multiple myeloma cell growth, Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 19(8), 2096-2106. doi:10.1158/1078-0432.CCR-12-3325 [doi]
    Raimondi, L., Amodio, N., Di Martino, M. T., Altomare, E., Leotta, M., Caracciolo, D., . . . Tassone, P. (2014), Targeting of multiple myeloma-related angiogenesis by miR-199a-5p mimics: In vitro and in vivo anti-tumor activity, Oncotarget, 5(10), 3039-3054. doi:1747 [pii]
    Stafman, L. L., Mruthyunjayappa, S., Waters, A. M., Garner, E. F., Aye, J. M., Stewart, J. E., . . . Beierle, E. A. (2018)., Targeting PIM kinase as a therapeutic strategy in human hepatoblastoma., Oncotarget, 9(32), 22665-22679. doi:10.18632/oncotarget.25205 [doi]
    Gedaly, R., Galuppo, R., Daily, M. F., Shah, M., Maynard, E., Chen, C., . . . Spear, B. T. (2014)., Targeting the Wnt/beta-catenin signaling pathway in liver cancer stem cells and hepatocellular carcinoma cell lines with FH535., PloS One, 9(6), e99272. doi:10.1371/journal.pone.0099272 [doi]
    Davidi, S., Fremder, E., Kan, T., Raviv, Z., Timaner, M., Karin, N., . . . Shaked, Y. (2017), The antiangiogenic role of the pro-inflammatory cytokine interleukin-31., Oncotarget, 8(10), 16430-16444. doi:10.18632/oncotarget.14857 [doi]
    Boi, M., Gaudio, E., Bonetti, P., Kwee, I., Bernasconi, E., Tarantelli, C., . . . Bertoni, F. (2015)., The BET bromodomain inhibitor OTX015 affects pathogenetic pathways in preclinical B-cell tumor models and synergizes with targeted drugs., Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 21(7), 1628-1638. doi:10.1158/1078-0432.CCR-14-1561 [doi]
    Boi, M., Gaudio, E., Bonetti, P., Kwee, I., Bernasconi, E., Tarantelli, C., . . . Bertoni, F. (2015)., The BET bromodomain inhibitor OTX015 affects pathogenetic pathways in preclinical B-cell tumor models and synergizes with targeted drugs., Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 21(7), 1628-1638. doi:10.1158/1078-0432.CCR-14-1561 [doi]
    Laurent, S., Queirolo, P., Boero, S., Salvi, S., Piccioli, P., Boccardo, S., . . . Pistillo, M. P. (2013)., The engagement of CTLA-4 on primary melanoma cell lines induces antibody-dependent cellular cytotoxicity and TNF-alpha production., Journal of Translational Medicine, 11, 108-5876-11-108. doi:10.1186/1479-5876-11-108 [doi]
    Adam, C., Baeurle, A., Brodsky, J. L., Wipf, P., Schrama, D., Becker, J. C., & Houben, R. (2014), The HSP70 modulator MAL3-101 inhibits merkel cell carcinoma., PloS One, 9(4), e92041. doi:10.1371/journal.pone.0092041 [doi]
    Fareh, M., Turchi, L., Virolle, V., Debruyne, D., Almairac, F., de-la-Forest Divonne, S., . . . Virolle, T. (2012)., The miR 302-367 cluster drastically affects self-renewal and infiltration properties of glioma-initiating cells through CXCR4 repression and consequent disruption of the SHH-GLI-NANOG network., Cell Death and Differentiation, 19(2), 232-244. doi:10.1038/cdd.2011.89 [doi]
    Ordonez, J. L., Amaral, A. T., Carcaboso, A. M., Herrero-Martin, D., del Carmen Garcia-Macias, M., Sevillano, V., . . . de Alava, E. (2015, The PARP inhibitor olaparib enhances the sensitivity of ewing sarcoma to trabectedin, Oncotarget, 6(22), 18875-18890. doi:10.18632/oncotarget.4303 [doi]
    Abbruzzese, C., Catalogna, G., Gallo, E., di Martino, S., Mileo, A. M., Carosi, M., . . . Paggi, M. G. (2017)., The small molecule SI113 synergizes with mitotic spindle poisons in arresting the growth of human glioblastoma multiforme., Oncotarget, 8(67), 110743-110755. doi:10.18632/oncotarget.22500 [doi]
    Komar-Stossel, C., Gross, E., Dery, E., Corchia, N., Meir, K., Fried, I., & Abramovitch, R. (2014), TL-118 and gemcitabine drug combination display therapeutic efficacy in a MYCN amplified orthotopic neuroblastoma murine model--evaluation by MRI, PloS One, 9(3), e90224. doi:10.1371/journal.pone.0090224 [doi]
    Cheng, K. W., Mattheolabakis, G., Wong, C. C., Ouyang, N., Huang, L., Constantinides, P. P., & Rigas, B. (2012)., Topical phospho-sulindac (OXT-328) is effective in the treatment of non-melanoma skin cancer., International Journal of Oncology, 41(4), 1199-1203. doi:10.3892/ijo.2012.1577 [doi]
    Signore, M., Buccarelli, M., Pilozzi, E., De Luca, G., Cappellari, M., Fanciulli, M., . . . Ricci-Vitiani, L. (2016)., UCN-01 enhances cytotoxicity of irinotecan in colorectal cancer stem-like cells by impairing DNA damage response, Oncotarget, 7(28), 44113-44128. doi:10.18632/oncotarget.9859 [doi]
    Dey, J., Deckwerth, T. L., Kerwin, W. S., Casalini, J. R., Merrell, A. J., Grenley, M. O., . . . Klinghoffer, R. A. (2017)., Voruciclib, a clinical stage oral CDK9 inhibitor, represses MCL-1 and sensitizes high-risk diffuse large B-cell lymphoma to BCL2 inhibition, Scientific Reports, 7(1), 18007-017-18368-w. doi:10.1038/s41598-017-18368-w [doi]
    Punzi, Simona; Balestrieri, Chiara; DAlesio, Carolina; Bossi, Daniela; Dellino, Gaetano Ivan; Gatti, Elena; Pruneri, Giancarlo; Criscitiello, Carmen; Lovati, Giulia; Meliksetyan, Marine; Carugo, Alessandro; Curigliano, Giuseppe; Natoli, Gioacchino; Pelicci, Pier Giuseppe; Lanfrancone, Luisa;, WDR5 inhibition halts metastasis dissemination by repressing the mesenchymal phenotype of breast cancer cells., Breast cancer research : BCR Vol.21, 2019
    Fischer, M. M., Cancilla, B., Yeung, V. P., Cattaruzza, F., Chartier, C., Murriel, C. L., . . . Hoey, T. (2017)., WNT antagonists exhibit unique combinatorial antitumor activity with taxanes by potentiating mitotic cell death, Science Advances, 3(6), e1700090. doi:10.1126/sciadv.1700090 [doi]
    Sabatino, M. A., Geroni, C., Ganzinelli, M., Ceruti, R., & Broggini, M. (2013)., Zebularine partially reverses GST methylation in prostate cancer cells and restores sensitivity to the DNA minor groove binder brostallicin, Epigenetics, 8(6), 656-665. doi:10.4161/epi.24916 [doi]
    Sharma S, Wu SY, Jimenez H, Xing F, Zhu D, Liu Y, Wu K, Tyagi A, Zhao D, Lo HW, Metheny-Barlow L, Sun P, Bourland JD, Chan MD, Thomas A, Barbault A, D'Agostino RB, Whitlow CT, Kirchner V, Blackman C, Pasche B, Watabe K, Ca(2+) and CACNA1H mediate targeted suppression of breast cancer brain metastasis by AM RF EMF., EBioMedicine. 2019 Jun;44:194-208.
    Nolting, S., Combination targeted therapies for malignant tumours – towards precision medicine, Endocrine Abstracts (2020) 70 S1.2 | DOI: 10.1530/endoabs.70.S1.2
    Maaland AF, Saidi A, Torgue J, Heyerdahl H, Stallons TAR, Kolstad A, Dahle J., Targeted alpha therapy for chronic lymphocytic leukaemia and non-Hodgkin's lymphoma with the anti-CD37 radioimmunoconjugate 212Pb-NNV003, PLoS One. 2020 Mar 18;15(3):e0230526. doi: 10.1371/journal.pone.0230526. eCollection 2020.
    Hong, J., Maacha, S., & Belkhiri, A. (2018), Transcriptional upregulation of c-MYC by AXL confers epirubicin resistance in esophageal adenocarcinoma., Molecular Oncology, doi:10.1002/1878-0261.12395 [doi]
    Chang YC, Ackerstaff E, Tschudi Y, Jimenez B, Foltz W, Fisher C, Lilge L, Cho H, Carlin S, Gillies RJ, Balagurunathan Y, Yechieli RL, Subhawong T, Turkbey B, Pollack A, Stoyanova R., Delineation of Tumor Habitats based on Dynamic Contrast Enhanced MRI., Sci Rep. 2017 Aug 29;7(1):9746.
    Fisher C, Obaid G, Niu C, Foltz W, Goldstein A, Hasan T, Lilge L., Liposomal Lapatinib in Combination with Low-Dose Photodynamic Therapy for the Treatment of Glioma., J Clin Med. 2019 Dec 14;8(12). pii: E2214.
    Le Joncour, Vadim; Martins, Ana; Puhka, Maija; Isola, Jorma; Salmikangas, Marko; Laakkonen, Pirjo; Joensuu, Heikki; Barok, Mark;, A Novel Anti-HER2 Antibody-Drug Conjugate XMT-1522 for HER2-Positive Breast and Gastric Cancers Resistant to Trastuzumab Emtansine., Molecular cancer therapeutics Vol.18, 2019
    Czardybon, W., Windak, R., Golas, A., Galezowski, M., Sabiniarz, A., Dolata, I., . . . Brzozka, K. (2018), A novel, dual pan-PIM/FLT3 inhibitor SEL24 exhibits broad therapeutic potential in acute myeloid leukemia., Oncotarget, 9(24), 16917-16931. doi:10.18632/oncotarget.24747 [doi]
    Landolina N, Zaffran I, Smiljkovic D, Serrano-Candelas E, Schmiedel D, Friedman S, Arock M, Hartmann K, Pikarsky E, Mandelboim O, Martin M, Valent P, Levi-Schaffer F., Activation of Siglec-7 results in inhibition of in vitro and in vivo growth of human mast cell leukemia cells, Pharmacol Res. 2020 Aug;158:104682. doi: 10.1016/j.phrs.2020.104682. Epub 2020 Feb 5.
    Kelly, R. K., Olson, D. L., Sun, Y., Wen, D., Wortham, K. A., Antognetti, G., . . . Sanicola, M. (2011), An antibody-cytotoxic conjugate, BIIB015, is a new targeted therapy for cripto positive tumours., . European Journal of Cancer (Oxford, England : 1990), 47(11), 1736-1746. doi:10.1016/j.ejca.2011.02.023 [doi]
    Urbinati, G., Ali, H. M., Rousseau, Q., Chapuis, H., Desmaele, D., Couvreur, P., & Massaad-Massade, L. (2015)., Antineoplastic effects of siRNA against TMPRSS2-ERG junction oncogene in prostate cancer., PloS One, 10(5), e0125277. doi:10.1371/journal.pone.0125277 [doi]
    Adepoju, L. J., & Geiger, J. D. (2010). ., Antitumor activity of polyuridylic acid in human soft tissue and bone sarcomas., The Journal of Surgical Research, 164(1), e107-14. doi:10.1016/j.jss.2010.05.038 [doi]
    Egberts, J. H., Cloosters, V., Noack, A., Schniewind, B., Thon, L., Klose, S., . . . Trauzold, A., Anti-tumor necrosis factor therapy inhibits pancreatic tumor growth and metastasis., Cancer Research, 68(5), 1443-1450. doi:10.1158/0008-5472.CAN-07-5704 [doi]
    Zhao, Ning; Peacock, Stephanie O; Lo, Chen Hao; Heidman, Laine M; Rice, Meghan A; Fahrenholtz, Cale D; Greene, Ann M; Magani, Fiorella;, Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancer., Science translational medicine Vol.11, 2019
    Parhi L, Alon-Maimon T, Sol A, Nejman D, Shhadeh A, Fainsod-Levi T, Yajuk O, Isaacson B, Abed J, Maalouf N, Nissan A, Sandbank J, Yehuda-Shnaidman E, Ponath F, Vogel J, Mandelboim O, Granot Z, Straussman R, Bachrach G., Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression, Nat Commun. 2020 Jun 26;11(1):3259. doi: 10.1038/s41467-020-16967-2.
    von Karstedt, S., Conti, A., Nobis, M., Montinaro, A., Hartwig, T., Lemke, J., . . . Walczak, H. (2015)., Cancer cell-autonomous TRAIL-R signaling promotes KRAS-driven cancer progression, invasion, and metastasis., Cancer Cell, 27(4), 561-573. doi:10.1016/j.ccell.2015.02.014 [doi]
    Pesakhov, S., Nachliely, M., Barvish, Z., Aqaqe, N., Schwartzman, B., Voronov, E., . . . Danilenko, M. (2016), Cancer-selective cytotoxic Ca2+ overload in acute myeloid leukemia cells and attenuation of disease progression in mice by synergistically acting polyphenols curcumin and carnosic acid, Oncotarget, 7(22), 31847-31861. doi:10.18632/oncotarget.7240 [doi]
    Assimon VA, Tang Y, Vargas JD, Lee GJ, Wu ZY, Lou K, Yao B, Menon MK, Pios A, Perez KC, Madriaga A, Buchowiecki PK, Rolfe M, Shawver L, Jiao X, Le Moigne R, Zhou HJ, Anderson DJ, CB-6644 Is a Selective Inhibitor of the RUVBL1/2 Complex with Anticancer Activity., ACS Chem Biol. 2019 Feb 15;14(2):236-244.
    Rakhmilevich, A. L., Buhtoiarov, I. N., Malkovsky, M., & Sondel, P. M. (2008)., CD40 ligation in vivo can induce T cell independent antitumor effects even against immunogenic tumors., Cancer Immunology, Immunotherapy : CII, 57(8), 1151-1160. doi:10.1007/s00262-007-0447-4 [doi]
    Sobot, D., Mura, S., Rouquette, M., Vukosavljevic, B., Cayre, F., Buchy, E., . . . Couvreur, P. (2017)., Circulating lipoproteins: A trojan horse guiding squalenoylated drugs to LDL-accumulating cancer cells., Molecular Therapy : The Journal of the American Society of Gene Therapy, 25(7), 1596-1605. doi:S1525-0016(17)30234-4 [pii]
    Kaeopookum, Piriya; Petrik, Milos; Summer, Dominik; Klinger, Maximilian; Zhai, Chuangyan; Rangger, Christine; Haubner, Roland; Haas, Hubertus; Hajduch, Marian; Decristoforo, Clemens;, Comparison of 68Ga-labeled RGD mono- and multimers based on a clickable siderophore-based scaffold., Nuclear medicine and biology Vol.78-79,
    Stangl, S., Wortmann, A., Guertler, U., & Multhoff, G. (2006)., Control of metastasized pancreatic carcinomas in SCID/beige mice with human IL-2/TKD-activated NK cells., Journal of Immunology (Baltimore, Md.: 1950), 176(10), 6270-6276. doi:176/10/6270 [pii]
    Glaser, G., Weroha, S. J., Becker, M. A., Hou, X., Enderica-Gonzalez, S., Harrington, S. C., & Haluska, P. (2015)., Conventional chemotherapy and oncogenic pathway targeting in ovarian carcinosarcoma using a patient-derived tumorgraft., PloS One, 10(5), e0126867. doi:10.1371/journal.pone.0126867 [doi]
    Bartalucci, N., Tozzi, L., Bogani, C., Martinelli, S., Rotunno, G., Villeval, J. L., & Vannucchi, A. M. (2013)., Co-targeting the PI3K/mTOR and JAK2 signalling pathways produces synergistic activity against myeloproliferative neoplasms., Journal of Cellular and Molecular Medicine, 17(11), 1385-1396. doi:10.1111/jcmm.12162 [doi]
    Egberts, J. H., Schniewind, B., Patzold, M., Kettler, B., Tepel, J., Kalthoff, H., & Trauzold, A. (2008)., Dexamethasone reduces tumor recurrence and metastasis after pancreatic tumor resection in SCID mice., Cancer Biology & Therapy, 7(7), 1044-1050. doi:6099 [pii]
    Nachliely M, Trachtenberg A, Khalfin B, Nalbandyan K, Cohen-Lahav M, Yasuda K, Sakaki T, Kutner A, Danilenko M., Dimethyl fumarate and vitamin D derivatives cooperatively enhance VDR and Nrf2 signaling in differentiating AML cells in vitro and inhibit leukemia progression in a xenograft mouse model., . J Steroid Biochem Mol Biol. 2019 Apr;188:8-16
    Hiriyan, J., Shivarudraiah, P., Gavara, G., Annamalai, P., Natesan, S., Sambasivam, G., & Sukumaran, S. K. (2015)., Discovery of PAT-1102, a novel, potent and orally active histone deacetylase inhibitor with antitumor activity in cancer mouse models, Anticancer Research, 35(1), 229-237. doi:35/1/229 [pii]
    Fonti, Claire; Saumet, Anne; Abi-Khalil, Amanda; Orsetti, Béatrice; Cleroux, Elouan; Bender, Ambre; Dumas, Michael; Schmitt, Emeline; Colinge, Jacques; Jacot, William; Weber, Michael; Sardet, Claude; du Manoir, Stanislas; Theillet, Charles;, Distinct oncogenes drive different genome and epigenome alterations in human mammary epithelial cells, International journal of cancer Vol.145, 2019
    Key, J., Aryal, S., Gentile, F., Ananta, J. S., Zhong, M., Landis, M. D., & Decuzzi, P. (2013)., Engineering discoidal polymeric nanoconstructs with enhanced magneto-optical properties for tumor imaging, Biomaterials, 34(21), 5402-5410. doi:10.1016/j.biomaterials.2013.03.078 [doi]
    Natoni, A., Smith, T. A. G., Keane, N., McEllistrim, C., Connolly, C., Jha, A., . . . O'Dwyer, M. E. (2017)., E-selectin ligands recognised by HECA452 induce drug resistance in myeloma, which is overcome by the E-selectin antagonist, GMI-1271., Leukemia, 31(12), 2642-2651. doi:10.1038/leu.2017.123 [doi]
    De Thaye E, Van de Vijver K, Van der Meulen J, Taminau J, Wagemans G, Denys H, Van Dorpe J, Berx G, Ceelen W, Van Bocxlaer J, De Wever O., Establishment and characterization of a cell line and patient-derived xenograft (PDX) from peritoneal metastasis of low-grade serous ovarian carcinoma, Sci Rep. 2020 Apr 21;10(1):6688. doi: 10.1038/s41598-020-63738-6.
    Naumann, C. M., Sperveslage, J., Hamann, M. F., Leuschner, I., Weder, L., Al-Najar, A. A., . . . Kalthoff, H. (2012)., Establishment and characterization of primary cell lines of squamous cell carcinoma of the penis and its metastasis., The Journal of Urology, 187(6), 2236-2242. doi:10.1016/j.juro.2012.01.035 [doi]
    Srivastava, Swati; Nataraj, Nishanth Belugali; Sekar, Arunachalam; Ghosh, Soma; Bornstein, Chamutal; Drago-Garcia, Diana; Roth, Lee; Romaniello, Donatella; Marrocco, Ilaria; David, Eyal; Gilad, Yuval; Lauriola, Mattia; Rotkopf, Ron; Kimchi, Adi; Haga, Yuya; Tsutsumi, Yasuo; Mirabeau, Olivier; Surdez, Didier; Zinovyev, Andrei; Delattre, Olivier; Kovar, Heinrich; Amit, Ido; Yarden, Yosef;, ETS Proteins Bind with Glucocorticoid Receptors: Relevance for Treatment of Ewing Sarcoma, Cell reports Vol.29, 2019
    Owonikoko, Taofeek K; Zhang, Guojing; Lallani, Shenila B; Chen, Zhengjia; Martinson, Deborah E; Khuri, Fadlo R; Lonial, Sagar; Marcus, Adam; Sun, Shi-Yong;, Evaluation of preclinical efficacy of everolimus and pasireotide in thyroid cancer cell lines and xenograft models., PloS one Vol.14, 2019
    Bailey, K. M., Cornnell, H. H., Ibrahim-Hashim, A., Wojtkowiak, J. W., Hart, C. P., Zhang, X., . . . Gillies, R. J. (2014)., Evaluation of the "steal" phenomenon on the efficacy of hypoxia activated prodrug TH-302 in pancreatic cancer., PloS One, 9(12), e113586. doi:10.1371/journal.pone.0113586 [doi]
    Cody, J. J., Rivera, A. A., Lyons, G. R., Yang, S. W., Wang, M., Ashley, J. W., . . . Douglas, J. T. (2013)., Expression of osteoprotegerin from a replicating adenovirus inhibits the progression of prostate cancer bone metastases in a murine model., Laboratory Investigation; a Journal of Technical Methods and Pathology, 93(3), 268-278. doi:10.1038/labinvest.2012.179 [doi]
    Ronca R, Ghedini GC, Maccarinelli F, Sacco A, Locatelli SL, Foglio E, Taranto S, Grillo E, Matarazzo S, Castelli R, Paganini G, Desantis V, Cattane N, Cattaneo A, Mor M, Carlo-Stella C, Belotti A, Roccaro AM, Presta M, Giacomini A., FGF Trapping Inhibits Multiple Myeloma Growth through c-Myc Degradation-Induced Mitochondrial Oxidative Stress, Cancer Res. 2020 Jun 1;80(11):2340-2354. doi: 10.1158/0008-5472.CAN-19-2714. Epub 2020 Feb 24.
    Kurdow, R., Boehle, A. S., Haye, S., Boenicke, L., Schniewind, B., Dohrmann, P., & Kalthoff, H. (2002)., Ganciclovir prodrug therapy is effective in a murine xenotransplant model of human lung cancer, The Annals of Thoracic Surgery, 73(3), 905-910.
    von Forstner, C., Egberts, J. H., Ammerpohl, O., Niedzielska, D., Buchert, R., Mikecz, P., . . . Brenner, W. (2008)., Gene expression patterns and tumor uptake of 18F-FDG, 18F-FLT, and 18F-FEC in PET/MRI of an orthotopic mouse xenotransplantation model of pancreatic cancer., Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, 49(8), 1362-1370. doi:10.2967/jnumed.107.050021 [doi]
    Ding, H., Peterson, K. L., Correia, C., Koh, B., Schneider, P. A., Nowakowski, G. S., & Kaufmann, S. H. (2017)., Histone deacetylase inhibitors interrupt HSP90*RASGRP1 and HSP90*CRAF interactions to upregulate BIM and circumvent drug resistance in lymphoma cells, Leukemia, 31(7), 1593-1602. doi:10.1038/leu.2016.357 [doi]
    Debeb, B. G., Lacerda, L., Xu, W., Larson, R., Solley, T., Atkinson, R., . . . Woodward, W. A. (2012)., Histone deacetylase inhibitors stimulate dedifferentiation of human breast cancer cells through WNT/beta-catenin signaling., Stem Cells (Dayton, Ohio), 30(11), 2366-2377. doi:10.1002/stem.1219 [doi]
    Gatto, F., Redaelli, D., Salvade, A., Marzorati, S., Sacchetti, B., Ferina, C., . . . Serafini, M. (2012)., Hurler disease bone marrow stromal cells exhibit altered ability to support osteoclast formation., Stem Cells and Development, 21(9), 1466-1477. doi:10.1089/scd.2011.0555 [doi]
    Lipnik, K., Greco, O., Scott, S., Knapp, E., Mayrhofer, E., Rosenfellner, D., . . . Hohenadl, C. (2006)., Hypoxia- and radiation-inducible, breast cell-specific targeting of retroviral vectors, Virology, 349(1), 121-133. doi:S0042-6822(05)00851-2 [pii]
    Feng, Yongmei; Sessions, E Hampton; Zhang, Fan; Ban, Fuqiang; Placencio-Hickok, Veronica; Ma, Chen-Ting; Zeng, Fu-Yue; Pass, Ian; Terry, David B; Cadwell, Gregory; Bankston, Laurie A; Liddington, Robert C; Chung, Thomas D Y; Pinkerton, Anthony B; Sergienko, Eduard; Gleave, Martin; Bhowmick, Neil A; Jackson, Michael R; Cherkasov, Artem; Ronai, Zeev A;, Identification and characterization of small molecule inhibitors of the ubiquitin ligases Siah1/2 in melanoma and prostate cancer cells., Cancer letters Vol.449, 2019
    Potter, D. S., Galvin, M., Brown, S., Lallo, A., Hodgkinson, C. L., Blackhall, F., . . . Dive, C. (2016)., Inhibition of PI3K/BMX cell survival pathway sensitizes to BH3 mimetics in SCLC, Molecular Cancer Therapeutics, 15(6), 1248-1260. doi:10.1158/1535-7163.MCT-15-0885 [doi]
    Gill, S. E., Zhang, Q., Keeney, G. L., Cliby, W. A., & Weroha, S. J. (2017)., Investigation of factors affecting the efficacy of 3C23K, a human monoclonal antibody targeting MISIIR, Oncotarget, 8(49), 85214-85223. doi:10.18632/oncotarget.19620 [doi]
    Bartnicka JJ, Al-Salemee F, Firth G, Blower PJ., L-Cysteine-mediated modulation of copper trafficking in prostate cancer cells: an in vitro and in vivo investigation with (64)Cu and (64)Cu-PET, Metallomics. 2020 Oct 21;12(10):1508-1520. doi: 10.1039/d0mt00161a.
    Gabay M, Weizman A, Zeineh N, Kahana M, Obeid F, Allon N, Gavish M., Liposomal Carrier Conjugated to APP-Derived Peptide for Brain Cancer Treatment, Cell Mol Neurobiol. 2020 Oct 6. doi: 10.1007/s10571-020-00969-1. Online ahead of print.
    Stein, U., Walther, W., Arlt, F., Schwabe, H., Smith, J., Fichtner, I., . . . Schlag, P. M. (2009)., MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis, . Nature Medicine, 15(1), 59-67. doi:10.1038/nm.1889 [doi]
    Wang, Wei; Shen, Tao; Dong, Bingning; Creighton, Chad J; Meng, Yanling; Zhou, Wolong; Shi, Qing; Zhou, Hao; Zhang, Yinjie; Moore, David D; Yang, Feng, MAPK4 overexpression promotes tumor progression via noncanonical activation of AKT/mTOR signaling., The Journal of clinical investigation Vol.129, 2019
    Satpathy S, Jaehnig EJ, Krug K, Kim BJ, Saltzman AB, Chan DW, Holloway KR, Anurag M, Huang C, Singh P, Gao A, Namai N, Dou Y, Wen B, Vasaikar SV, Mutch D, Watson MA, Ma C, Ademuyiwa FO, Rimawi MF, Schiff R, Hoog J, Jacobs S, Malovannaya A, Hyslop T, Clauser KR, Mani DR, Perou CM, Miles G, Zhang B, Gillette MA, Carr SA, Ellis MJ., Microscaled proteogenomic methods for precision oncology, Nat Commun. 2020 Jan 27;11(1):532. doi: 10.1038/s41467-020-14381-2.
    van de Ven, A. L., Abdollahi, B., Martinez, C. J., Burey, L. A., Landis, M. D., Chang, J. C., . . . Frieboes, H. B. (2013)., Modeling of nanotherapeutics delivery based on tumor perfusion., New Journal of Physics, 15, 55004. doi:10.1088/1367-2630/15/5/055004 [doi]
    van Brussel, A. S., Adams, A., Vermeulen, J. F., Oliveira, S., van der Wall, E., Mali, W. P., . . . van Bergen En Henegouwen, P. M. (2013), Molecular imaging with a fluorescent antibody targeting carbonic anhydrase IX can successfully detect hypoxic ductal carcinoma in situ of the breast., Breast Cancer Research and Treatment, 140(2), 263-272. doi:10.1007/s10549-013-2635-6 [doi]
    Vermeulen, J. F., van Brussel, A. S., Adams, A., Mali, W. P., van der Wall, E., van Diest, P. J., & Derksen, P. W. (2013)., Near-infrared fluorescence molecular imaging of ductal carcinoma in situ with CD44v6-specific antibodies in mice: A preclinical study., Molecular Imaging and Biology : MIB : The Official Publication of the Academy of Molecular Imaging, 15(3), 290-298. doi:10.1007/s11307-012-0605-8 [doi]
    Zheng ZY, Anurag M, Lei JT, Cao J, Singh P, Peng J, Kennedy H, Nguyen NC, Chen Y, Lavere P, Li J, Du XH, Cakar B, Song W, Kim BJ, Shi J, Seker S, Chan DW, Zhao GQ, Chen X, Banks KC, Lanman RB, Shafaee MN, Zhang XH, Vasaikar S, Zhang B, Hilsenbeck SG, Li W, Foulds CE, Ellis MJ, Chang EC., Neurofibromin Is an Estrogen Receptor-α Transcriptional Co-repressor in Breast Cancer, Cancer Cell. 2020 Mar 16;37(3):387-402.e7. doi: 10.1016/j.ccell.2020.02.003. Epub 2020 Mar 5.
    Abelson, S., Shamai, Y., Berger, L., Skorecki, K., & Tzukerman, M. (2013)., Niche-dependent gene expression profile of intratumoral heterogeneous ovarian cancer stem cell populations., PloS One, 8(12), e83651. doi:10.1371/journal.pone.0083651 [doi]
    Katz, E., Skorecki, K., & Tzukerman, M. (2009), Niche-dependent tumorigenic capacity of malignant ovarian ascites-derived cancer cell subpopulations, Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 15(1), 70-80. doi:10.1158/1078-0432.CCR-08-1233 [doi]
    Torres, Diogo; Hou, Xiaonan; Bale, Laurie; Heinzen, Ethan P; Maurer, Matthew J; Zanfagnin, Valentina; Oberg, Ann L; Conover, Cheryl; Weroha, S John, Overcoming platinum resistance in ovarian cancer by targeting pregnancy-associated plasma protein-A, PloS one Vol.14, 2019
    Reka, A. K., Kurapati, H., Narala, V. R., Bommer, G., Chen, J., Standiford, T. J., & Keshamouni, V. G. (2010)., Peroxisome proliferator-activated receptor-gamma activation inhibits tumor metastasis by antagonizing Smad3-mediated epithelial-mesenchymal transition., Molecular Cancer Therapeutics, 9(12), 3221-3232. doi:10.1158/1535-7163.MCT-10-0570 [doi]
    Hong, S. H., Youbi, S. E., Hong, S. P., Kallakury, B., Monroe, P., Erkizan, H. V., . . . Toretsky, J. A. (2014)., Pharmacokinetic modeling optimizes inhibition of the 'undruggable' EWS-FLI1 transcription factor in ewing sarcoma, Oncotarget, 5(2), 338-350. doi:1495 [pii]
    Davila-Gonzalez, D., Choi, D. S., Rosato, R. R., Granados-Principal, S. M., Kuhn, J. G., Li, W. F., . . . Chang, J. C. (2018)., Pharmacological inhibition of NOS activates ASK1/JNK pathway augmenting docetaxel-mediated apoptosis in triple-negative breast cancer., Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 24(5), 1152-1162. doi:10.1158/1078-0432.CCR-17-1437 [doi]
    Zhao, N., Cao, J., Xu, L., Tang, Q., Dobrolecki, L. E., Lv, X., . . . Chen, X. (2018), Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer., The Journal of Clinical Investigation, 128(4), 1283-1299. doi:10.1172/JCI95873 [doi]
    Colon-Otero G, Zanfagnin V, Hou X, Foster NR, Asmus EJ, Wahner Hendrickson A, Jatoi A, Block MS, Langstraat CL, Glaser GE, Dinh TA, Robertson MW, Camoriano JK, Butler KA, Copland JA, Weroha SJ., Phase II trial of ribociclib and letrozole in patients with relapsed oestrogen receptor-positive ovarian or endometrial cancers, ESMO Open. 2020 Oct;5(5):e000926. doi: 10.1136/esmoopen-2020-000926.
    Santiago-O'Farrill JM, Weroha SJ, Hou X, Oberg AL, Heinzen EP, Maurer MJ, Pang L, Rask P, Amaravadi RK, Becker SE, Romero I, Rubio MJ, Matias-Guiu X, Santacana M, Llombart-Cussac A, Poveda A, Lu Z, Bast RC Jr., Poly(adenosine diphosphate ribose) polymerase inhibitors induce autophagy-mediated drug resistance in ovarian cancer cells, xenografts, and patient-derived xenograft models, Cancer. 2020 Feb 15;126(4):894-907. doi: 10.1002/cncr.32600. Epub 2019 Nov 12.
    Ingallina, C., Costa, P. M., Ghirga, F., Klippstein, R., Wang, J. T., Berardozzi, S., . . . Al-Jamal, K. T. (2017)., Polymeric glabrescione B nanocapsules for passive targeting of hedgehog-dependent tumor therapy in vitro., Nanomedicine (London, England), 12(7), 711-728. doi:10.2217/nnm-2016-0388 [doi]
    Schott, A. F., Landis, M. D., Dontu, G., Griffith, K. A., Layman, R. M., Krop, I., . . . Chang, J. C. (2013), Preclinical and clinical studies of gamma secretase inhibitors with docetaxel on human breast tumors, Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 19(6), 1512-1524. doi:10.1158/1078-0432.CCR-11-3326 [doi]
    Abrams, T., Connor, A., Fanton, C., Cohen, S. B., Huber, T., Miller, K., . . . Schleyer, S. C. (2018), Preclinical antitumor activity of a novel anti-c-KIT antibody-drug conjugate against mutant and wild-type c-KIT-positive solid tumors, Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 24(17), 4297-4308. doi:10.1158/1078-0432.CCR-17-3795 [doi]
    Lee, F. Y., Smykla, R., Johnston, K., Menard, K., McGlinchey, K., Peterson, R. W., . . . Kramer, R. (2009, Preclinical efficacy spectrum and pharmacokinetics of ixabepilone, Cancer Chemotherapy and Pharmacology, 63(2), 201-212. doi:10.1007/s00280-008-0727-5 [doi]
    Huang, K. L., Li, S., Mertins, P., Cao, S., Gunawardena, H. P., Ruggles, K. V., . . . Ding, L. (2017)., Proteogenomic integration reveals therapeutic targets in breast cancer xenografts, Nature Communications, 8, 14864. doi:10.1038/ncomms14864 [doi]
    Goswami, M. T., Reka, A. K., Kurapati, H., Kaza, V., Chen, J., Standiford, T. J., & Keshamouni, V. G. (2015), Regulation of complement-dependent cytotoxicity by TGF-beta-induced epithelial-mesenchymal transition., Oncogene, doi:10.1038/onc.2015.258 [doi]
    McDaid, William J; Greene, Michelle K; Johnston, Michael C; Pollheimer, Ellen; Smyth, Peter; McLaughlin, Kirsty; Van Schaeybroeck, Sandra; Straubinger, Robert M; Longley, Daniel B; Scott, Christopher J;, Repurposing of Cetuximab in antibody-directed chemotherapy-loaded nanoparticles in EGFR therapy-resistant pancreatic tumours, Nanoscale Vol.11, 2019
    Speyer, C. L., Bukhsh, M. A., Jafry, W. S., Sexton, R. E., Bandyopadhyay, S., & Gorski, D. H. (2017)., Riluzole synergizes with paclitaxel to inhibit cell growth and induce apoptosis in triple-negative breast cancer., Breast Cancer Research and Treatment, 166(2), 407-419. doi:10.1007/s10549-017-4435-x [doi]
    Miron, T., Wilchek, M., Shvidel, L., Berrebi, A., & Arditti, F. D. (2012)., S-allyl derivatives of 6-mercaptopurine are highly potent drugs against human B-CLL through synergism between 6-mercaptopurine and allicin., Leukemia Research, 36(12), 1536-1540. doi:10.1016/j.leukres.2012.08.023 [doi]
    Rzymski, T., Mikula, M., Zylkiewicz, E., Dreas, A., Wiklik, K., Golas, A., . . . Brzozka, K. (2017)., SEL120-34A is a novel CDK8 inhibitor active in AML cells with high levels of serine phosphorylation of STAT1 and STAT5 transactivation domains., Oncotarget, 8(20), 33779-33795. doi:10.18632/oncotarget.16810 [doi]
    Reddy TP, Choi DS, Anselme AC, Qian W, Chen W, Lantto J, Horak ID, Kragh M, Chang JC, Rosato RR., Simultaneous targeting of HER family pro-survival signaling with Pan-HER antibody mixture is highly effective in TNBC: a preclinical trial with PDXs, Breast Cancer Res. 2020 May 15;22(1):48. doi: 10.1186/s13058-020-01280-z.
    Li, X., Wu, J. B., Li, Q., Shigemura, K., Chung, L. W., & Huang, W. C. (2016)., SREBP-2 promotes stem cell-like properties and metastasis by transcriptional activation of c-myc in prostate cancer, Lee, F. Y., Smykla, R., Johnston, K., Menard, K., McGlinchey, K., Peterson, R. W., . . . Kramer, R. (2009
    Egberts, J. H., Schniewind, B., Sipos, B., Hinz, S., Kalthoff, H., & Tepel, J. (2007)., Superiority of extended neoadjuvant chemotherapy with gemcitabine in pancreatic cancer: A comparative analysis in a clinically adapted orthotopic xenotransplantation model in SCID beige mice., Cancer Biology & Therapy, 6(8), 1227-1232. doi:4414 [pii]
    Vallejo-Diaz, J., Olazabal-Moran, M., Cariaga-Martinez, A. E., Pajares, M. J., Flores, J. M., Pio, R., . . . Carrera, A. C. (2016), Targeted depletion of PIK3R2 induces regression of lung squamous cell carcinoma., Oncotarget, 7(51), 85063-85078. doi:10.18632/oncotarget.13195 [doi]
    Harris, Faye R; Zhang, Piyan; Yang, Lin; Hou, Xiaonan; Leventakos, Konstantinos; Weroha, Saravut J; Vasmatzis, George; Kovtun, Irina V;, Targeting HER2 in patient-derived xenograft ovarian cancer models sensitizes tumors to chemotherapy., Molecular oncology Vol.13, 2019
    Guerra-Rebollo, Marta; Garrido, Cristina; Sánchez-Cid, Lourdes; Soler-Botija, Carolina; Meca-Cortés, Oscar; Rubio, Nuria; Blanco, Jerónimo;, Targeting of replicating CD133 and OCT4/SOX2 expressing glioma stem cells selects a cell population that reinitiates tumors upon release of therapeutic pressure., Scientific reports Vol.9, 2019
    Xu, W., Lacerda, L., Debeb, B. G., Atkinson, R. L., Solley, T. N., Li, L., . . . Woodward, W. A. (2013)., The antihelmintic drug pyrvinium pamoate targets aggressive breast cancer., PloS One, 8(8), e71508. doi:10.1371/journal.pone.0071508 [doi]
    Serebrenik AA, Argyris PP, Jarvis MC, Brown WL, Bazzaro M, Vogel RI, Erickson BK, Lee SH, Goergen KM, Maurer MJ, Heinzen EP, Oberg AL, Huang Y, Hou X, Weroha SJ, Kaufmann SH, Harris RS., The DNA Cytosine Deaminase APOBEC3B is a Molecular Determinant of Platinum Responsiveness in Clear Cell Ovarian Cancer, Clin Cancer Res. 2020 Jul 1;26(13):3397-3407. doi: 10.1158/1078-0432.CCR-19-2786. Epub 2020 Feb 14.
    Kollmann, Karoline; Briand, Coralie; Bellutti, Florian; Schicher, Nikolaus; Blunder, Stefan; Zojer, Markus; Hoeller, Christoph;, The interplay of CDK4 and CDK6 in melanoma, Oncotarget Vol.10, 2019
    Le Moigne, R., Aftab, B. T., Djakovic, S., Dhimolea, E., Valle, E., Murnane, M., . . . Rolfe, M. (2017), The p97 inhibitor CB-5083 is a unique disrupter of protein homeostasis in models of multiple myeloma., Molecular Cancer Therapeutics, 16(11), 2375-2386. doi:10.1158/1535-7163.MCT-17-0233 [doi]
    Sukowati, C. H., Anfuso, B., Croce, L. S., & Tiribelli, C. (2015)., The role of multipotent cancer associated fibroblasts in hepatocarcinogenesi, BMC Cancer, 15, 188-015-1196-y. doi:10.1186/s12885-015-1196-y [doi]
    Zhang, X. D., Baladandayuthapani, V., Lin, H., Mulligan, G., Li, B., Esseltine, D. W., . . . Orlowski, R. Z. (2016)., Tight junction protein 1 modulates proteasome capacity and proteasome inhibitor sensitivity in multiple myeloma via EGFR/JAK1/STAT3 signaling., Cancer Cell, 29(5), 639-652. doi:S1535-6108(16)30109-X [pii]
    Chang G, Shi L, Ye Y, Shi H, Zeng L, Tiwary S, Huse JT, Huo L, Ma L, Ma Y, Zhang S, Zhu J, Xie V, Li P, Han L, He C, Huang S., YTHDF3 Induces the Translation of m(6)A-Enriched Gene Transcripts to Promote Breast Cancer Brain Metastasis, Cancer Cell. 2020 Dec 14;38(6):857-871.e7. doi: 10.1016/j.ccell.2020.10.004. Epub 2020 Oct 29.
    Kanakkanthara, Arun; Huntoon, Catherine J; Hou, Xiaonan; Zhang, Minzhi; Heinzen, Ethan P; OBrien, Daniel R; Oberg, Ann L; John Weroha, S; Kaufmann, Scott H; Karnitz, Larry M;, ZC3H18 specifically binds and activates the BRCA1 promoter to facilitate homologous recombination in ovarian cancer., Nature communications Vol.10, 2019
    Jeffrey, S. C., Burke, P. J., Lyon, R. P., Meyer, D. W., Sussman, D., Anderson, M., . . . Senter, P. D. (2013)., A potent anti-CD70 antibody-drug conjugate combining a dimeric pyrrolobenzodiazepine drug with site-specific conjugation technology., Bioconjugate Chemistry, 24(7), 1256-1263. doi:10.1021/bc400217g [doi]
    Thomas A, Samykutty A, Gomez-Gutierrez JG, Yin W, Egger ME, McNally M, Chuong P, MacCuaig WM, Albeituni S, Zeiderman M, Li M, Edil BH, Grizzle WE, McMasters KM, McNally LR., Actively Targeted Nanodelivery of Echinomycin Induces Autophagy-Mediated Death in Chemoresistant Pancreatic Cancer In Vivo, Cancers (Basel). 2020 Aug 14;12(8):2279. doi: 10.3390/cancers12082279.
    Mahasreshti, P. J., Navarro, J. G., Kataram, M., Wang, M. H., Carey, D., Siegal, G. P., . . . Curiel, D. T. (2001), Adenovirus-mediated soluble FLT-1 gene therapy for ovarian carcinoma., Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 7(7), 2057-2066.
    Sutherland, M. K., Yu, C., Lewis, T. S., Miyamoto, J. B., Morris-Tilden, C. A., Jonas, M., . . . Law, C. L. (2009)., Anti-leukemic activity of lintuzumab (SGN-33) in preclinical models of acute myeloid leukemia., Mabs, 1(5), 481-490. doi:9288 [pii]
    Abuqayyas, L., & Balthasar, J. P. (2012)., Application of PBPK modeling to predict monoclonal antibody disposition in plasma and tissues in mouse models of human colorectal cancer., Journal of Pharmacokinetics and Pharmacodynamics, 39(6), 683-710. doi:10.1007/s10928-012-9279-8 [doi]
    Do, T. V., Hirst, J., Hyter, S., Roby, K. F., & Godwin, A. K. (2017)., Aurora A kinase regulates non-homologous end-joining and poly(ADP-ribose) polymerase function in ovarian carcinoma cells., Oncotarget, 8(31), 50376-50392. doi:10.18632/oncotarget.18970 [doi]
    Zhang, L., Nomie, K., Zhang, H., Bell, T., Pham, L., Kadri, S., . . . Wang, M. (2017), B-cell lymphoma patient-derived xenograft models enable drug discovery and are a platform for personalized therapy., Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 23(15), 4212-4223. doi:10.1158/1078-0432.CCR-16-2703 [doi]
    Zhang, C. C., Pavlicek, A., Zhang, Q., Lira, M. E., Painter, C. L., Yan, Z., . . . Christensen, J. G. (2012)., Biomarker and pharmacologic evaluation of the gamma-secretase inhibitor PF-03084014 in breast cancer models., Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 18(18), 5008-5019. doi:10.1158/1078-0432.CCR-12-1379 [doi]
    Francisco, J. A., Cerveny, C. G., Meyer, D. L., Mixan, B. J., Klussman, K., Chace, D. F., . . . Wahl, A. F. (2003)., cAC10-vcMMAE, an anti-CD30-monomethyl auristatin E conjugate with potent and selective antitumor activity., Blood, 102(4), 1458-1465. doi:10.1182/blood-2003-01-0039 [doi]
    Bhatta, Puspanjali; Dhukhwa, Asmita; Sheehan, Kelly; Al Aameri, Raheem F H; Borse, Vikrant; Ghosh, Sumana; Sheth, Sandeep; Mamillapalli, Chaitanya; Rybak, Leonard; Ramkumar, Vickram; Mukherjea, Debashree;, Capsaicin Protects Against Cisplatin Ototoxicity by Changing the STAT3/STAT1 Ratio and Activating Cannabinoid (CB2) Receptors in the Cochlea., Scientific reports Vol.9, 2019
    McKnight BN, Kim S, Boerner JL, Viola NT., Cetuximab PET delineated changes in cellular distribution of EGFR upon dasatinib treatment in triple negative breast cancer, Breast Cancer Res. 2020 Apr 15;22(1):37. doi: 10.1186/s13058-020-01270-1.
    Kryeziu, K., Pirker, C., Englinger, B., van Schoonhoven, S., Spitzwieser, M., Mohr, T., . . . Heffeter, P. (2016), Chronic arsenic trioxide exposure leads to enhanced aggressiveness via met oncogene addiction in cancer cells, Oncotarget, 7(19), 27379-27393. doi:10.18632/oncotarget.8415 [doi]
    Cocco, E., Shapiro, E. M., Gasparrini, S., Lopez, S., Schwab, C. L., Bellone, S., . . . Santin, A. D. (2015)., Clostridium perfringens enterotoxin C-terminal domain labeled to fluorescent dyes for in vivo visualization of micrometastatic chemotherapy-resistant ovarian cancer, International Journal of Cancer, 137(11), 2618-2629. doi:10.1002/ijc.29632 [doi]
    Balkin, E. R., Liu, D., Jia, F., Ruthengael, V. C., Shaffer, S. M., Miller, W. H., & Lewis, M. R. (2014)., Comparative biodistributions and dosimetry of [(1)(7)(7)lu]DOTA-anti-bcl-2-PNA-tyr(3)-octreotate and [(1)(7)(7)lu]DOTA-tyr(3)-octreotate in a mouse model of B-cell lymphoma/leukemia., Nuclear Medicine and Biology, 41(1), 36-42. doi:10.1016/j.nucmedbio.2013.10.006 [doi]
    Glaser, G., Weroha, S. J., Becker, M. A., Hou, X., Enderica-Gonzalez, S., Harrington, S. C., & Haluska, P. (2015)., Conventional chemotherapy and oncogenic pathway targeting in ovarian carcinosarcoma using a patient-derived tumorgraft, PloS One, 10(5), e0126867. doi:10.1371/journal.pone.0126867 [doi]
    Jia, F., Balaji, B. S., Gallazzi, F., & Lewis, M. R. (2015)., Copper-64-labeled anti-bcl-2 PNA-peptide conjugates selectively localize to bcl-2-positive tumors in mouse models of B-cell lymphoma., Nuclear Medicine and Biology, doi:S0969-8051(15)00094-3 [pii]
    Aregueta-Robles, U., Fajardo-Ramirez, O. R., Villela, L., Gutierrez-Uribe, J. A., Hernandez-Hernandez, J., Lopez-Sanchez, R. D. C., . . . Serna-Saldivar, S. (2018)., Cytotoxic activity of a black bean (phaseolus vulgaris L.) extract and its flavonoid fraction in both in vitro and in vivo models of lymphoma., Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion, 70(1), 32-39. doi:10.24875/RIC.17002395 [doi]
    Hamblett, K. J., Senter, P. D., Chace, D. F., Sun, M. M., Lenox, J., Cerveny, C. G., . . . Francisco, J. A. (2004)., Effects of drug loading on the antitumor activity of a monoclonal antibody drug conjugate., Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 10(20), 7063-7070. doi:10/20/7063 [pii]
    Romani, C., Cocco, E., Bignotti, E., Moratto, D., Bugatti, A., Todeschini, P., . . . Mitola, S. (2015), Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery, Oncotarget, 6(33), 34617-34628. doi:10.18632/oncotarget.5315 [doi]
    Dingli, D., Diaz, R. M., Bergert, E. R., O'Connor, M. K., Morris, J. C., & Russell, S. J. (2003)., Genetically targeted radiotherapy for multiple myeloma, Blood, 102(2), 489-496. doi:10.1182/blood-2002-11-3390 [doi]
    Han, Chanhee; Perrone, Emanuele; Zeybek, Burak; Bellone, Stefania; Tymon-Rosario, Joan; Altwerger, Gary; Menderes, Gulden; Feinberg, Jacqueline; Haines, Kaitlin; Muller Karger, Mariana Espinal; Bianchi, Anna; Zammataro, Luca; Manzano, Aranzazu; Bonazzoli, Elena; Manara, Paola; Buza, Natalia; Hui, Pei; Ratner, Elena; Silasi, Dan-Arin; Huang, Gloria S; Azodi, Masoud; Schwartz, Peter E; Lopez, Salvatore; Santin, Alessandro D, In vitro and in vivo activity of sacituzumab govitecan, an antibody-drug conjugate targeting trophoblast cell-surface antigen 2 (Trop-2) in uterine serous carcinoma., Gynecologic oncology Vol.10, 2019
    Zhang, L., Pham, L. V., Newberry, K. J., Ou, Z., Liang, R., Qian, J., . . . Wang, M. (2013)., In vitro and in vivo therapeutic efficacy of carfilzomib in mantle cell lymphoma: Targeting the immunoproteasome., Molecular Cancer Therapeutics, 12(11), 2494-2504. doi:10.1158/1535-7163.MCT-13-0156 [doi]
    Han C, Perrone E, Zeybek B, Bellone S, Tymon-Rosario J, Altwerger G, Menderes G, Feinberg J, Haines K, Muller Karger ME, Bianchi A, Zammataro L, Manzano A, Bonazzoli E, Manara P, Buza N, Hui P, Ratner E, Silasi DA, Huang GS, Azodi M, Schwartz PE, Lopez S, Santin AD., In vitro and in vivo activity of sacituzumab govitecan, an antibody-drug conjugate targeting trophoblast cell-surface antigen 2 (Trop-2) in uterine serous carcinoma, Gynecol Oncol. 2020 Feb;156(2):430-438. doi: 10.1016/j.ygyno.2019.11.018. Epub 2019 Dec 12.
    Lu, A., Pallero, M. A., Lei, W., Hong, H., Yang, Y., Suto, M. J., & Murphy-Ullrich, J. E. (2016), Inhibition of transforming growth factor-beta activation diminishes tumor progression and osteolytic bone disease in mouse models of multiple myeloma., The American Journal of Pathology, 186(3), 678-690. doi:10.1016/j.ajpath.2015.11.003 [doi]
    Jones RJ, Singh RK, Shirazi F, Wan J, Wang H, Wang X, Ha MJ, Baljevic M, Kuiatse I, Davis RE, Orlowski RZ., Intravenous Immunoglobulin G Suppresses Heat Shock Protein (HSP)-70 Expression and Enhances the Activity of HSP90 and Proteasome Inhibitors, Front Immunol. 2020 Aug 13;11:1816. doi: 10.3389/fimmu.2020.01816. eCollection 2020.
    Gross, A. C., Cam, H., Phelps, D. A., Saraf, A. J., Bid, H. K., Cam, M., . . . Roberts, R. D. (2018), L-6 and CXCL8 mediate osteosarcoma-lung interactions critical to metastasis., JCI Insight, 3(16), 10.1172/jci.insight.99791. doi:10.1172/jci.insight.99791 [doi]
    Junttila, T. T., Akita, R. W., Parsons, K., Fields, C., Lewis Phillips, G. D., Friedman, L. S., . . . Sliwkowski, M. X. (2009)., Ligand-independent HER2/HER3/PI3K complex is disrupted by trastuzumab and is effectively inhibited by the PI3K inhibitor GDC-0941., Cancer Cell, 15(5), 429-440. doi:10.1016/j.ccr.2009.03.020 [doi]
    Ashley, J. D., Stefanick, J. F., Schroeder, V. A., Suckow, M. A., Alves, N. J., Suzuki, R., . . . Bilgicer, B. (2014)., Liposomal carfilzomib nanoparticles effectively target multiple myeloma cells and demonstrate enhanced efficacy in vivo, Journal of Controlled Release : Official Journal of the Controlled Release Society, 196, 113-121. doi:10.1016/j.jconrel.2014.10.005 [doi]
    Taylor, C. A., Liu, Z., Tang, T. C., Zheng, Q., Francis, S., Wang, T. W., . . . Thompson, J. E. (2012)., Modulation of eIF5A expression using SNS01 nanoparticles inhibits NF-kappaB activity and tumor growth in murine models of multiple myeloma, Molecular Therapy : The Journal of the American Society of Gene Therapy, 20(7), 1305-1314. doi:10.1038/mt.2012.94 [doi]
    Pepin, K. M., Chen, J., Glaser, K. J., Mariappan, Y. K., Reuland, B., Ziesmer, S., . . . McGee, K. P. (2014)., MR elastography derived shear stiffness--a new imaging biomarker for the assessment of early tumor response to chemotherapy., Magnetic Resonance in Medicine, 71(5), 1834-1840. doi:10.1002/mrm.24825 [doi]
    Smith, R. C., Cramer, M. S., Mitchell, P. J., Capen, A., Huber, L., Wang, R., . . . Heuer, J. G. (2015)., Myostatin neutralization results in preservation of muscle mass and strength in preclinical models of tumor-induced muscle wasting., Molecular Cancer Therapeutics, 14(7), 1661-1670. doi:10.1158/1535-7163.MCT-14-0681 [doi]
    Moquist PN, Bovee TD, Waight AB, Mitchell JA, Miyamoto JB, Mason ML, Emmerton KK, Stevens N, Balasubramanian C, Simmons JK, Lyon RP, Senter PD, Doronina SO., Novel Auristatins with High Bystander and Cytotoxic Activities in Drug-Efflux Positive Tumor Models, Mol Cancer Ther. 2020 Dec 7:molcanther.0618.2020. doi: 10.1158/1535-7163.MCT-20-0618. Online ahead of print.
    Somwar R, Hofmann NE, Smith B, Odintsov I, Vojnic M, Linkov I, Tam A, Khodos I, Mattar MS, de Stanchina E, Flynn D, Ladanyi M, Drilon A, Shinde U, Davare MA., NTRK kinase domain mutations in cancer variably impact sensitivity to type I and type II inhibitors, Commun Biol. 2020 Dec 16;3(1):776. doi: 10.1038/s42003-020-01508-w.
    Jin UH, Michelhaugh SK, Polin LA, Shrestha R, Mittal S, Safe S., Omeprazole Inhibits Glioblastoma Cell Invasion and Tumor Growth, Cancers (Basel). 2020 Jul 28;12(8):2097. doi: 10.3390/cancers12082097.
    Chu, K. S., Hasan, W., Rawal, S., Walsh, M. D., Enlow, E. M., Luft, J. C., . . . DeSimone, J. M. (2013)., Plasma, tumor and tissue pharmacokinetics of docetaxel delivered via nanoparticles of different sizes and shapes in mice bearing SKOV-3 human ovarian carcinoma xenograft., Nanomedicine : Nanotechnology, Biology, and Medicine, 9(5), 686-693. doi:10.1016/j.nano.2012.11.008 [doi]
    Lopez S, Perrone E, Bellone S, Bonazzoli E, Zeybek B, Han C, Tymon-Rosario J, Altwerger G, Menderes G, Bianchi A, Zammataro L, Manzano A, Manara P, Ratner E, Silasi DA, Huang GS, Azodi M, Schwartz PE, Raspagliesi F, Angioli R, Buza N, Hui P, Bond HM, Santin AD., Preclinical activity of sacituzumab govitecan (IMMU-132) in uterine and ovarian carcinosarcomas, Oncotarget. 2020 Feb 4;11(5):560-570. doi: 10.18632/oncotarget.27342. eCollection 2020 Feb 4.
    Perrone E, Lopez S, Zeybek B, Bellone S, Bonazzoli E, Pelligra S, Zammataro L, Manzano A, Manara P, Bianchi A, Buza N, Tymon-Rosario J, Altwerger G, Han C, Menderes G, Ratner E, Silasi DA, Azodi M, Hui P, Schwartz PE, Scambia G, Santin AD., Preclinical Activity of Sacituzumab Govitecan, an Antibody-Drug Conjugate Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) Linked to the Active Metabolite of Irinotecan (SN-38), in Ovarian Cancer, Front Oncol. 2020 Feb 12;10:118. doi: 10.3389/fonc.2020.00118. eCollection 2020.
    McEarchern, J. A., Smith, L. M., McDonagh, C. F., Klussman, K., Gordon, K. A., Morris-Tilden, C. A., . . . Law, C. L. (2008)., Preclinical characterization of SGN-70, a humanized antibody directed against CD70., Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 14(23), 7763-7772. doi:10.1158/1078-0432.CCR-08-0493 [doi]
    Dingli, D., Timm, M., Russell, S. J., Witzig, T. E., & Rajkumar, S. V. (2002)., Promising preclinical activity of 2-methoxyestradiol in multiple myeloma, Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 8(12), 3948-3954.
    Ghilu S, Li Q, Fontaine SD, Santi DV, Kurmasheva RT, Zheng S, Houghton PJ., Prospective use of the single-mouse experimental design for the evaluation of PLX038A, Cancer Chemother Pharmacol. 2020 Feb;85(2):251-263. doi: 10.1007/s00280-019-04017-8. Epub 2020 Jan 11.
    Zhou W, Yao Y, Scott AJ, Wilder-Romans K, Dresser JJ, Werner CK, Sun H, Pratt D, Sajjakulnukit P, Zhao SG, Davis M, Nelson BS, Halbrook CJ, Zhang L, Gatto F, Umemura Y, Walker AK, Kachman M, Sarkaria JN, Xiong J, Morgan MA, Rehemtualla A, Castro MG, Lowenstein P, Chandrasekaran S, Lawrence TS, Lyssiotis CA, Wahl DR., Purine metabolism regulates DNA repair and therapy resistance in glioblastoma, Nat Commun. 2020 Jul 30;11(1):3811. doi: 10.1038/s41467-020-17512-x.
    Kiziltepe, T., Ashley, J. D., Stefanick, J. F., Qi, Y. M., Alves, N. J., Handlogten, M. W., . . . Bilgicer, B. (2012)., Rationally engineered nanoparticles target multiple myeloma cells, overcome cell-adhesion-mediated drug resistance, and show enhanced efficacy in vivo, Blood Cancer Journal, 2(4), e64. doi:10.1038/bcj.2012.10 [doi]
    Lyon, R. P., Bovee, T. D., Doronina, S. O., Burke, P. J., Hunter, J. H., Neff-LaFord, H. D., . . . Senter, P. D. (2015)., Reducing hydrophobicity of homogeneous antibody-drug conjugates improves pharmacokinetics and therapeutic index., Nature Biotechnology, 33(7), 733-735. doi:10.1038/nbt.3212 [doi]
    Li, Y., Williams, M. E., Cousar, J. B., Pawluczkowycz, A. W., Lindorfer, M. A., & Taylor, R. P. (2007)., Rituximab-CD20 complexes are shaved from Z138 mantle cell lymphoma cells in intravenous and subcutaneous SCID mouse models., Journal of Immunology (Baltimore, Md.: 1950), 179(6), 4263-4271. doi:179/6/4263 [pii]
    Cai D, Wang J, Gao B, Li J, Wu F, Zou JX, Xu J, Jiang Y, Zou H, Huang Z, Borowsky AD, Bold RJ, Lara PN, Li JJ, Chen X, Lam KS, To KF, Kung HJ, Fiehn O, Zhao R, Evans RM, Chen HW, ROR? is a targetable master regulator of cholesterol biosynthesis in a cancer subtype., Nat Commun. 2019 Oct 11;10(1):4621.
    Morelli, E., Leone, E., Cantafio, M. E., Di Martino, M. T., Amodio, N., Biamonte, L., . . . Tassone, P. (2015)., Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivo, Leukemia, 29(11), 2173-2183. doi:10.1038/leu.2015.124 [doi]
    Lyon, R. P., Setter, J. R., Bovee, T. D., Doronina, S. O., Hunter, J. H., Anderson, M. E., . . . Senter, P. D. (2014)., Self-hydrolyzing maleimides improve the stability and pharmacological properties of antibody-drug conjugates., Nature Biotechnology, 32(10), 1059-1062. doi:10.1038/nbt.2968 [doi]
    Kung Sutherland, M. S., Walter, R. B., Jeffrey, S. C., Burke, P. J., Yu, C., Kostner, H., . . . McEarchern, J. A. (2013)., SGN-CD33A: A novel CD33-targeting antibody-drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML., Blood, 122(8), 1455-1463. doi:10.1182/blood-2013-03-491506 [doi]
    Di Martino, M. T., Leone, E., Amodio, N., Foresta, U., Lionetti, M., Pitari, M. R., . . . Tassone, P. (2012)., Synthetic miR-34a mimics as a novel therapeutic agent for multiple myeloma: In vitro and in vivo evidence., Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 18(22), 6260-6270. doi:10.1158/1078-0432.CCR-12-1708 [doi]
    Peng, K. W., Ahmann, G. J., Pham, L., Greipp, P. R., Cattaneo, R., & Russell, S. J. (2001)., Systemic therapy of myeloma xenografts by an attenuated measles virus., Blood, 98(7), 2002-2007.
    Pfitzer L, Moser C, Gegenfurtner F, Arner A, Foerster F, Atzberger C, Zisis T, Kubisch-Dohmen R, Busse J, Smith R, Timinszky G, Kalinina OV, Müller R, Wagner E, Vollmar AM, Zahler S., Targeting actin inhibits repair of doxorubicin-induced DNA damage: a novel therapeutic approach for combination therapy., Cell Death Dis. 2019 Apr 3;10(4):302.
    Tabe, Y., Shi, Y. X., Zeng, Z., Jin, L., Shikami, M., Hatanaka, Y., . . . Konopleva, M. (2013)., TGF-beta-neutralizing antibody 1D11 enhances cytarabine-induced apoptosis in AML cells in the bone marrow microenvironment., PloS One, 8(6), e62785. doi:10.1371/journal.pone.0062785 [doi]
    Daniluk, U., Kerros, C., Tao, R. H., Wise, J. F., Ao, X., Berkova, Z., & Samaniego, F. (2012), The peptide derived from the ig-like domain of human herpesvirus 8 K1 protein induces death in hematological cancer cells., Journal of Experimental & Clinical Cancer Research : CR, 31, 69-9966-31-69. doi:10.1186/1756-9966-31-69 [doi]
    Ryan, M. C., Palanca-Wessels, M. C., Schimpf, B., Gordon, K. A., Kostner, H., Meyer, B., . . . Benjamin, D. (2017)., Therapeutic potential of SGN-CD19B, a PBD-based anti-CD19 drug conjugate, for treatment of B-cell malignancies., Blood, 130(18), 2018-2026. doi:10.1182/blood-2017-04-779389 [doi]
    Wang, Yongqiang; Huang, Zenghong; Chen, Christopher Z; Liu, Chengfei; Evans, Christopher P; Gao, Allen C; Zhou, Fangjian; Chen, Hong-Wu;, Therapeutic targeting MDR1 expression by ROR? antagonists resensitizes cross-resistant CRPC to taxane via coordinated induction of cell death programs., Molecular cancer therapeutics Vol.10, 2019
    Amodio, N., Stamato, M. A., Gulla, A. M., Morelli, E., Romeo, E., Raimondi, L., . . . Tassone, P. (2016)., Therapeutic targeting of miR-29b/HDAC4 epigenetic loop in multiple myeloma., Molecular Cancer Therapeutics, 15(6), 1364-1375. doi:10.1158/1535-7163.MCT-15-0985 [doi]
    Jafri, S. H., Glass, J., Shi, R., Zhang, S., Prince, M., & Kleiner-Hancock, H. (2010)., Thymoquinone and cisplatin as a therapeutic combination in lung cancer: In vitro and in vivo., Journal of Experimental & Clinical Cancer Research : CR, 29, 87-9966-29-87. doi:10.1186/1756-9966-29-87 [doi]
    Gunawardane, R. N., Nepomuceno, R. R., Rooks, A. M., Hunt, J. P., Ricono, J. M., Belli, B., & Armstrong, R. C. (2013), Transient exposure to quizartinib mediates sustained inhibition of FLT3 signaling while specifically inducing apoptosis in FLT3-activated leukemia cells, Molecular Cancer Therapeutics, 12(4), 438-447. doi:10.1158/1535-7163.MCT-12-0305 [doi]
    Santin, A. D., Cane, S., Bellone, S., Palmieri, M., Siegel, E. R., Thomas, M., . . . Pecorelli, S. (2005)., Treatment of chemotherapy-resistant human ovarian cancer xenografts in C.B-17/SCID mice by intraperitoneal administration of clostridium perfringens enterotoxin., Cancer Research, 65(10), 4334-4342. doi:65/10/4334 [pii]
    Dembinski, J. L., Wilson, S. M., Spaeth, E. L., Studeny, M., Zompetta, C., Samudio, I., . . . Marini, F. C. (2013)., Tumor stroma engraftment of gene-modified mesenchymal stem cells as anti-tumor therapy against ovarian cancer, Cytotherapy, 15(1), 20-32. doi:10.1016/j.jcyt.2012.10.003 [doi]
    Nguyen T, Kirsch BJ, Asaka R, Nabi K, Quinones A, Tan J, Antonio MJ, Camelo F, Li T, Nguyen S, Hoang G, Nguyen K, Udupa S, Sazeides C, Shen YA, Elgogary A, Reyes J, Zhao L, Kleensang A, Chaichana KL, Hartung T, Betenbaugh MJ, Marie SK, Jung JG, Wang TL, Gabrielson E, Le A, Uncovering the Role of N-Acetyl-Aspartyl-Glutamate as a Glutamate Reservoir in Cancer., Cell Rep. 2019 Apr 9;27(2):491-501.e6.
    Kathagen-Buhmann, A., Schulte, A., Weller, J., Holz, M., Herold-Mende, C., Glass, R., & Lamszus, K. (2016)., Glycolysis and the pentose phosphate pathway are differentially associated with the dichotomous regulation of glioblastoma cell migration versus proliferation., Neuro-Oncology, doi:now024 [pii]
    Xiao, S., Tang, Y. S., Khan, R. A., Zhang, Y., Kusumanchi, P., Stabler, S. P., . . . Antony, A. C. (2012)., Influence of physiologic folate deficiency on human papillomavirus type 16 (HPV16)-harboring human keratinocytes in vitro and in vivo., The Journal of Biological Chemistry, 287(15), 12559-12577. doi:10.1074/jbc.M111.317040 [doi]
    Crottes, D., Rapetti-Mauss, R., Alcaraz-Perez, F., Tichet, M., Gariano, G., Martial, S., . . . Soriani, O. (2016)., SIGMAR1 regulates membrane electrical activity in response to extracellular matrix stimulation to drive cancer cell invasiveness., Cancer Research, 76(3), 607-618. doi:10.1158/0008-5472.CAN-15-1465 [doi]
    Guinn, Z., Brown, D. M., & Petro, T. M. (2017)., Activation of IRF3 contributes to IFN-gamma and ISG54 expression during the immune responses to B16F10 tumor growth, International Immunopharmacology, 50, 121-129. doi:S1567-5769(17)30238-2 [pii]
    Assimon VA, Tang Y, Vargas JD, Lee GJ, Wu ZY, Lou K, Yao B, Menon MK, Pios A, Perez KC, Madriaga A, Buchowiecki PK, Rolfe M, Shawver L, Jiao X, Le Moigne R, Zhou HJ, Anderson DJ., CB-6644 Is a Selective Inhibitor of the RUVBL1/2 Complex with Anticancer Activity, ACS Chem Biol. 2019 Feb 15;14(2):236-244
    Forsgard, R. A., Marrachelli, V. G., Korpela, K., Frias, R., Collado, M. C., Korpela, R., . . . Osterlund, P. (2017), Chemotherapy-induced gastrointestinal toxicity is associated with changes in serum and urine metabolome and fecal microbiota in male sprague-dawley rats., Cancer Chemotherapy and Pharmacology, 80(2), 317-332. doi:10.1007/s00280-017-3364-z [doi]
    Lyski RD, Bou LB, Lau UY, Meyer DW, Cochran JH, Okeley NM, Emmerton KK, Zapata F, Simmons JK, Trueblood ES, Ortiz DJ, Zaval MC, Snead KM, Jin S, Farr LM, Ryan MC, Senter PD, Jeffrey SC., Development of Novel Antibody-Camptothecin Conjugates, Mol Cancer Ther. 2020 Dec 3:molcanther.0526.2020. doi: 10.1158/1535-7163.MCT-20-0526. Online ahead of print.
    Khazal, K. F., Samuel, T., Hill, D. L., & Grubbs, C. J. (2013)., Effect of an extract of withania somnifera root on estrogen receptor-positive mammary carcinomas., Anticancer Research, 33(4), 1519-1523. doi:33/4/1519 [pii]
    Eskra, Jillian N; Dodge, Alaina; Schlicht, Michael J; Bosland, Maarten C;, Effects of Black Raspberries and Their Constituents on Rat Prostate Carcinogenesis and Human Prostate Cancer Cell Growth In Vitro., Nutrition and cancer Vol.48, 2019
    Dennison, K. L., Chack, A. C., Hickman, M. P., Harenda, Q. E., & Shull, J. D. (2018), Ept7, a quantitative trait locus that controls estrogen-induced pituitary lactotroph hyperplasia in rat, is orthologous to a locus in humans that has been associated with numerous cancer types and common diseases., PloS One, 13(9), e0204727. doi:10.1371/journal.pone.0204727 [doi]
    Griffiths, L. A., Duggett, N. A., Pitcher, A. L., & Flatters, S. J. L. (2018), Evoked and ongoing pain-like behaviours in a rat model of paclitaxel-induced peripheral neuropathy, Pain Research & Management, 2018, 8217613. doi:10.1155/2018/8217613 [doi]
    Allen, J. E., Crowder, R. N., & El-Deiry, W. S. (2015)., First-in-class small molecule ONC201 induces DR5 and cell death in tumor but not normal cells to provide a wide therapeutic index as an anti-cancer agent., PloS One, 10(11), e0143082. doi:10.1371/journal.pone.0143082 [doi]
    Wong, R. L., Wang, Q., Trevino, L. S., Bosland, M. C., Chen, J., Medvedovic, M., . . . Walker, C. L. (2015)., Identification of secretaglobin Scgb2a1 as a target for developmental reprogramming by BPA in the rat prostate., Epigenetics, 10(2), 127-134. doi:10.1080/15592294.2015.1009768 [doi]
    Pi, C., Allott, E. H., Ren, D., Poulton, S., Lee, S. Y., Perkins, S., . . . Parker, W. (2015)., Increased biodiversity in the environment improves the humoral response of rats, PloS One, 10(4), e0120255. doi:10.1371/journal.pone.0120255 [doi]
    Shiota, M., Bishop, J. L., Takeuchi, A., Nip, K. M., Cordonnier, T., Beraldi, E., . . . Zoubeidi, A. (2015)., Inhibition of the HER2-YB1-AR axis with lapatinib synergistically enhances enzalutamide anti-tumor efficacy in castration resistant prostate cancer., Oncotarget, 6(11), 9086-9098. doi:3602 [pii]
    Sgarra, L., Leo, V., Addabbo, F., Iacobazzi, D., Carratu, M. R., Montagnani, M., & Potenza, M. A. (2014)., Intermittent losartan administration triggers cardiac post-conditioning in isolated rat hearts: Role of BK2 receptors., PloS One, 9(2), e88542. doi:10.1371/journal.pone.0088542 [doi]
    Forsgard, R. A., Korpela, R., Holma, R., Linden, J., Frias, R., Spillmann, T., & Osterlund, P. (2016), Intestinal permeability to iohexol as an in vivo marker of chemotherapy-induced gastrointestinal toxicity in sprague-dawley rats., Cancer Chemotherapy and Pharmacology, 78(4), 863-874. doi:10.1007/s00280-016-3150-3 [doi]
    Thompson, M. D., Grubbs, C. J., Bode, A. M., Reid, J. M., McGovern, R., Bernard, P. S., . . . Lubet, R. A. (2015)., Lack of effect of metformin on mammary carcinogenesis in nondiabetic rat and mouse models., Cancer Prevention Research (Philadelphia, Pa.), 8(3), 231-239. doi:10.1158/1940-6207.CAPR-14-0181-T [doi]
    Zaidi, A. H., Saldin, L. T., Kelly, L. A., Bergal, L., Londono, R., Kosovec, J. E., . . . Jobe, B. A. (2015)., MicroRNA signature characterizes primary tumors that metastasize in an esophageal adenocarcinoma rat model., PloS One, 10(3), e0122375. doi:10.1371/journal.pone.0122375 [doi]
    England, C. G., Ehlerding, E. B., Hernandez, R., Rekoske, B. T., Graves, S. A., Sun, H., . . . Cai, W. (2017)., Preclinical pharmacokinetics and biodistribution studies of 89Zr-labeled pembrolizumab., Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, 58(1), 162-168. doi:10.2967/jnumed.116.177857 [doi]
    ThyagaRajan, S., Tran, L., Molinaro, C. A., Gridley, D. S., Felten, D. L., & Bellinger, D. L. (2013), Prevention of mammary tumor development through neuroimmunomodulation in the spleen and lymph nodes of old female sprague-dawley rats by L-deprenyl., Neuroimmunomodulation, 20(3), 141-151. doi:10.1159/000346200 [doi]
    He Y, Hwang DJ, Ponnusamy S, Thiyagarajan T, Mohler ML, Narayanan R, Miller DD., Pyrazol-1-yl-propanamides as SARD and Pan-Antagonists for the Treatment of Enzalutamide-Resistant Prostate Cancer, J Med Chem. 2020 Nov 12;63(21):12642-12665. doi: 10.1021/acs.jmedchem.0c00943. Epub 2020 Oct 23.
    Neumann, C. S., Olivas, K. C., Anderson, M. E., Cochran, J. H., Jin, S., Li, F., . . . Senter, P. D. (2018)., Targeted delivery of cytotoxic NAMPT inhibitors using antibody-drug conjugates., Molecular Cancer Therapeutics, doi:molcanther.0643.2018 [pii]
    Carroll, C. E., Liang, Y., Benakanakere, I., Besch-Williford, C., & Hyder, S. M. (2013)., The anticancer agent YC-1 suppresses progestin-stimulated VEGF in breast cancer cells and arrests breast tumor development., International Journal of Oncology, 42(1), 179-187. doi:10.3892/ijo.2012.1675 [doi]
    De La Chapa JJ, Singha PK, Self KK, Sallaway ML, McHardy SF, Hart MJ, McGuff HS, Valdez MC, Ruiz F 2nd, Polusani SR, Gonzales CB, The novel capsazepine analog, CIDD-99, significantly inhibits oral squamous cell carcinoma in vivo through a TRPV1-independent induction of ER stress, mitochondrial dysfunction, and apoptosis., J Oral Pathol Med. 2019 May;48(5):389-399.
    Forsgård, Richard A; Marrachelli, Vannina G; Lindén, Jere; Frias, Rafael; Collado, Maria Carmen; Korpela, Riitta; Monleon, Daniel; Spillmann, Thomas; Österlund, Pia, Two-Week Aflibercept or Erlotinib Administration Does Not Induce Changes in Intestinal Morphology in Male Sprague-Dawley Rats But Aflibercept Affects Serum and Urine Metabolic Profiles., Translational oncology Vol.12, 2019
    Sharp AM, Lertphinyowong S, Yee SS, Paredes D, Gelfond J, Johnson-Pais TL, Leach RJ, Liss M, Risinger AL, Sullivan AC, Thompson IM, Morilak DA., Vortioxetine reverses medial prefrontal cortex-mediated cognitive deficits in male rats induced by castration as a model of androgen deprivation therapy for prostate cancer, Psychopharmacology (Berl). 2019 Nov;236(11):3183-3195. doi: 10.1007/s00213-019-05274-4. Epub 2019 May 28.
    Woditschka, S., Haag, J. D., Mau, B., Lubet, R. A., & Gould, M. N. (2008)., Chemopreventive effects of celecoxib are limited to hormonally responsive mammary carcinomas in the neu-induced retroviral rat model., Breast Cancer Research : BCR, 10(1), R18. doi:10.1186/bcr1864 [doi]
    Zawaski, J. A., Gaber, M. W., Sabek, O. M., Wilson, C. M., Duntsch, C. D., & Merchant, T. E. (2012)., Effects of irradiation on brain vasculature using an in situ tumor model., International Journal of Radiation Oncology, Biology, Physics, 82(3), 1075-1082. doi:10.1016/j.ijrobp.2011.06.1984 [doi]
    Cotroneo, M. S., Haag, J. D., Stapel, N. R., Waller, J. L., Woditschka, S., & Gould, M. N. (2009)., Freund's vaccine adjuvant promotes Her2/neu breast cancer., BMC Cancer, 9, 19-2407-9-19. doi:10.1186/1471-2407-9-19 [doi]
    Fukuoka, H., Cooper, O., Mizutani, J., Tong, Y., Ren, S. G., Bannykh, S., & Melmed, S. (2011)., HER2/ErbB2 receptor signaling in rat and human prolactinoma cells: Strategy for targeted prolactinoma therapy., Molecular Endocrinology (Baltimore, Md.), 25(1), 92-103. doi:10.1210/me.2010-0353 [doi]
    Weber, K., Garman, R. H., Germann, P. G., Hardisty, J. F., Krinke, G., Millar, P., & Pardo, I. D. (2011)., Classification of neural tumors in laboratory rodents, emphasizing the rat, Toxicologic Pathology, 39(1), 129-151. doi:10.1177/0192623310392249 [doi]
    Moilanen, A. M., Riikonen, R., Oksala, R., Ravanti, L., Aho, E., Wohlfahrt, G., . . . Kallio, P. J. (2015)., Discovery of ODM-201, a new-generation androgen receptor inhibitor targeting resistance mechanisms to androgen signaling-directed prostate cancer therapies, Scientific Reports, 5, 12007. doi:10.1038/srep12007 [doi]
    Moilanen, A. M., Riikonen, R., Oksala, R., Ravanti, L., Aho, E., Wohlfahrt, G., . . . Kallio, P. J. (2015)., Discovery of ODM-201, a new-generation androgen receptor inhibitor targeting resistance mechanisms to androgen signaling-directed prostate cancer therapies., Scientific Reports, 5, 12007. doi:10.1038/srep12007 [doi]
    Keiler, A. M., Macejova, D., Dietz, B. M., Bolton, J. L., Pauli, G. F., Chen, S. N., . . . Vollmer, G. (2017)., Evaluation of estrogenic potency of a standardized hops extract on mammary gland biology and on MNU-induced mammary tumor growth in rats., The Journal of Steroid Biochemistry and Molecular Biology, 174, 234-241. doi:S0960-0760(17)30268-6 [pii]
    Rivera-Huerta, M., Lizarraga-Grimes, V. L., Castro-Torres, I. G., Tinoco-Mendez, M., Macias-Rosales, L., Sanchez-Bartez, F., . . . Gracia-Mora, M. I. (2017), Functional effects of prebiotic fructans in colon cancer and calcium metabolism in animal models, BioMed Research International, 2017, 9758982. doi:10.1155/2017/9758982 [doi]
    Bradley, A. E., & Keane, K. (2011)., Neurooncology, Toxicologic Pathology, 39(1), 124-128. doi:10.1177/0192623310389477 [doi]
    Bolli, M. H., Abele, S., Birker, M., Bravo, R., Bur, D., de Kanter, R., . . . Weller, T. (2014)., Novel S1P(1) receptor agonists--part 3: From thiophenes to pyridines, Journal of Medicinal Chemistry, 57(1), 110-130. doi:10.1021/jm4014696 [doi]
    Empl, M. T., Kammeyer, P., Ulrich, R., Joseph, J. F., Parr, M. K., Willenberg, I., . . . Steinberg, P. (2014), The influence of chronic L-carnitine supplementation on the formation of preneoplastic and atherosclerotic lesions in the colon and aorta of male F344 rats., Archives of Toxicology, doi:10.1007/s00204-014-1341-4 [doi]
    Colli-Dula, R. C., Friedman, M. A., Hansen, B., & Denslow, N. D. (2016), Transcriptomics analysis and hormonal changes of male and female neonatal rats treated chronically with a low dose of acrylamide in their drinking water., Toxicology Reports, 3, 414-426. doi:10.1016/j.toxrep.2016.03.009 [doi]
    Maronpot, R. R., Thoolen, R. J., & Hansen, B. (2015)., Two-year carcinogenicity study of acrylamide in wistar han rats with in utero exposure., Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie, 67(2), 189-195. doi:10.1016/j.etp.2014.11.009 [doi]
    Maronpot, R. R., Thoolen, R. J., & Hansen, B. (2015), Two-year carcinogenicity study of acrylamide in wistar han rats with in utero exposure., Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie, 67(2), 189-195. doi:10.1016/j.etp.2014.11.009 [doi]
    Dauchy, R. T., Dauchy, E. M., Mao, L., Belancio, V. P., Hill, S. M., & Blask, D. E. (2012)., A new apparatus and surgical technique for the dual perfusion of human tumor xenografts in situ in nude rats., Comparative Medicine, 62(2), 99-108.
    Lemasson, B., Christen, T., Tizon, X., Farion, R., Fondraz, N., Provent, P., . . . Remy, C. (2011)., Assessment of multiparametric MRI in a human glioma model to monitor cytotoxic and anti-angiogenic drug effects., NMR in Biomedicine, 24(5), 473-482. doi:10.1002/nbm.1611 [doi]
    Lo, V. C., Akens, M. K., Moore, S., Yee, A. J., Wilson, B. C., & Whyne, C. M. (2012)., Beyond radiation therapy: Photodynamic therapy maintains structural integrity of irradiated healthy and metastatically involved vertebrae in a pre-clinical in vivo model., Breast Cancer Research and Treatment, 135(2), 391-401. doi:10.1007/s10549-012-2146-x [doi]
    Chaves C, Declèves X, Taghi M, Menet MC, Lacombe J, Varlet P, Olaciregui NG, Carcaboso AM, Cisternino S., Characterization of the Blood-Brain Barrier Integrity and the Brain Transport of SN-38 in an Orthotopic Xenograft Rat Model of Diffuse Intrinsic Pontine Glioma, Pharmaceutics. 2020 Apr 27;12(5):399. doi: 10.3390/pharmaceutics12050399.
    Dauchy, R. T., Xiang, S., Mao, L., Brimer, S., Wren, M. A., Yuan, L., . . . Hill, S. M. (2014)., Circadian and melatonin disruption by exposure to light at night drives intrinsic resistance to tamoxifen therapy in breast cancer., Cancer Research, 74(15), 4099-4110. doi:10.1158/0008-5472.CAN-13-3156 [doi]
    Eschbach, R. S., Clevert, D. A., Hirner-Eppeneder, H., Ingrisch, M., Moser, M., Schuster, J., . . . Cyran, C. C. (2017)., Contrast-enhanced ultrasound with VEGFR2-targeted microbubbles for monitoring regorafenib therapy effects in experimental colorectal adenocarcinomas in rats with DCE-MRI and immunohistochemical validation., PloS One, 12(1), e0169323. doi:10.1371/journal.pone.0169323 [doi]
    Eschbach, R. S., Fendler, W. P., Kazmierczak, P. M., Hacker, M., Rominger, A., Carlsen, J., . . . Cyran, C. C. (2015)., Correlation of perfusion MRI and 18F-FDG PET imaging biomarkers for monitoring regorafenib therapy in experimental colon carcinomas with immunohistochemical validation., PloS One, 10(2), e0115543. doi:10.1371/journal.pone.0115543 [doi]
    Eschbach, R. S., Fendler, W. P., Kazmierczak, P. M., Hacker, M., Rominger, A., Carlsen, J., . . . Cyran, C. C. (2015)., Correlation of perfusion MRI and 18F-FDG PET imaging biomarkers for monitoring regorafenib therapy in experimental colon carcinomas with immunohistochemical validation., PloS One, 10(2), e0115543. doi:10.1371/journal.pone.0115543 [doi]
    Rau, R. E., Rodriguez, B. A., Luo, M., Jeong, M., Rosen, A., Rogers, J. H., . . . Goodell, M. A. (2016)., DOT1L as a therapeutic target for the treatment of DNMT3A-mutant acute myeloid leukemia., Blood, 128(7), 971-981. doi:10.1182/blood-2015-11-684225 [doi]
    Duong le, T., Wesolowski, G. A., Leung, P., Oballa, R., & Pickarski, M. (2014)., Efficacy of a cathepsin K inhibitor in a preclinical model for prevention and treatment of breast cancer bone metastasis. Molecular Cancer Therapeutics, 13(12), 2898-2909. doi:10.1158/1535-7163.MCT-14-0253 [doi], Molecular Cancer Therapeutics, 13(12), 2898-2909. doi:10.1158/1535-7163.MCT-14-0253 [doi]
    Atkins, Ayelet; Burke, Mikhail; Samiezadeh, Saeid; Akens, Margarete K; Hardisty, Michael; Whyne, Cari M;, Elevated Microdamage Spatially Correlates with Stress in Metastatic Vertebrae, Annals of biomedical engineering Vol.47, 2019
    Van de Sande, Leen; Willaert, Wouter; Cosyns, Sarah; De Clercq, Kaat; Shariati, Molood; Remaut, Katrien; Ceelen, Wim, Establishment of a rat ovarian peritoneal metastasis model to study pressurized intraperitoneal aerosol chemotherapy (PIPAC)., BMC cancer Vol.19, 2019
    Halle, B., Thisgaard, H., Hvidsten, S., Dam, J. H., Aaberg-Jessen, C., Thykjaer, A. S., . . . Kristensen, B. W. (2015)., Estimation of tumor volumes by 11C-MeAIB and 18F-FDG PET in an orthotopic glioblastoma rat model., Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, 56(10), 1562-1568. doi:10.2967/jnumed.115.162511 [doi]
    Wise-Milestone, L., Akens, M. K., Rosol, T. J., Hojjat, S. P., Grynpas, M. D., & Whyne, C. M. (2012)., Evaluating the effects of mixed osteolytic/osteoblastic metastasis on vertebral bone quality in a new rat model., Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society, 30(5), 817-823. doi:10.1002/jor.21577 [doi]
    Cyran, C. C., Fu, Y., Rogut, V., Chaopathomkul, B., Wendland, M. F., Shames, D. M., & Brasch, R. C. (2013)., Evaluation of a novel macromolecular cascade-polymer contrast medium for dynamic contrast-enhanced MRI monitoring of antiangiogenic bevacizumab therapy in a human melanoma model., Academic Radiology, 20(10), 1256-1263. doi:10.1016/j.acra.2013.07.010 [doi]
    Li, S., Goins, B., Hrycushko, B. A., Phillips, W. T., & Bao, A. (2012)., Feasibility of eradication of breast cancer cells remaining in postlumpectomy cavity and draining lymph nodes following intracavitary injection of radioactive immunoliposomes., Molecular Pharmaceutics, 9(9), 2513-2522. doi:10.1021/mp300132f [doi]
    Sakuma, S., Yu, J. Y., Quang, T., Hiwatari, K., Kumagai, H., Kao, S., . . . Pham, W. (2015)., Fluorescence-based endoscopic imaging of thomsen-friedenreich antigen to improve early detection of colorectal cancer. International Journal of Cancer., Journal International Du Cancer, 136(5), 1095-1103. doi:10.1002/ijc.29093 [doi]
    Panella, C., Castellvi, Q., Moll, X., Quesada, R., Villanueva, A., Iglesias, M., . . . Burdio, F. (2017)., Focused transhepatic electroporation mediated by hypersaline infusion through the portal vein in rat model. preliminary results on differential conductivity., Radiology and Oncology, 51(4), 415-421. doi:10.1515/raon-2017-0051 [doi]
    Shariati, Molood; Zhang, Heyang; Van de Sande, Leen; Descamps, Benedicte; Vanhove, Chris; Willaert, Wouter; Ceelen, Wim; De Smedt, Stefaan C; Remaut, Katrien, High Pressure Nebulization (PIPAC) Versus Injection for the Intraperitoneal Administration of mRNA Complexes, Pharmaceutical research Vol.36, 2019
    Thisgaard, H., Halle, B., Aaberg-Jessen, C., Olsen, B. B., Therkelsen, A. S., Dam, J. H., . . . Kristensen, B. W. (2016)., Highly effective auger-electron therapy in an orthotopic glioblastoma xenograft model using convection-enhanced delivery., Theranostics, 6(12), 2278-2291. doi:10.7150/thno.15898 [doi]
    Chaumeil, M. M., Ozawa, T., Park, I., Scott, K., James, C. D., Nelson, S. J., & Ronen, S. M. (2012)., Hyperpolarized 13C MR spectroscopic imaging can be used to monitor everolimus treatment in vivo in an orthotopic rodent model of glioblastoma., Neuroimage, 59(1), 193-201. doi:10.1016/j.neuroimage.2011.07.034 [doi]
    Tokalov, S. V., Enghardt, W., & Abolmaali, N. (2010)., Improvement of radiation-mediated immunosuppression of human NSCLC tumour xenografts in a nude rat model., Journal of Biomedicine & Biotechnology, 2010, 580531. doi:10.1155/2010/580531 [doi]
    Akens, M. K., Wise-Milestone, L., Won, E., Schwock, J., Yee, A. J., Wilson, B. C., & Whyne, C. M. (2014)., In vitro and in vivo effects of photodynamic therapy on metastatic breast cancer cells pre-treated with zoledronic acid., Photodiagnosis and Photodynamic Therapy, 11(3), 426-433. doi:10.1016/j.pdpdt.2014.04.002 [doi]
    Verco, James; Johnston, William; Frost, Michael; Baltezor, Michael; Kuehl, Philip J; Lopez, Anita; Gigliotti, Andrew; Belinsky, Steven A; Wolff, Ronald; diZerega, Gere;, Inhaled Submicron Particle Paclitaxel (NanoPac) Induces Tumor Regression and Immune Cell Infiltration in an Orthotopic Athymic Nude Rat Model of Non-Small Cell Lung Cancer, Journal of aerosol medicine and pulmonary drug delivery Vol.32, 2019
    Wise-Milestone, L., Akens, M. K., Lo, V. C., Yee, A. J., Wilson, B. C., & Whyne, C. M. (2012)., Local treatment of mixed osteolytic/osteoblastic spinal metastases: Is photodynamic therapy effective?, Breast Cancer Research and Treatment, 133(3), 899-908. doi:10.1007/s10549-011-1854-y [doi]
    Kuhn, M. W., Hadler, M. J., Daigle, S. R., Koche, R. P., Krivtsov, A. V., Olhava, E. J., . . . Armstrong, S. A. (2015)., MLL partial tandem duplication leukemia cells are sensitive to small molecule DOT1L inhibition., Haematologica, 100(5), e190-3. doi:10.3324/haematol.2014.115337 [doi]
    Kazmierczak, P. M., Burian, E., Eschbach, R., Hirner-Eppeneder, H., Moser, M., Havla, L., . . . Cyran, C. C. (2015)., Monitoring cell death in regorafenib-treated experimental colon carcinomas using annexin-based optical fluorescence imaging validated by perfusion MRI., PloS One, 10(9), e0138452. doi:10.1371/journal.pone.0138452 [doi]
    Bechet, D., Auger, F., Couleaud, P., Marty, E., Ravasi, L., Durieux, N., . . . Barberi-Heyob, M. (2015)., Multifunctional ultrasmall nanoplatforms for vascular-targeted interstitial photodynamic therapy of brain tumors guided by real-time MRI., Nanomedicine : Nanotechnology, Biology, and Medicine, 11(3), 657-670. doi:10.1016/j.nano.2014.12.007 [doi]
    Li C, Xu X, McMahon N, Alhaj Ibrahim O, Sattar HA, Tichauer KM., Paired-Agent Fluorescence Molecular Imaging of Sentinel Lymph Nodes Using Indocyanine Green as a Control Agent for Antibody-Based Targeted Agents, Contrast Media Mol Imaging. 2019 Jan 3;2019:7561862.
    Cyran, C. C., Sennino, B., Fu, Y., Rogut, V., Shames, D. M., Chaopathomkul, B., . . . Raatschen, H. J. (2012)., Permeability to macromolecular contrast media quantified by dynamic MRI correlates with tumor tissue assays of vascular endothelial growth factor (VEGF)., European Journal of Radiology, 81(5), 891-896. doi:10.1016/j.ejrad.2011.07.016 [doi]
    Isal, S., Pierson, J., Imbert, L., Clement, A., Collet, C., Pinel, S., . . . Maskali, F. (2018)., PET imaging of (68)ga-NODAGA-RGD, as compared with (18)F-fluorodeoxyglucose, in experimental rodent models of engrafted glioblastoma., EJNMMI Research, 8(1), 51-018-0405-5. doi:10.1186/s13550-018-0405-5 [doi]
    Buck, J. R., McKinley, E. T., Fu, A., Abel, T. W., Thompson, R. C., Chambless, L., . . . Manning, H. C. (2015)., Preclinical TSPO ligand PET to visualize human glioma xenotransplants: A preliminary study., PloS One, 10(10), e0141659. doi:10.1371/journal.pone.0141659 [doi]
    Hardisty, M. R., Akens, M. K., Hojjat, S. P., Yee, A., & Whyne, C. M. (2012)., Quantification of the effect of osteolytic metastases on bone strain within whole vertebrae using image registration., Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society, 30(7), 1032-1039. doi:10.1002/jor.22045 [doi]
    Li, L., Zhu, L., Ma, C., Lin, L., Yao, J., Wang, L., . . . Wang, L. V. (2017)., Single-impulse panoramic photoacoustic computed tomography of small-animal whole-body dynamics at high spatiotemporal resolution., Nature Biomedical Engineering, 1(5), 10.1038/s41551-017-0071. Epub 2017 May 10. doi:0071 [pii]
    Shariati M, Lollo G, Matha K, Descamps B, Vanhove C, Van de Sande L, Willaert W, Balcaen L, Vanhaecke F, Benoit JP, Ceelen W, De Smedt SC, Remaut K., Synergy between Intraperitoneal Aerosolization (PIPAC) and Cancer Nanomedicine: Cisplatin-Loaded Polyarginine-Hyaluronic Acid Nanocarriers Efficiently Eradicate Peritoneal Metastasis of Advanced Human Ovarian Cancer, ACS Appl Mater Interfaces. 2020 Jul 1;12(26):29024-29036. doi: 10.1021/acsami.0c05554. Epub 2020 Jun 22.
    Karp NA, Wilson Z, Stalker E, Mooney L, Lazic SE, Zhang B, Hardaker E., A multi-batch design to deliver robust estimates of efficacy and reduce animal use - a syngeneic tumour case study, Sci Rep. 2020 Apr 10;10(1):6178. doi: 10.1038/s41598-020-62509-7.
    Forte, B. L., Slosky, L. M., Zhang, H., Arnold, M. R., Staatz, W. D., Hay, M., . . . Vanderah, T. W. (2016)., Angiotensin-(1-7)/Mas receptor as an antinociceptive agent in cancer-induced bone pain., Pain, 157(12), 2709-2721. doi:10.1097/j.pain.0000000000000690 [doi]
    Bonavita E, Bromley CP, Jonsson G, Pelly VS, Sahoo S, Walwyn-Brown K, Mensurado S, Moeini A, Flanagan E, Bell CR, Chiang SC, Chikkanna-Gowda CP, Rogers N, Silva-Santos B, Jaillon S, Mantovani A, Reis E Sousa C, Guerra N, Davis DM, Zelenay S., Antagonistic Inflammatory Phenotypes Dictate Tumor Fate and Response to Immune Checkpoint Blockade, Immunity. 2020 Dec 15;53(6):1215-1229.e8. doi: 10.1016/j.immuni.2020.10.020. Epub 2020 Nov 20.
    Nuñez-Rivera A, Fournier PGJ, Arellano DL, Rodriguez-Hernandez AG, Vazquez-Duhalt R, Cadena-Nava RD., Brome mosaic virus-like particles as siRNA nanocarriers for biomedical purposes, Beilstein J Nanotechnol. 2020 Feb 20;11:372-382. doi: 10.3762/bjnano.11.28. eCollection 2020.
    Arroyo-Crespo, Juan J; Armiñán, Ana; Charbonnier, David; Deladriere, Coralie; Palomino-Schätzlein, Martina; Lamas-Domingo, Rubén; Forteza, Jerónimo; Pineda-Lucena, Antonio; Vicent, María J, Characterization of triple-negative breast cancer preclinical models provides functional evidence of metastatic progression., International journal of cancer Vol.145, 2019
    Teijeira Á, Garasa S, Gato M, Alfaro C, Migueliz I, Cirella A, de Andrea C, Ochoa MC, Otano I, Etxeberria I, Andueza MP, Nieto CP, Resano L, Azpilikueta A, Allegretti M, de Pizzol M, Ponz-Sarvisé M, Rouzaut A, Sanmamed MF, Schalper K, Carleton M, Mellado M, Rodriguez-Ruiz ME, Berraondo P, Perez-Gracia JL, Melero I., CXCR1 and CXCR2 Chemokine Receptor Agonists Produced by Tumors Induce Neutrophil Extracellular Traps that Interfere with Immune Cytotoxicity, Immunity. 2020 May 19;52(5):856-871.e8. doi: 10.1016/j.immuni.2020.03.001. Epub 2020 Apr 13.
    Falvo P, Orecchioni S, Hillje R, Raveane A, Mancuso P, Camisaschi C, Luzi L, Pelicci P, Bertolini F., Cyclophosphamide and vinorelbine activate stem-like CD8+ T cells and improve anti-PD-1 efficacy in triple-negative breast cancer, Cancer Res. 2020 Dec 2:canres.1818.2020. doi: 10.1158/0008-5472.CAN-20-1818. Online ahead of print.
    Shamni, Ofer; Grievink, Hilbert; Itamar, Batel; Mishani, Eyal; Abourbeh, Galith;, Development of a Fluorinated Analogue of Erlotinib for PET Imaging of EGFR Mutation-Positive NSCLC, Molecular imaging and biology Vol.21, 2019
    Suurs FV, Qiu SQ, Yim JJ, Schröder CP, Timmer-Bosscha H, Bensen ES, Santini JT Jr, de Vries EGE, Bogyo M, van Dam GM., Fluorescent image-guided surgery in breast cancer by intravenous application of a quenched fluorescence activity-based probe for cysteine cathepsins in a syngeneic mouse model, EJNMMI Res. 2020 Sep 29;10(1):111. doi: 10.1186/s13550-020-00688-0.
    Rivera-Huerta, M., Lizarraga-Grimes, V. L., Castro-Torres, I. G., Tinoco-Mendez, M., Macias-Rosales, L., Sanchez-Bartez, F., . . . Gracia-Mora, M. I. (2017)., Functional effects of prebiotic fructans in colon cancer and calcium metabolism in animal models., BioMed Research International, 2017, 9758982. doi:10.1155/2017/9758982 [doi]
    Sanchez-Gonzalez, B., Garcia-Vazquez, F. J., Farfan-Morales, J. E., & Jimenez-Zamudio, L. A. (2015)., Increased NHC cells in the peritoneal cavity of plasmacytoma susceptible BALB/c mouse., Mediators of Inflammation, 2015, 313140. doi:10.1155/2015/313140 [doi]
    Kranjc Brezar S, Mrak V, Bosnjak M, Savarin M, Sersa G, Cemazar M., Intratumoral Gene Electrotransfer of Plasmid DNA Encoding shRNA against Melanoma Cell Adhesion Molecule Radiosensitizes Tumors by Antivascular Effects and Activation of an Immune Response, Vaccines (Basel). 2020 Mar 19;8(1):135. doi: 10.3390/vaccines8010135.
    Alessandri, Giulio; Coccè, Valentina; Pastorino, Fabio; Paroni, Rita; Dei Cas, Michele; Restelli, Francesco; Pollo, Bianca; Gatti, Laura; Tremolada, Carlo; Berenzi, Angiola; Parati, Eugenio; Brini, Anna Teresa; Bondiolotti, Gianpietro; Ponzoni, Mirco; Pessina, Augusto, Microfragmented human fat tissue is a natural scaffold for drug delivery: Potential application in cancer chemotherapy., Journal of controlled release : official journal of the Controlled Release Society Vol.302, 2019
    Bach-Griera M, Campo-Pérez V, Barbosa S, Traserra S, Guallar-Garrido S, Moya-Andérico L, Herrero-Abadía P, Luquin M, Rabanal RM, Torrents E, Julián E., Mycolicibacterium brumae Is a Safe and Non-Toxic Immunomodulatory Agent for Cancer Treatment, Vaccines (Basel). 2020 Apr 25;8(2):198. doi: 10.3390/vaccines8020198.
    Raineri D, Dianzani C, Cappellano G, Maione F, Baldanzi G, Iacobucci I, Clemente N, Baldone G, Boggio E, Gigliotti CL, Boldorini R, Rojo JM, Monti M, Birolo L, Dianzani U, Chiocchetti A., Osteopontin binds ICOSL promoting tumor metastasis, Commun Biol. 2020 Oct 26;3(1):615. doi: 10.1038/s42003-020-01333-1.
    Di Tano M, Raucci F, Vernieri C, Caffa I, Buono R, Fanti M, Brandhorst S, Curigliano G, Nencioni A, de Braud F, Longo VD., Synergistic effect of fasting-mimicking diet and vitamin C against KRAS mutated cancers, Nat Commun. 2020 May 11;11(1):2332. doi: 10.1038/s41467-020-16243-3.
    Pfitzer, Lisa; Moser, Christina; Gegenfurtner, Florian; Arner, Anja; Foerster, Florian; Atzberger, Carina; Zisis, Themistoklis; Kubisch-Dohmen, Rebekka; Busse, Johanna; Smith, Rebecca, Targeting actin inhibits repair of doxorubicin-induced DNA damage: a novel therapeutic approach for combination therapy., Cell death & disease Vol.10, 2019
    Drescher F, Juárez P, Arellano DL, Serafín-Higuera N, Olvera-Rodriguez F, Jiménez S, Licea-Navarro AF, Fournier PG., TIE2 Induces Breast Cancer Cell Dormancy and Inhibits the Development of Osteolytic Bone Metastases, Cancers (Basel). 2020 Apr 3;12(4):868. doi: 10.3390/cancers12040868.
    Nguyen, O. N., Grimm, C., Schneider, L. S., Chao, Y. K., Atzberger, C., Bartel, K., . . . Vollmar, A. M. (2017), Two-pore channel function is crucial for the migration of invasive cancer cells., Cancer Research, 77(6), 1427-1438. doi:10.1158/0008-5472.CAN-16-0852 [doi]
    Allen KL, Cann J, Zhao W, Peterson N, Lazzaro M, Zhong H, Wu H, Dall'Acqua WF, Borrok MJ, Damschroder MM, Tsui P, Li Q., Upregulation of annexin A1 protein expression in the intratumoral vasculature of human non-small-cell lung carcinoma and rodent tumor models, PLoS One. 2020 Jun 4;15(6):e0234268. doi: 10.1371/journal.pone.0234268. eCollection 2020.
    Cheng, K. W., Wong, C. C., Alston, N., Mackenzie, G. G., Huang, L., Ouyang, N., . . . Rigas, B. (2013)., Aerosol administration of phospho-sulindac inhibits lung tumorigenesis., Molecular Cancer Therapeutics, 12(8), 1417-1428. doi:10.1158/1535-7163.MCT-13-0006-T [doi]
    Muscella, A., Vetrugno, C., Migoni, D., Biagioni, F., Fanizzi, F. P., Fornai, F., . . . Marsigliante, S. (2014)., Antitumor activity of [pt(O,O'-acac)(gamma-acac)(DMS)] in mouse xenograft model of breast cancer., Cell Death & Disease, 5, e1014. doi:10.1038/cddis.2013.554 [doi]
    Mertens-Talcott, S. U., Noratto, G. D., Li, X., Angel-Morales, G., Bertoldi, M. C., & Safe, S. (2013)., Betulinic acid decreases ER-negative breast cancer cell growth in vitro and in vivo: Role of sp transcription factors and microRNA-27a:ZBTB10., Molecular Carcinogenesis, 52(8), 591-602. doi:10.1002/mc.21893 [doi]
    Johnson, T. J., Hoti, N., Liu, C., Chowdhury, W. H., Li, Y., Zhang, Y., . . . Rodriguez, R. (2013)., Bicalutamide-activated oncolytic adenovirus for the adjuvant therapy of high-risk prostate cancer., Cancer Gene Therapy, 20(7), 394-402. doi:10.1038/cgt.2013.34 [doi]
    Accardo, A., Mansi, R., Salzano, G., Morisco, A., Aurilio, M., Parisi, A., . . . Morelli, G. (2012)., Bombesin peptide antagonist for target-selective delivery of liposomal doxorubicin on cancer cells., Journal of Drug Targeting, doi:10.3109/1061186X.2012.741138 [doi]
    Tuscano, J. M., Kato, J., Pearson, D., Xiong, C., Newell, L., Ma, Y., . . . O'Donnell, R. T. (2012)., CD22 antigen is broadly expressed on lung cancer cells and is a target for antibody-based therapy., Cancer Research, 72(21), 5556-5565. doi:10.1158/0008-5472.CAN-12-0173 [doi]
    Schmid, D., Fay, F., Small, D. M., Jaworski, J., Riley, J. S., Tegazzini, D., . . . Scott, C. J. (2014)., Efficient drug delivery and induction of apoptosis in colorectal tumors using a death receptor 5-targeted nanomedicine., Molecular Therapy : The Journal of the American Society of Gene Therapy, 22(12), 2083-2092. doi:10.1038/mt.2014.137 [doi]
    Tome-Amat, J., Olombrada, M., Ruiz-de-la-Herran, J., Perez-Gomez, E., Andradas, C., Sanchez, C., . . . Lacadena, J. (2015)., Efficient in vivo antitumor effect of an immunotoxin based on ribotoxin alpha-sarcin in nude mice bearing human colorectal cancer xenografts., Springerplus, 4, 168-015-0943-5. eCollection 2015. doi:10.1186/s40064-015-0943-5 [doi]
    Gundala, S. R., Mukkavilli, R., Yang, C., Yadav, P., Tandon, V., Vangala, S., . . . Aneja, R. (2014)., Enterohepatic recirculation of bioactive ginger phytochemicals is associated with enhanced tumor growth-inhibitory activity of ginger extract., Carcinogenesis, 35(6), 1320-1329. doi:10.1093/carcin/bgu011 [doi]
    Chen, C., Constantinou, A., Chester, K. A., Vyas, B., Canis, K., Haslam, S. M., . . . Deonarain, M. P. (2012)., Glycoengineering approach to half-life extension of recombinant biotherapeutics., Bioconjugate Chemistry, 23(8), 1524-1533. doi:10.1021/bc200624a [doi]
    Gundala, S. R., Yang, C., Mukkavilli, R., Paranjpe, R., Brahmbhatt, M., Pannu, V., . . . Aneja, R. (2014)., Hydroxychavicol, a betel leaf component, inhibits prostate cancer through ROS-driven DNA damage and apoptosis., Toxicology and Applied Pharmacology, 280(1), 86-96. doi:10.1016/j.taap.2014.07.012 [doi]
    Cho, E. J., Sun, B., Doh, K. O., Wilson, E. M., Torregrosa-Allen, S., Elzey, B. D., & Yeo, Y. (2015)., Intraperitoneal delivery of platinum with in-situ crosslinkable hyaluronic acid gel for local therapy of ovarian cancer., Biomaterials, 37, 312-319. doi:10.1016/j.biomaterials.2014.10.039 [doi]
    Ganapathy, S., Xiao, S., Seo, S. J., Lall, R., Yang, M., Xu, T., . . . Yuan, Z. M. (2014)., Low-dose arsenic induces chemotherapy protection via p53/NF-kappaB-mediated metabolic regulation., Oncogene, 33(11), 1359-1366. doi:10.1038/onc.2013.81 [doi]
    Banerjee, N., Kim, H., Krenek, K., Talcott, S. T., & Mertens-Talcott, S. U. (2015)., Mango polyphenolics suppressed tumor growth in breast cancer xenografts in mice: Role of the PI3K/AKT pathway and associated microRNAs., Nutrition Research (New York, N.Y.), 35(8), 744-751. doi:10.1016/j.nutres.2015.06.002 [doi]
    Bofill-De Ros, X., Gironella, M., & Fillat, C. (2014)., miR-148a- and miR-216a-regulated oncolytic adenoviruses targeting pancreatic tumors attenuate tissue damage without perturbation of miRNA activity., Molecular Therapy : The Journal of the American Society of Gene Therapy, 22(9), 1665-1677. doi:10.1038/mt.2014.98 [doi]
    Wong, H. H., Jiang, G., Gangeswaran, R., Wang, P., Wang, J., Yuan, M., . . . Wang, Y. (2012)., Modification of the early gene enhancer-promoter improves the oncolytic potency of adenovirus 11., Molecular Therapy : The Journal of the American Society of Gene Therapy, 20(2), 306-316. doi:10.1038/mt.2011.242 [doi]
    Mu, Z., Ma, C. M., Chen, X., Cvetkovic, D., Pollack, A., & Chen, L. (2012)., MR-guided pulsed high intensity focused ultrasound enhancement of docetaxel combined with radiotherapy for prostate cancer treatment., Physics in Medicine and Biology, 57(2), 535-545. doi:10.1088/0031-9155/57/2/535 [doi]
    Wang, C. Z., Zhang, Z., Anderson, S., & Yuan, C. S. (2014)., Natural products and chemotherapeutic agents on cancer: Prevention vs. treatment., The American Journal of Chinese Medicine, 42(6), 1555-1558. doi:10.1142/S0192415X1420002X [doi]
    Accardo, A., Salsano, G., Morisco, A., Aurilio, M., Parisi, A., Maione, F., . . . Morelli, G. (2012)., Peptide-modified liposomes for selective targeting of bombesin receptors overexpressed by cancer cells: A potential theranostic agent., International Journal of Nanomedicine, 7, 2007-2017. doi:10.2147/IJN.S29242 [doi]
    Gundala, S. R., Yang, C., Lakshminarayana, N., Asif, G., Gupta, M. V., Shamsi, S., & Aneja, R. (2013)., Polar biophenolics in sweet potato greens extract synergize to inhibit prostate cancer cell proliferation and in vivo tumor growth., Carcinogenesis, 34(9), 2039-2049. doi:10.1093/carcin/bgt141 [doi]
    Wang, C. Z., Zhang, Z., Wan, J. Y., Zhang, C. F., Anderson, S., He, X., . . . Yuan, C. S. (2015)., Protopanaxadiol, an active ginseng metabolite, significantly enhances the effects of fluorouracil on colon cancer., Nutrients, 7(2), 799-814. doi:10.3390/nu7020799 [doi]
    Xu, W., Liu, L., Brown, N. J., Christian, S., & Hornby, D. (2012)., Quantum dot-conjugated anti-GRP78 scFv inhibits cancer growth in mice., Molecules (Basel, Switzerland), 17(1), 796-808. doi:10.3390/molecules17010796 [doi]
    Saelen, M. G., Ree, A. H., Kristian, A., Fleten, K. G., Furre, T., Hektoen, H. H., & Flatmark, K. (2012)., Radiosensitization by the histone deacetylase inhibitor vorinostat under hypoxia and with capecitabine in experimental colorectal carcinoma., Radiation Oncology (London, England), 7, 165-717X-7-165. doi:10.1186/1748-717X-7-165 [doi]
    Pozzi, V., Sartini, D., Morganti, S., Giuliante, R., Di Ruscio, G., Santarelli, A., . . . Emanuelli, M. (2013)., RNA-mediated gene silencing of nicotinamide N-methyltransferase is associated with decreased tumorigenicity in human oral carcinoma cells., PloS One, 8(8), e71272. doi:10.1371/journal.pone.0071272 [doi]
    Fokas, E., Prevo, R., Pollard, J. R., Reaper, P. M., Charlton, P. A., Cornelissen, B., . . . Brunner, T. B. (2012)., Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation., Cell Death & Disease, 3, e441. doi:10.1038/cddis.2012.181 [doi]
    Jin, H. R., Zhao, J., Zhang, Z., Liao, Y., Wang, C. Z., Huang, W. H., . . . Du, W. (2012)., The antitumor natural compound falcarindiol promotes cancer cell death by inducing endoplasmic reticulum stress., Cell Death & Disease, 3, e376. doi:10.1038/cddis.2012.122 [doi]
    Solodeev, I., Zahalka, M. A., & Moroz, C. (2014)., The novel C24D synthetic polypeptide inhibits binding of placenta immunosuppressive ferritin to human T cells and elicits anti-breast cancer immunity in vitro and in vivo., Neoplasia (New York, N.Y.), 16(9), 741-750. doi:10.1016/j.neo.2014.08.005 [doi]
    Zhou, H., Ekmekcioglu, S., Marks, J. W., Mohamedali, K. A., Asrani, K., Phillips, K. K., . . . Rosenblum, M. G. (2013)., The TWEAK receptor Fn14 is a therapeutic target in melanoma: Immunotoxins targeting Fn14 receptor for malignant melanoma treatment., The Journal of Investigative Dermatology, 133(4), 1052-1062. doi:10.1038/jid.2012.402 [doi]